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Abstract
In educational contexts, students often self-select into specific interventions (e.g.,
courses, majors, extracurricular programming). When students self-select into an
intervention, systematic group differences may impact the validity of inferences made
regarding the effect of the intervention. Propensity score methods are commonly used to
reduce selection bias in estimates of treatment effects. In educational contexts, often a
larger number of students receive a treatment than not. However, recommendations
regarding the application of propensity score methods when the treatment group is larger
than the comparison group have not been empirically examined. The current study
examined the recommendation to recode the treatment and comparison groups (i.e., two
types of treatment effect coding; Ho et al., 2007).
A simulation study was conducted to examine the performance of three
propensity score methods (nearest neighbor matching, nearest neighbor matching with a
0.20 SD caliper, and generalized boosted modeling), using two coding methods (ATT and
ATC) when the treatment group was larger than the comparison group. Additionally,
three treatment sample sizes (200, 600, 1,000), three treatment to comparison group ratios
(2:1, 4:3, 1:4), and four true treatment effects (Cohen’s d of 0, 0.20, 0.50, 0.80) were
simulated.
For nearest neighbor matching with a 0.20 SD caliper, adequate group covariate
balance and low bias in the estimated treatment effect were observed across both coding
methods regardless of which group was larger. In contrast, for generalized boosted
modeling and nearest neighbor matching, group covariate balance and bias in the
estimated treatment effect differed across coding method. When the treatment group was

x

larger than the comparison group, ATC coding resulted in better group covariate balance
and lower bias than ATT coding. However, ideal balance was not obtained on all
covariates, and bias in the estimated treatment effect was high for generalized boosted
modeling and nearest neighbor matching. In sum, when the treatment group was larger
than the comparison group, coding method did not matter for nearest neighbor matching
with a 0.20 SD caliper. Conversely, for generalized boosted modeling, ATC coding
performed better than ATT coding. Nearest neighbor matching did not perform well
regardless of coding method.

xi
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CHAPTER 1
Introduction
Although random assignment is often considered the gold standard when
designing studies from which causal inferences are drawn, there are circumstances under
which random assignment to groups is not justified (e.g., Austin, 2011; Shadish et al.,
2002). Consider the assessment specialist at a university who wishes to understand the
effectiveness of general education writing courses on student learning. If desiring the
ideal research design for making causal inferences about course effectiveness, students
would be randomly assigned across general education writing courses (e.g., Shadish et
al., 2002). However, realistically, it is typically not feasible to randomly assign students
to a particular class.
When students cannot be randomly assigned to classes, there may be systematic
differences between students who choose one class over another. Perhaps students who
have stronger writing skills choose a more difficult writing course than students who
have weaker writing skills. Students who completed the more difficult writing class may
have higher scores on an end-of-the-semester test of general education writing skills than
students who completed another class, simply because the students who enroll in those
classes may have stronger writing skills. Thus, the inference regarding the effect of
taking one course over another may be biased due to self-selection into a particular class.
Causal Inferences
When group comparisons are made between those who have and have not
received an intervention, researchers are often interested in making a causal claim about
the effectiveness of that intervention. That is, if students who completed a general
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education writing course scored higher on a writing prompt than students who did not
complete a general education writing course, the general education faculty would be
likely to claim that the curriculum of the writing course resulted in increased writing
ability. Thus, the causal claim would be that the writing course increased students’
writing ability.
To understand the causal effect of a treatment for a single individual, the outcome
when treatment is implemented and when treatment is not implemented must be known
(e.g., Rubin’s Causal Model, potential outcomes framework; Rubin, 1974). An
approximation of the counterfactual, or what the outcome would have been for an
individual under both treatment conditions, is necessary for making causal claims
(Shadish et al., 2002). However, the counterfactual is unobservable at the individual level
(because an individual cannot both receive and not receive treatment); instead, groups of
individuals exposed (or not exposed) to treatment can be compared on the outcome of
interest (Rubin, 1974; Shadish et al., 2002; Wainer, 2016). Thus, the treatment effect is
the difference between the outcome when treatment is received and not received across
all individuals (Rubin, 1974; Wainer, 2016).
Random assignment to groups is essential for approximating the counterfactual
(Rubin, 1974). When random assignment is employed, the treatment and comparison
groups should not differ systematically. The groups are expected to be balanced on both
known and unknown variables, thus there are no variables that are related to treatment
selection (Pedhazur & Schmelkin, 1991b; Rubin, 1974). When random assignment is not
feasible, groups may systematically differ on known and unknown variables related to
treatment selection. Specifically, when individuals self-select or are not randomly
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assigned to receive or not receive a treatment, there are likely to be variables related to
self-selection. Systematic group differences due to self-selected or non-random
participation threaten the internal validity of the inferences that are drawn regarding the
treatment effect (Shadish et al., 2002).
Internal Validity
Internal validity refers to whether the observed relation between treatment and
outcome can be deemed causal as a result of study design (Shadish et al., 2002). That is,
can an observed effect be attributed to the treatment that was implemented given the
study design? Or, are there factors or confounds related to the treatment that could have
led to the observed effect? When random assignment to treatment is not feasible,
selection bias is a threat to the validity of the causal claims that can be made regarding
the effect of receiving treatment.
In non-randomized (quasi-experimental) studies, the estimated treatment effect
could appear to be stronger or weaker than it is in the population due to the systematic
group differences on variables related to treatment selection (Rosenbaum & Rubin,
1983b; Rubin, 1973a, 1973b). However, when random assignment is not feasible, there
are statistical methods that can be employed to reduce systematic differences between the
groups, thus approximating random assignment to groups. By reducing systematic
differences across the treatment and comparison groups, the researcher can reduce the
impact of selection bias on the estimated treatment effect (Austin, 2011; Cochran &
Rubin, 1973; Rosenbaum & Rubin, 1983b; Rubin, 1973a, 1973b, 1974; Shadish et al.,
2008). Propensity score methods are commonly used to balance treatment and
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comparison groups on covariates to reduce systematic group differences (e.g., Austin,
2011, 2013; Bai, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010).
Propensity Score Methods
Propensity score methods are one way to reduce systematic group differences,
thus reducing bias in the estimated treatment effect (Austin, 2011; Caliendo & Kopeinig,
2008; Rosenbaum & Rubin, 1983b, 1985; Stuart, 2010; Stuart & Rubin, 2008).
Propensity for treatment is estimated (typically via logistic regression) from variables that
relate to treatment selection, the outcome, or both treatment selection and the outcome
(i.e., confounders; Austin, 2011; Bai, 2011; Caliendo & Kopeinig, 2008; Rosenbaum &
Rubin, 1985). After propensity scores are estimated, they can be used to match
comparison group members to similar treatment group members, or to weight individuals
based on their propensity score (Austin, 2009, 2011; Caliendo & Kopeinig, 2008;
Rosenbaum & Rubin, 1983b, 1985; Stuart, 2010). When groups are balanced on all
confounding covariates, selection bias is no longer present in the estimated treatment
effect (Rubin, 1973a, 1973b).
When matching on the propensity score, there are various matching algorithms
that can be used. With nearest neighbor matching (a greedy algorithm), a comparison
group member is matched to a treatment group member with the closest propensity score
value (Austin, 2011; Caliendo & Kopeinig, 2008; Rosenbaum & Rubin, 1983b, 1985;
Stuart, 2010). Using this method, all treatment group members receive a match from the
comparison pool. Nearest neighbor matching can also be implemented with a distance
caliper. When a caliper is specified, the researcher defines the maximum difference on
the propensity score that is allowable for a comparison group member to be matched to a
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treatment group member (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010). A
typical caliper that is used is 0.20 standard deviations of the logit of the propensity score
(Austin, 2009). When nearest neighbor matching is employed with a caliper, there is the
potential for some treatment group members to not receive a match from the comparison
pool (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010).
Propensity score methods work well to create balanced groups when certain key
assumptions are not violated (Austin, 2011; Caliendo & Kopeinig, 2008; Ho et al., 2007).
The first crucial assumption is that of strong ignorability (or no unmeasured
confounders). The strong ignorability assumption means that conditional on the
covariates, treatment assignment is not related to the outcome (Rosenbaum & Rubin,
1983a; Stuart, 2010). Thus, if all sources of selection bias are included in the estimation
of the propensity score, treatment assignment should not be related to the outcome. The
second crucial assumption is that of common support (or sufficient overlap of propensity
scores across treatment and comparison groups). Common support refers to the degree to
which the propensity score distributions of each group overlap (Guo & Fraser, 2015).
Sufficient overlap between groups is necessary for obtaining adequately balanced
matched treatment and comparison groups. In contrast, if there is little overlap between
the propensity score distributions of the groups, then obtaining good comparison pool
matches for the treatment group members will be difficult. The third crucial assumption
is that of stable unit treatment value. Stable unit treatment value refers to independence
between the treatment of one individual and another individual (and thus, independence
between the outcome of individuals; Stuart, 2010). In order to estimate the effect of the
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treatment, comparison group members should receive no treatment and all treatment
members should receive the intended degree of treatment.
The goal of propensity score matching is to construct a comparison group that
does not systematically differ from the treatment group on variables related to treatment
selection. Thus, in order to attain a match for every treatment group member, it is
beneficial to have a comparison group that is larger than the treatment group (Pan & Bai,
2015; Rosenbaum & Rubin, 1985; Rubin, 1979; Stuart, 2010; Stuart & Rubin, 2008).
However, there may be situations in which the number of individuals who receive
treatment is greater than the number of individuals in the comparison pool. For example,
in higher education, it is desirable that all students complete general education courses.
That is, all students should receive an intervention aimed at increasing their general
education knowledge, skills, and abilities. If educational researchers are interested in
comparing learning outcomes of students who have and have not completed coursework,
it is possible that they might face a scenario in which there will be a larger number of
students who received treatment than who did not. A larger treatment than comparison
group might also be obtained if the desire is to compare learning outcomes across
students who completed different general education courses within the same domain.
More research is needed regarding the use of propensity score methods to reduce
selection bias when there are more treatment group members than comparison group
members.
In the quasi-experimental literature, propensity score methods have been used
with a larger treatment than comparison group; to compare two labor success programs
(Lechner, 2000), to compare results obtained with different comparison to treatment
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group ratios (Holzman & Horst, 2019), to compare survival rates of those who did and
did not receive a smoking-cessation intervention (Austin & Cafri, 2020), to compare
results obtained from different matching and coding methods (Perkins & Horst, 2020),
and to compare math performance of students who completed traditional or new math
curricula (Powell et al., 2020). Additionally, some guidance regarding how to implement
propensity score methods when the treatment is larger than the comparison group has
been provided; however, the recommendations lack empirical support (Ho et al., 2007;
Stuart, 2010). These recommendations include using subclassification, full matching,
weighting by the odds (Stuart, 2010), matching with replacement, or switching the coding
of the treatment and comparison group (Ho et al., 2007).
Current Study
The aim of the current study was to examine how well propensity score methods
reduce systematic differences between groups when the treatment group is larger than the
comparison group. Although methods for addressing a larger treatment than comparison
group have been suggested in the literature, there is little evidence to support those
suggestions. Thus, it is important to understand whether propensity score methods result
in adequate balance between the treatment and comparison groups and accurate estimates
of the treatment effect when the treatment group is larger than the comparison group. The
aim of the current study was to examine bias in the estimated treatment effect, covariate
balance after matching or weighting, loss of treatment group members, and the direction
and magnitude of the estimated treatment effect across different propensity score
methods. Therefore, a simulation study was used in order to specify the true treatment
effect and examine the research questions under varying conditions (Feinberg &
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Rubright, 2016). Given the lack of research on the use of propensity score methods when
the treatment group is larger than the comparison group, three propensity score methods
(i.e., nearest neighbor matching, nearest neighbor matching with a caliper, and
generalized boosted modeling) were evaluated across different coding methods, treatment
to comparison group ratios, treatment sample sizes, and true treatment effect sizes. The
following research questions were specified:
Research Question 1a: When the Treatment Group is Larger Than the Comparison
Group, Can Propensity Score Methods Accurately Recover the True Treatment Effect?
The first research question was crucial for providing guidance regarding the use
of propensity score methods when the treatment group is larger than the comparison
group. The goal of propensity score methods is to reduce bias in the estimated treatment
effect that is due to systematic differences between the groups on confounding variables
(Austin, 2011, 2013; Bai, 2011; Caliendo & Kopeinig, 2008; Rosenbaum & Rubin,
1983b, 1985). Thus, information regarding the accuracy of propensity score methods
under various conditions when the treatment group is larger than the comparison group
can provide guidance to researchers.
Research Question 1b: Does the Magnitude and Direction of the Estimated Treatment
Effect Differ Across Propensity Score Methods Depending on Group Coding?
The first research question also pertained to whether the magnitude and direction
of the estimated treatment effect differed depending on the whether the treatment group
was coded 1 or 0. In typical applications of propensity score methods, the treatment
group is coded 1 and the comparison group is coded 0. This coding aligns with the
estimation of the average treatment effect for the treated (ATT). One recommendation
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when the treatment group is larger than the comparison group is to switch the coding of
the treatment and comparison groups. In doing so, the comparison group will be coded 1
and the treatment group coded 0. When the coding is reversed, a treatment group member
match is selected for each comparison group member, with the goal of creating a
treatment group that is similar to the comparison group on the covariates. This coding
aligns with the estimation of the average treatment effect for the comparison group
(ATC). In other words, ATC coding answers a different research question than ATT
coding. There is little explanation of the ATC in the propensity score literature.
Examination of the magnitude and direction of the treatment effect for the same
propensity score method across different coding methods will expand the current
understanding of the ATC.
Research Question 2: When the Treatment Group is Larger Than the Comparison
Group, Can Propensity Score Methods Achieve Adequate Group Balance on the
Covariates?
The second research question examined the extent to which balanced groups
could be created when there is a comparison pool that is smaller than the treatment group.
Adequate group balance on the covariates after matching or weighting indicates that
selection bias due to the included covariates has been reduced or removed from the
estimated treatment effect (Ho et al., 2007). Thus, the validity of the inferences made
regarding an observed treatment effect is strengthened. Inadequate group balance after
matching or weighting on the covariates indicates that the groups systematically differ
and estimation of the treatment effect from the matched or weighted sample is not
appropriate (Ho et al., 2007). Examination of group balance on the covariates after
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matching or weighting will provide information regarding the quality of the matched or
weighted samples.
Research Question 3: When the Treatment Group is Larger Than the Comparison
Group, Does the Loss of Treatment Group Members for Nearest Neighbor Matching
With a Caliper Differ Across Coding Methods, Treatment to Comparison Ratios, and
Treatment Sample Sizes?
When the treatment group is larger than the comparison group and one-to-one
matching is implemented, there will be treatment members who do not receive a match.
Specifically, the number of treatment group members who receive a match can, at a
maximum, equal the number of comparison group members. When nearest neighbor
matching is used with a caliper, there can be a larger loss of treatment group members if
there is no comparison group match within the specified caliper distance. Loss of
treatment group members is undesirable because it leads to a loss of treatment
representation and a decrease in the matched sample size (Jacovidis et al., 2017).
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CHAPTER 2
Review of the Literature
Within educational research, random assignment of students to groups (e.g.,
courses, remediation programs, majors) is often outside of the researcher’s control. When
random assignment to groups is not feasible, there are statistical methods that can be
employed to reduce systematic group differences. Throughout the quasi-experimental
literature, covariate adjustment (e.g., Cochran, 1953; Cochran & Rubin, 1973; Lord,
1960; Pascarella et al., 2013; Pedhazur & Schmelkin, 1991a; Rubin, 1973b, 1974, 1979),
stratification (Austin, 2011; Maxwell & Delaney, 2004; Rosenbaum & Rubin, 1983b;
Stuart, 2010), matching (Rubin, 1973a, 1973b, 1979), and propensity score matching
(Austin, 2011, 2013; Bai, 2011; Caliendo & Kopeinig, 2008; Rosenbaum & Rubin,
1983b, 1985) are among the most frequently used methods for reducing systematic group
differences when random assignment is not feasible. The goal of these methods is to
control for variables that relate to group selection, thus reducing systematic differences
between the groups.
In this chapter, I review the literature on four common quasi-experimental
methods that are used to reduce systematic group differences (covariate adjustment,
stratification, matching, and propensity score matching). Next, I provide an in-depth
description of the steps involved in propensity score matching. I then explain generalized
boosted modeling (an extension of propensity score methods). Finally, I review the
limited literature on propensity score matching when the treatment group is larger than
the comparison group.
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Covariate Adjustment
Researchers refer to covariate adjustment by different names throughout the
literature (e.g., analysis of covariance [ANCOVA], regression adjustment for background
variables). In the traditional ANCOVA approach, group differences are estimated on a
continuous outcome variable after controlling for covariates that are included in the
model. Instead of estimating raw group mean differences on the outcome variable, the
researcher is now examining differences in the group means of the outcome variable that
have been adjusted based on how each groups’ means on the covariate(s) differ from the
grand mean of the covariate(s). This technique is straightforward, as it is simply multiple
regression with categorical and continuous predictors. However, there is conflicting
empirical evidence regarding the ability of ANCOVA to accurately reduce selection bias
in the estimated treatment effect. Some studies have shown that covariate adjustment did
not adequately reduce selection bias (Rubin, 1973b, 1979); whereas, others have argued
that covariate adjustment works just as well as, or better than matching methods (Cochran
& Rubin, 1973; Pascarella et al., 2013).
In a study on liberal arts versus other 4-year universities’ impacts on students’
critical thinking skills, need for cognition, and positive attitudes toward literacy,
Pascarella et al. (2013) examined differences between the use of covariate adjustment and
propensity score matching. Twelve covariates (race, sex, parental education, ACT
composite score, federal grant receipt, institutional grant receipt, precollege major intent,
precollege political views, precollege purpose in life scores, precollege critical thinking
scores, precollege need for cognition scores, and precollege attitude toward literacy
scores) were identified as variables that were confounded with selection into attending a
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liberal arts or 4-year university. For both propensity score matching and covariate
adjustment, a model without the pretest as a covariate and a model with the pretest as a
covariate were estimated. Baseline mean differences (unadjusted) on critical thinking
skills, need for cognition, and positive attitudes toward literacy between those who
attended a liberal university versus a 4-year university were statistically significant. The
magnitude of each mean difference decreased from the baseline difference for all four
models except for need for cognition scores using covariate adjustment with the pretest
excluded. Pascarella et al. (2013) concluded that propensity score matching does not
provide a substantial benefit over covariate adjustment. Additionally, Pascarella et al.
(2013) concluded that both methods led to a substantial reduction in the amount of bias in
the estimated mean difference between liberal and 4-year university student impact, and
the models including the pretest as a covariate resulted in the largest reduction in bias.
The comparison of covariate adjustment to propensity score matching is useful
to inform researchers’ selection between the two methods. However, the claims made by
Pascarella et al. (2013) based on their study overreach. The researchers focused on how
different models including covariates (both propensity score matching and covariate
adjustment) reduced the amount of bias in the estimated treatment effect. Given that they
used empirical data from an applied study, it was not possible to determine whether and
to what extent bias was present in the estimated treatment effect. Pascarella et al. (2013)
assumed that the unadjusted treatment effect was biased, and that any change to the
estimated treatment effect was due solely to a reduction in bias.
A fundamental consideration when choosing an appropriate statistical method is
how well the method aligns with the research questions and the data that were collected.
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That is, statistical methods were developed to answer specific types of research questions.
ANCOVA was developed to allow for the comparison of randomly assigned groups’
adjusted means, and, in particular, to reduce the error term, which results in a more
powerful test of statistical significance (Pedhazur & Schmelkin, 1991a; 1991b).
ANCOVA was intended for randomly assigned groups or groups for which there are no
expected differences on a covariate, rather than quasi-experiments prone to self-selection
bias. Although ANCOVA is a useful tool for understanding group differences while
controlling for known covariates, it is not appropriate for accounting for self-selection
into treatment unless the research question of interest is how groups differ on the
outcome when both groups have equivalent means on the covariates (Pedhazur &
Schmelkin, 1991b).
Indeed, in two different simulation studies, Rubin (1973b, 1979) demonstrated
that ANCOVA alone did not adequately reduce selection bias. ANCOVA only reduced
bias well when there were equal numbers of treatment and comparison group members
and equal group covariate variances. The exception was when there was a large ratio of
comparison to treatment group members (at least 4:1; Rubin, 1973b). ANCOVA can also
be conducted after creating treatment and comparison groups that are matched on
covariates related to selection bias. Specifically, each treatment group member receives a
comparison group member match with similar covariate values. Instead of conducting the
ANCOVA on scores from the original, unbalanced sample, scores from the matched
sample are used for the analysis. Thus, the matched sample approximates random
assignment of participants to treatment and comparison groups (if the treatment and
comparison group are balanced on the covariates in the matched sample). Researchers
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might use ANCOVA on matched samples to understand group differences while
controlling for known covariates.
Extending his earlier work, Rubin (1979) showed that ANCOVA after matching
worked consistently well because very few conditions resulted in increased bias. An
alternative to samples matched on individual covariate values is to estimate propensity
scores, and then conduct an ANCOVA using the propensity score as the covariate
(Austin, 2011; Rubin, 1973b, 1979). ANCOVA used in conjunction with a matching
procedure or with propensity scores has been shown to work reasonably well for reducing
selection bias (Austin, 2011; Austin et al., 2007; Rubin, 1973b, 1979).
When using ANCOVA, group differences on the outcome are adjusted as if both
groups were the same on the covariates. In other methods that use covariates to reduce
systematic group differences the covariates are used as a balancing score.
Balancing Score
In order to reduce the bias in the estimated treatment effect that is due to
treatment selection, the treatment and comparison groups must be balanced on the
variables related to treatment selection (Rosenbaum & Rubin, 1983b). Rosenbaum and
Rubin (1983b) described balancing scores as scores that are used to aid in the creation of
balanced treatment and comparison groups. Balancing scores range from fine to coarse,
with the observed values on the covariates being the finest balancing score. Using the
values of the covariates results in the finest balancing score because a treatment and
comparison group member with the same balancing score will have the same values on
each covariate. Conversely, the propensity score is the coarsest balancing score, because
two individuals with the same propensity score do not necessarily have the exact same
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values on all covariates used to estimate the propensity score (Rosenbaum & Rubin,
1983b).
The balancing score is sufficient for eliminating systematic differences between
the treatment and comparison groups assuming that all relevant covariates have been
included. Balancing scores can be used for stratification (strata are created based on the
balancing score; Austin, 2011; Austin et al., 2007; Rosenbaum & Rubin, 1983b) and
matching (Austin, 2011; Austin et al., 2007; Rosenbaum & Rubin, 1983b, 1985; Rubin,
1973b, 1979).
Stratification
Another method for reducing systematic group differences is stratification.
Stratifying (i.e., subclassifying, blocking) is the process of sorting the entire sample into
blocks based on the covariate values. In doing so, treatment and comparison group
members within each block should be relatively homogenous on the covariates that are
related to treatment selection (Austin, 2011; Cochran, 1968; Guo & Fraser, 2015;
Maxwell & Delaney, 2004). After creating strata, the treatment effect is estimated for
each stratum, after which the individual estimates are pooled together (Austin, 2011;
Cochran, 1968; Guo & Fraser, 2015). Pooling allows for each stratum to be weighted
based on the number of treatment and comparison group members within each stratum
(Austin, 2011; Cochran, 1968; Guo & Fraser, 2015).
Five strata are recommended (Austin, 2011; Cochran, 1968), which resulted in a
reduction of 90% to 95% of the bias in the treatment effect that was due to one covariate
(Cochran, 1968). Stratification can be done using the actual values of the covariates
(Cochran, 1968) or using the propensity score (Austin, 2011; Caliendo & Kopeinig,
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2008; Guo & Fraser, 2015). Using too many strata can result in smaller reduction in bias
in the treatment effect than using fewer strata (Cochran, 1968). Whereas stratification
uses the balancing score to sort the entire sample into subsets (or strata), matching
methods use the balancing score to create matched treatment and comparison groups that
have similar covariate distributions.
Matching
Matching methods were introduced as a means of creating balanced treatment and
comparison groups by matching on variables related to treatment selection (covariates;
Rubin, 1973a). Matching methods involve selecting a portion of the comparison group
sample that most similarly resembles the treatment group sample on the covariates
(Rubin, 1973a). This matching can occur in different ways. Pair-matching (or exact
matching) works by selecting a comparison group member as a match for a treatment
group member if all values of the covariates match those of the treatment group member.
Nearest pair-matching works in the same way except the values of the covariates do not
have to match exactly. Rather, the comparison group member with the closest values on
the covariates to the treatment group member is selected as the match. Mean-matching
works by selecting a comparison group member match for the treatment group member
that will result in balance between the two group means (Rubin, 1973a).
When all appropriate covariates are selected, matching methods will remove
selection bias from the treatment effect conditional upon the covariates included in the
model by balancing the groups on the covariates (Rubin, 1973a, 1973b). When bias in
each covariate is reduced by the same amount, matching methods result in equal percent
bias reduction (EPBR; Rosenbaum & Rubin, 1985). If a method is EPBR, then the
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method is appropriate for reducing systematic group differences and bias in the estimated
treatment effect (Rubin, 1979; Rosenbaum & Rubin, 1985).
Although the procedure used with matching is straightforward, the process of
matching becomes increasingly complicated as the number of covariates increases
(Rosenbaum & Rubin, 1985). First, to ease the matching process, researchers may make
the decision to categorize continuous variables. When this is done, it can be easier to
match individuals on the covariate; however, there is a substantial loss of information
when a continuous variable is categorized (MacCallum et al., 2002). Due to the loss of
information, categorization of continuous variables is typically not recommended, unless
it makes sense to do so (MacCallum et al., 2002). Second, even if all covariates are
categorical variables, the potential for unmatched treatment group individuals increases
as the number of covariates increase. Rosenbaum and Rubin (1985) demonstrated this
problem by considering a scenario where there are 20 covariates on which the treatment
and comparison groups are matched. If each of the 20 variables were binary (only two
response options), there would be over one million different possible response patterns
across the 20 variables. Even with a very large sample, there will likely be many
treatment group members for which there is no exact match from the comparison group
pool. Thus, it may not be possible to find an appropriate comparison group member
match for all treatment group members (Rosenbaum & Rubin, 1985). Propensity score
matching was developed to reduce the complexity of matching on a large number of
covariates while still creating matched treatment and comparison groups (Rosenbaum &
Rubin, 1983b, 1985; Stuart & Rubin, 2008).
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Propensity Score Methods
Another method for reducing selection bias is through the estimation of
propensity scores. Propensity score methods involve the estimation of the propensity for
treatment for each individual in the sample, conditional upon researcher-identified
covariates. The propensity score is estimated such that individuals with the same
propensity score will have the same propensity for treatment, regardless of whether they
belong to the treatment or comparison group (Rosenbaum & Rubin, 1983). When
comparison group members are matched to treatment group members using the
propensity score, the matched treatment and comparison groups should have similar
covariate distributions. Thus, the propensity score is a balancing score conditional upon
the covariates used to estimate the propensity score (Austin, 2011). After the propensity
score is estimated, treatment group members can be matched to comparison group
members with the same or similar propensity score (depending on the matching method
implemented). Treatment assignment is said to be ignorable conditional upon the
propensity score, because a treatment group member and a comparison group member
with the same propensity score are, in theory, interchangeable even if their specific
covariate values differ (Rosenbaum & Rubin, 1983b). By creating matched pairs of
treatment and comparison group members, a comparison group is created that is similar
to the treatment group on variables that are related to selection into treatment. Thus,
systematic differences between the treatment and comparison group will be reduced or
eliminated and the estimated treatment effect will not be biased due to self-selection.
Matching on the balancing score results in groups that are balanced on the
observed covariates. Any covariates on which the groups are unbalanced that are not
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included when estimating the propensity score (whether these covariates are measured or
not) will result in systematic group differences (Rosenbaum & Rubin, 1985). Thus, the
estimated propensity scores are only as good as the model used to estimate them. That is,
if relevant covariates are omitted or the functional form of the relation between the
covariates and the propensity score is misspecified, the use of the propensity scores to
create balanced groups may not effectively reduce systematic differences between the
groups (Austin, 2009; Craig, 2020; Rosenbaum & Rubin, 1985). By matching treatment
group members to comparison group members on the propensity score, the researcher can
create groups that have the same distribution of propensity for treatment selection,
conditional upon the covariates. Achieving this balance makes the examination of the
treatment effect more reasonable when randomization is not feasible (Rosenbaum &
Rubin, 1983b), strengthening the validity of the inferences made regarding the treatment
effect. Without balancing the groups on the covariates, researchers have little evidence
that any observed treatment effect is indeed attributable to the occurrence of the treatment
(Cochran & Rubin, 1973; Rosenbaum & Rubin, 1983b, 1985; Rubin, 1973a, 1979;
Shadish et al., 2002). Any magnitude of estimated treatment effect could reflect
systematic group differences rather than the true treatment effect in the population. Thus,
without reducing or removing systematic group differences, researchers can easily
conclude that an ineffective treatment is indeed effective or that an effective treatment is
ineffective (Rosenbaum & Rubin, 1983b, 1985; Rubin, 1973a, 1979).
Assumptions of Propensity Score Matching
Propensity score matching has key assumptions, which if not met, can impact the
credibility and generalizability of the results (Austin, 2011; Caliendo & Kopeinig, 2008;
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Ho et al., 2007; Rosenbaum & Rubin, 1983b). When the assumptions of propensity score
matching hold for the data that are being analyzed, propensity score matching should
reduce the effect of selection bias on the estimated treatment effect (Rosenbaum &
Rubin, 1983b). Some assumptions are difficult to evidence with empirical data; however,
researchers can examine these assumptions to some extent, providing evidence for the
appropriateness of propensity score matching for their study.
Strong Ignorability. A key assumption that is two-fold is the strong ignorability
assumption (Rosenbaum & Rubin, 1983b; Stuart, 2010). Strong ignorability means that
the treatment selection is independent of the measured outcome, given the covariates. For
example, with random assignment, treatment assignment is strongly ignorable. This is the
case because the outcome is not dependent upon treatment assignment. When using
propensity score matching, we are trying to mimic a similar situation. Thus, after
balancing groups on the covariates, treatment selection is strongly ignorable if
assignment or selection into treatment conditions is unrelated to the observed outcome.
This assumption is important because if treatment selection is related to the outcome,
then treatment selection is not independent of the outcome (i.e., treatment selection is a
confound). When treatment selection is not independent of the outcome, the treatment
and comparison groups should not be directly compared on the outcome of interest
(Rosenbaum & Rubin, 1983b). Interwoven with strong ignorability is the assumption that
all variables that relate to treatment selection are included in the estimation of the
propensity score (i.e., no unmeasured confounders). If variables that are related to
treatment selection are omitted from the propensity score model, the estimated treatment
effect will be biased due to treatment selection. Moreover, any unmeasured covariates
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will threaten the independence of treatment selection and the outcome. Although this
assumption is not directly testable, researchers can guard against severe violations of this
assumption by consulting theory and empirical studies to determine what variables are
likely related to treatment selection (Austin, 2011; Rosenbaum & Rubin, 1983a; Steiner
et al., 2010; Stuart, 2010; Stuart & Rubin, 2010). A lack of careful consideration of which
variables to measure during the study design phase cannot be corrected for through
statistical analyses. Careful thought and thorough review of the relevant literature is the
best safeguard against violation of this key assumption (Steiner et al., 2010). Although
there is no method to determine whether the strong ignorability assumption has been
violated, sensitivity analysis can provide an indication as to whether the strong
ignorability assumption has been violated (Austin, 2011; Steiner et al., 2010; Stuart,
2010). If the estimated treatment effect differs with the inclusion of additional covariates,
it is likely that the strong ignorability assumption has been violated (Stuart, 2010).
Common Support. Common support (or sufficient overlap of propensity scores)
is related to the assumption of strong ignorability (Guo & Fraser, 2015). Common
support refers to the amount of overlap between the propensity score distributions in the
treatment and comparison group. If there is not sufficient overlap between the groups’
propensity score distributions, the strong ignorability assumption will not be met
(Caliendo & Kopeinig, 2008). That is, if the propensity score distributions differ to a
large degree, sufficient treatment and comparison group matched pairs cannot be found.
Thus, groups will likely not be balanced on the covariates after matching. If there are
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systematic differences between the groups after matching, selection bias is still present
and the treatment assignment is not independent of the outcome.
Stable Unit Treatment Value. The stable unit treatment value (SUTVA)
assumption specifies that the treatment of one individual is not affected by the treatment
of another individual (Stuart, 2010). The biggest threat to this assumption is interaction
between treatment and comparison group members. For example, if a treatment group
member shares details of the treatment with a comparison group member, the comparison
group member’s outcome may be influenced by this information. Thus, rather than the
comparison group member’s outcome score representing no treatment (and no treatment
was intended), it is instead the outcome under receiving some treatment. If the intention is
to understand the treatment effect by comparing treated and non-treated individuals, the
inclusion of this comparison group member in the sample would threaten the validity of
the estimated treatment effect. To determine whether this assumption holds, researchers
should give careful consideration to potential interaction of group members during the
study design phase. Additionally, during the treatment implementation, researchers
should record any events that indicate that this assumption has been violated.
Propensity Score Matching Steps
When implementing propensity score matching, there are two general stages; the
non-parametric, pre-processing stage and the treatment effect estimation stage (e.g., Ho et
al., 2007). The first non-parametric, pre-processing stage can be further broken down into
steps. Some of the steps may be combined or omitted in the propensity score matching
literature (Austin, 2011; Bai, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010; Stuart &
Rubin, 2008). Nonetheless, the steps are the same and each step requires careful
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consideration from the researcher (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart,
2010; Stuart & Rubin, 2008). The stages can be broken down as follows:
1. Selection of covariates/estimation of propensity scores.
2. Selection of matching method(s).
3. Evaluation of common support.
4. Evaluation of matching quality.
5. Estimation of the treatment effect.
6. Evaluation of sensitivity analysis.
Steps one through four comprise the non-parametric, pre-processing stage; step
five is the treatment effect estimation stage. Step six is a follow-up procedure to
determine the potential impact of unmeasured covariates on the estimated treatment
effect.
Step 1: Selection of Covariates and Estimation of Propensity Scores. The first
step (which is most often conducted during the study design phase) is the selection of
relevant variables to include in the propensity score model and specification of the
propensity score model. First, I will discuss important considerations for variable
selection, then specification of the propensity score model.
Variable Selection. Variable selection is important when specifying the
propensity score model (Caliendo & Kopeinig, 2008; Dehejia & Wahba, 1999; Steiner et
al., 2010). The goal of matching on the propensity score is to reduce systematic
differences between the groups, which in turn will decrease the bias in the estimated
treatment effect that is due to treatment selection. If relevant variables are omitted from
the model, the estimated treatment effect may be more biased than if no matching was
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implemented (Bai, 2011; Dehejia & Wahba, 1999; Rosenbaum & Rubin, 1983b; Stuart,
2010). Some researchers caution that the inclusion of variables that are not meaningful
for the estimation of the propensity (i.e., including all variables that a researcher has
available to use) can be detrimental (Bai & Clark, 2019; Shadish et al., 2008), whereas
others indicate that the inclusion of irrelevant variables does not bias the estimate of the
treatment effect (Caliendo & Kopeinig, 2008).
Due to the importance of variable selection, there is a wealth of literature that
provides guidance for selecting variables to include in the propensity score model
(Austin, 2011; Bai, 2011; Bai & Clark, 2019; Brookhart et al., 2006; Caliendo &
Kopeinig, 2008; Ho et al., 2007; Steiner et al., 2010; Stuart, 2010; Stuart & Rubin, 2008).
In general, theory and previous research should guide variable selection. A review of the
relevant literature should reveal variables that are theoretically or empirically related to
either treatment selection or the outcome of interest (Austin, 2011; Bai, 2011; Bai &
Clark, 2019; Caliendo & Kopeinig, 2008; Ho et al., 2007; Stuart, 2010; Stuart & Rubin,
2008). Bias is best reduced when the propensity score model includes covariates that
relate to both treatment selection and the outcome of interest (Austin et al., 2007; Bai &
Clark, 2019; Brookhart et al., 2006; Caliendo & Kopeinig, 2008; Ho et al., 2007; Stuart
& Rubin, 2008). Variables that are only related to the outcome (and not treatment
selection) should also be included to reduce bias in the estimated treatment effect (Bai &
Clark, 2019; Brookhart et al., 2006). Including variables that are only related to treatment
selection may be inefficient and provide no benefit in terms of bias reduction because the
variables are not related to the outcome (Brookhart et al., 2006; Stuart & Rubin, 2008).
Others state that in most settings researchers can likely include all available covariates
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without risking severe consequences in the form of bias in the estimated treatment effect
(Austin, 2011; Caliendo & Kopeinig, 2008).
The covariates selected for the propensity score model should be measured prior
to treatment implementation (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010;
Stuart & Rubin, 2008). That is, covariates that are affected by the treatment should not be
included in the propensity score model. If it is not possible to measure certain covariates
prior to treatment implementation, then they should not be included in the propensity
score model. The only exception is variables that are constant over time (e.g.,
demographic variables that do not change, proxies for student ability, historical variables;
Caliendo & Kopeinig, 2008). Because the propensity score model is predicting the
probability of receiving treatment, the inclusion of a variable that is affected by treatment
would result in propensity scores that are conflated with the treatment itself.
Propensity Score Model. Once the covariates are selected and measured, the
propensity score model is selected. When selecting the propensity score model, one
consideration is the number of treatment options (Caliendo & Kopeinig, 2008). That is,
how many different possible group membership variables are to be estimated? Typically,
there are two treatment options (i.e., received treatment, did not receive treatment), which
would indicate that a model that allows for the estimation of a binary outcome would be
necessary. Although the logit model is used most frequently in the propensity score
matching literature, any model that accommodates a binary outcome will work well
(Caliendo & Kopeinig, 2008). If there are more than two treatment options (e.g.,
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comparing two different treatment methods and no treatment), a multinomial probit
model or a series of binomial models may be appropriate (Caliendo & Kopeinig, 2008).
Consideration must also be given to the functional form of the relation between
the covariates and treatment selection (Rosenbaum & Rubin, 1985). The researcher
should determine the appropriate form for the propensity score model. Rosenbaum and
Rubin (1985) cautioned that estimated propensity scores from an incorrect model will not
be useful for balancing the groups nor for reducing selection bias. However, propensity
score methods have been shown to result in adequate balance even when the propensity
score model is misspecified (Craig, 2020).
Logistic Regression. Logistic regression is most frequently used to estimate
propensity scores when there are two groups (e.g., treatment group, comparison group;
Austin, 2011; Bai, 2011; Caliendo & Kopeinig, 2008, Rosenbaum & Rubin, 1985). When
using logistic regression, the value predicted by the model is the logit of the propensity
score. Thus, the predicted outcome (probability of receiving or not receiving treatment) is
on the logit metric, which allows for the estimation of a linear relation between the
covariates and treatment selection via the following model:
𝑃(𝑦 =1|𝑿 )

𝑙𝑛 [1−𝑃(𝑦𝑖 =1|𝑿𝑖 )] = 𝐗 𝑖 𝛃
𝑖

𝑖

(1)

where the logit is the natural log of the odds of treatment. The odds of treatment is
represented as the probability of treatment (𝑦𝑖 = 1) conditional upon the vector of
covariates (𝐗 𝑖 ), divided by one minus the probability of treatment conditional upon the
vector of covariates. The logit for person 𝑖 is equal to the product of 𝐗 𝑖 (a vector of
covariate values for person 𝑖) and 𝛃 (a vector of logistic regression coefficients; Guo &
Fraser, 2015). The propensity score on the logit metric can also be transformed onto a
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probability metric, resulting in the probability (or propensity) for treatment selection,
conditional upon the covariates in the model.
Logistic regression can accommodate categorical and continuous covariates as
well as interactions and polynomial terms (Tabachnick & Fidell, 2013). Although logistic
regression is often used as a parametric procedure (where the model parameters are tested
for statistical significance), that is not the case when logistic regression is used to
estimate the propensity scores. The regression parameters and model deviance from the
propensity score model are not of primary interest. The interest is predicting the
propensity for treatment in order to create matched treatment and comparison groups
(Pan & Bai, 2015; Stuart, 2010).
Step 2: Selection of Matching Method(s). There are a variety of matching
methods from which to choose, and they can result in different matched treatment and
comparison groups depending on the data. Thus, when selecting a matching method it is
common practice to audition multiple matching methods (Austin, 2011; Caliendo &
Kopeinig, 2008; Ho et al., 2007; Rubin, 1973a; Stuart & Rubin, 2008). After evaluating
the quality of the matched sample resulting from each matching method, researchers are
then able to champion one or multiple matching methods best suited to their study.
Although all matching methods work well in general, this does not mean that they work
well for all samples, under all circumstances (Caliendo & Kopeinig, 2008; Stuart &
Rubin, 2008). The recommendation to implement multiple matching methods allows the
researcher to evaluate the quality of matches for each method individually and compare
the quality of matches across methods. Sometimes evaluation of the matching quality will
illuminate that one method results in better group balance after matching than the other
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methods. Other times, the results can be less clear. Caliendo and Kopeinig (2008)
suggested that when the matching quality is similar across methods, then the choice of
which method to champion matters less. That is, if all methods result in similar balance,
then all methods should result in similar adjustment for selection bias in the eventual
estimation of the treatment effect.
The suggestion to audition multiple matching methods may seem daunting to
researchers with little propensity score matching experience. It is important to point out
that the researcher is not conducting a full analysis using each method (Stuart & Rubin,
2008). Specifically, several matching methods are used to create different matched
samples from the complete dataset. The quality of matches for each of the resulting
matched datasets is evaluated using multiple criteria. The treatment effect is not
estimated for each matching method (Stuart & Rubin, 2008). If a researcher estimated the
treatment effect for matched samples from five different matching methods, there is the
potential that different conclusions would be made regarding the treatment effect
depending on which matching method the researcher championed. Indeed, when the
quality of matches differed across methods, the magnitude and direction of the estimated
treatment effect differed across matching methods (Austin, 2013; Austin et al., 2007;
Jacovidis et al., 2017; Perkins & Horst, 2020). Therefore, researchers are cautioned
against examining the treatment effect prior to the selection of which matching method
results in the best balance for the study (Bai, 2011; Stuart & Rubin, 2008)
Matching algorithms can be categorized into optimal and greedy methods.
Optimal methods are designed to select matches so as to optimize group balance on the
covariates; whereas greedy methods are designed to select the closest match from the
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remaining comparison group pool (Austin, 2011; Cochran & Rubin, 1973; Gu &
Rosenbaum, 1993; Rubin, 1973a; Stuart, 2010).
Optimal matching methods minimize the average propensity score difference
across all matched pairs (Austin, 2013; Gu & Rosenbaum, 1993). The optimal algorithm
works to ensure that these individual matches result in the lowest average within-pair
difference on the propensity score. A nice feature of optimal matching methods is that
they result in every single treatment member receiving a match. That is, there is no loss
of treatment group representation when optimal matching is used (Austin, 2013; Gu &
Rosenbaum, 1993).
Greedy matching methods process through the treatment group members one by
one and select the comparison group member with the closest propensity score to the
treatment member (Austin, 2011; Gu & Rosenbaum, 1993). At first glance, greedy
matching methods may sound identical to optimal matching methods, but there are
certain distinctions between the two algorithms. Greedy matching methods differ from
optimal matching methods in that with the greedy algorithm, there is no value that the
method is trying to minimize. After a match is made, it is not re-evaluated. However,
greedy matching methods tend to result in similar group balance to optimal matching
methods, with generally the same comparison members selected from the comparison
group pool (Gu & Rosenbaum, 1993). Although the same comparison group members
were selected from the comparison pool, the matched treatment and comparison group
pairs were not the same across greedy and optimal methods (Gu & Rosenbaum, 1993).
Nearest Neighbor Matching. Nearest Neighbor (NN) matching is a greedy
matching method (Rubin, 1973a). After the propensity score is estimated for treatment
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and comparison group members, the treatment group members are ordered based on the
estimated propensity score (Rubin, 1973a). Ordering of treatment member selection can
be done from high to low, from low to high, or randomly (Rubin, 1973a). Random
ordering of treatment members based on the propensity score in order to select matches
tends to result in better matches and lower bias than high to low or low to high ordering
(Austin, 2013).
For each treatment member, the NN algorithm will select the comparison group
member with the closest propensity score. After the treatment group member receives a
comparison group member match, both participants are removed from the unmatched
sample and are placed into the matched sample (unless matching with replacement,
where the comparison group member would be returned to the comparison group pool
and could be matched to additional treatment group members). As long as the comparison
group is larger than the treatment group, all treatment group members will receive a
comparison group member match, with only unmatched comparison group members
excluded from the matched sample.
If there are large differences in the distribution of the propensity score across the
treatment and comparison groups, NN matching can result in poorer balance than other
methods (Stuart, 2010). Importantly, greedy matching methods do not ensure that there
will be a small difference between propensity scores for each match. For example, a
treatment group member with a propensity score of 0.80 could be matched with a
comparison group member with a propensity score of 0.50 because this comparison
group member is indeed the closest match. If matched pairs differ to a large extent on the
propensity score, there may still be systematic differences between the treatment and
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comparison group even after matching. However, greedy matching methods have been
shown to produce similar group balance to optimal matching methods (Gu &
Rosenbaum, 1993). Like optimal matching, greedy matching methods result in every
treatment member receiving a match (Austin, 2013).
Nearest Neighbor Matching With Caliper. Calipers can be specified when using
greedy matching methods to restrict the maximum distance between a matched treatment
and comparison pair (Austin, 2011, 2013; Rosenbaum & Rubin, 1985). By employing a
caliper method with propensity score matching, the researcher defines the maximum
possible difference on the propensity score between a matched treatment and comparison
pair (Austin, 2011; Caliendo & Kopeinig, 2008; Cochran & Rubin, 1973; Rosenbaum &
Rubin, 1985; Stuart & Rubin, 2008). If there is no comparison group member with a
propensity score within the specified caliper of the treatment member, no match is
selected and the treatment member will not be included in the matched sample. Common
calipers are 0.20 standard deviations of the logit of the propensity score or 0.02 or 0.03
standard deviations of the propensity score (Austin, 2009).
Compared to non-caliper methods, caliper matching can improve the balance on
the covariates between the treatment and comparison group, but often comes at a cost to
treatment group (and matched sample) size (Austin, 2009; Austin, 2011; Austin, 2013;
Caliendo & Kopeinig, 2008; Jacovidis, 2017; Jacovidis et al., 2017; Stuart, 2010). Loss
of treatment group members can be problematic for two reasons. First, there is a loss of
treatment representation. That is, depending on the treatment and comparison group
propensity score distributions, the loss of treatment members may result in decreased
variance and restriction of range of the propensity score distribution (Caliendo &
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Kopeinig, 2008). Second, loss of treatment members will decrease the matched sample
size (Austin, 2009, 2011; Jacovidis et al., 2007). Although the original, unmatched
sample size may have been adequate for the outcome analysis, loss of treatment members
may lead to the matched sample no longer being of adequate size for the outcome
analysis. Even if the matched sample size is sufficient for the outcome analysis, the
results may be impacted by loss of power (Stuart, 2010). When using caliper matching
methods, researchers need to be cognizant of the benefits and drawbacks of the method
and use their best judgement as to whether the loss of treatment sample is concerning or
acceptable (Jacovidis et al., 2007). If very few treatment group members are lost from the
matched sample or there is a high degree of common support, the researcher may not
have reason to be concerned about whether the estimated treatment effect is generalizable
to the population.
Additional Matching Considerations. When selecting the matching method, the
researcher must also consider two additional matching specifications: matching with or
without replacement and one-to-one or many-to-one matching (Austin, 2011; Caliendo &
Kopeinig, 2008). Matching is typically implemented without replacement (Austin, 2009,
2013). When using a greedy algorithm, such as nearest neighbor, once a comparison
group member is matched to a treatment group member, the comparison group member is
removed from the comparison pool and cannot be matched with any other treatment
group members (even if the comparison group member is a good match for a subsequent
treatment group member). Matching without replacement ensures that each matched
individual is included in the matched sample only once (Austin, 2011, 2013; Caliendo &
Kopeinig, 2008). When matching with replacement, after a comparison group member is
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matched to a treatment group member, the comparison group member is returned to the
comparison pool and can be matched with other treatment group members. Matching
with replacement can result in better quality of matches than matching without
replacement (because one comparison group member may be a good match for multiple
treatment group members). However, matching with replacement can result in the same
comparison group member being included in the matched sample multiple times (Austin,
2011, 2013; Caliendo & Kopeinig, 2008). When matching with replacement is used, an
outcome analysis that can account for the lack of independence within the comparison
group must be used (Stuart, 2010). Moreover, matching with replacement resulted in a
greater reduction in bias than other matching methods, however variance in the treatment
effect and mean squared error were larger for matching with replacement than with other
methods (Austin, 2013; Caliendo & Kopeinig, 2008).
One-to-one matching is used more frequently than many-to-one matching within
the PSM literature (Austin, 2009, 2011; Stuart & Rubin, 2008). With one-to-one
matching, matched pairs consist of one treatment group member and one comparison
group member. This will result in equal group sizes after matching, which is preferred for
many outcome analyses. Many-to-one matching (ratio matching) allows multiple
comparison group members to be matched to one treatment group member (Stuart, 2010;
Stuart & Rubin, 2008). The researcher can specify the number of comparison group
members to be matched with one treatment group member (e.g., 2 to 1) or the number of
comparison group members matched to one treatment group member can be allowed to
vary (Austin, 2011). Many-to-one matching might be preferred when the comparison
group pool is much larger than the treatment group (Stuart, 2010; Stuart & Rubin, 2008).
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In this situation, there may be multiple comparison group members who are a good match
for each treatment group member. However, using many-to-one matching can increase
bias in the estimated treatment effect (Caliendo & Kopeinig, 2008; Stuart, 2010; Stuart &
Rubin, 2008).
After matching method decisions are made and the matching methods are
implemented, the quality of matches are examined. Doing so allows the researcher to
determine which matching method is preferred for the study and whether the group
balance after matching is adequate. Evaluation of matching quality is conducted using
multiple criteria. Caliendo and Kopeinig (2008) separated this evaluation into two steps:
evaluation of common support and evaluation of matching quality.
Step 3: Evaluation of Common Support. Common support refers to the extent
to which the distribution of the propensity scores for the treatment group overlaps with
the distribution of the propensity scores for the comparison group (Austin, 2011;
Caliendo & Kopeinig, 2008; Ho et al., 2007; Stuart, 2010; Stuart & Rubin, 2008). A high
degree of common support indicates that the propensity score distributions of the two
groups are similar, or at least overlapping, and that the quality of matches may be
favorable. A low degree of common support indicates that the propensity score
distribution of the two groups differ greatly, and that the quality of matches may not be
adequate (Austin, 2011; Caliendo & Kopeinig, 2008).
Common support is evaluated in two ways: visually checking the amount of
overlap in the propensity score distributions and comparing the minimum and maximum
propensity score across groups (Caliendo & Kopeinig, 2008; Ho et al., 2007; Stuart,
2010). Visual checks of common support are often done by examining jitter plots. Each
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group member’s propensity score is plotted, allowing the researcher to compare the
propensity score distributions across groups (see Figure 1). Common support can also be
examined by comparing the minimum and maximum propensity score values across
groups (Caliendo & Kopeinig, 2008; Stuart, 2010). Any comparison group members with
a propensity score that falls outside of the minimum or maximum in the treatment group
can be removed, as these comparison group members are unlike the treatment group
members in terms of their propensity for treatment selection (Caliendo & Kopeinig,
2008). Differences in the minimum and maximum values of the groups’ propensity score
distributions are not the only threat to common support. There could also be a range of
propensity scores in which only treatment group members fall (and no comparison group
members). Thus, lack of common support may result in a treatment group member being
matched to a comparison group member who is qualitatively different on the covariates
(depending on the matching method that is used; Caliendo & Kopeinig, 2008).
A jitter plot can also be produced after matching has been implemented, with the
propensity scores plotted for each of four categories: unmatched comparison group
members, matched comparison group members, matched treatment group members, and
unmatched treatment group members (see Figure 1). Evaluation of common support sets
the stage for examination of matching quality. If the matched treatment and comparison
group members have a similar distribution of propensity scores and there are few
unmatched treatment group members, matching quality may be favorable. If the matched
treatment and comparison group members do not have similar distributions of propensity
scores, or if there are many unmatched treatment group members, matching quality may
not be ideal or adequate (Austin, 2011; Stuart, 2010). Assessing common support after

37

matching can also be useful for understanding lack of propensity score and covariate
balance after matching. For example, if a researcher found that a large proportion of
treatment group members were not matched using a caliper matching method, the jitter
plot would be a means of diagnosing whether there were comparison group members
with similar propensity scores (e.g., Ho et al., 2007).
The evaluation of common support allows the researcher to understand the
propensity score distributions of the treatment and comparison groups (both before and
after matching) and a researcher may be able to anticipate the matching quality they will
observe based on the similarities or differences in the propensity score distributions.
Direct evaluation of matching quality can provide a picture of how well each matching
method worked, and which matching method worked the best for the study.
Step 4: Evaluation of Matching Quality. After creating matched groups and
evaluating common support, the next step is to evaluate match quality for each
implemented matching method. After matching quality is deemed to be adequate for a
method, the treatment effect can be estimated (step five). If matching quality is not
acceptable, the researcher must consider reasons why (e.g., an important covariate was
excluded, the model for estimating the propensity scores was wrong, there was little
common support, etc.) and either address those reasons (if possible) or conclude that the
employed matching methods did not work well for the data. Estimation of the treatment
effect from the poorly matched sample would be inappropriate.
Group Balance on the Covariates. Matching quality is evaluated by comparing
the group balance on the covariates and propensity score before and after matching
(Austin, 2011; Caliendo & Kopeinig, 2008). Group balance on each covariate and the
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propensity score can be examined in multiple ways: examining raw and standardized
mean differences on each covariate and the propensity score, examining the average
standardized mean difference across all covariates, examining the ratio of the groups’
propensity score variances, and visually examining the distributions of each covariate and
the propensity score in each group (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart,
2010).
One of the easiest and most straightforward methods for examining matching
quality is by comparing raw mean differences on each covariate before and after
matching (Austin, 2011). If there were no systematic differences between the groups, the
raw means should be equal. Any difference between the means needs to be considered in
terms of the scale of the variable. When comparing raw means, it can be difficult to
discern how large a difference indicates lack of balance. Similarly, the lack of balance
cannot be compared across variables that are on different metrics. Therefore,
standardized mean differences are often compared (Austin, 2011; Stuart, 2010).
The standardized mean difference is computed for each continuous covariate by
dividing the mean difference by either the standard deviation of the covariate in the
treatment group, comparison group, or pooled across groups. Different researchers or
matching programs use different standardizers. The standardized mean difference is a
standardized effect size, allowing for the covariates to be compared in terms of any
remaining lack of balance. There are different views regarding what value of
standardized mean difference constitutes adequate balance. Some consider a standardized
mean difference less than |0.25| (Rubin, 2001), |0.10| (Austin, 2009, 2011, 2013), or |0.05|
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(What Works Clearinghouse, 2017) as an indication of adequate balance on a covariate or
the propensity score.
Variance Ratio. A ratio of the treatment group propensity score variance to the
comparison group propensity score variance can provide information regarding the
quality of balance for each method (Rubin, 2001; Stuart, 2010). A variance ratio close to
1 indicates that the propensity score variances in each group are similar (Stuart & Rubin,
2008). Equal propensity score variances in the treatment and comparison group (in
tandem with adequate group covariate balance) indicate that the distributions of the
propensity score overlap to a large degree, providing evidence in favor of common
support (Rubin, 2001).
Group Covariate Distributions. Visually examining the group distributions of
each covariate can reveal areas of imbalance that might not have been revealed using
other methods of examining balance (Austin, 2011). Balancing on the covariates is
intended to remove all systematic differences between the groups on those covariates.
When there are still systematic differences between the groups after matching, the
estimated treatment effect may still be biased due to treatment selection.
Evaluation of matching quality may reveal that all auditioned matching methods
worked equally well (e.g., Gu & Rosenbaum, 1993). When this occurs, the choice of
matching method to champion does not matter (Caliendo & Kopeinig, 2008). If the
standardized mean difference across all covariates after matching is similar across all
methods, then the variance ratio of the propensity scores, or amount of treatment sample
loss (with caliper methods) could potentially guide the selection of which matching
method to champion.
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Evaluation of matching quality may reveal that some matching methods worked
better than others (Caliendo & Kopeinig, 2008; Stuart & Rubin, 2008). When this occurs,
the choice of which matching method to champion may be more easily made than when
the results from all methods are similar (Caliendo & Kopeinig, 2008).
Evaluation of matching quality may reveal that none of the auditioned matching
methods work well. When this occurs, additional evaluation of the included covariates or
propensity score model is necessary (Bai, 2011; Caliendo & Kopeinig, 2008; Stuart,
2010). If adequate balance is not achieved (i.e., groups are still unbalanced on the
covariates), it is not appropriate to estimate the treatment effect because selection bias
will still be present (Ho et al., 2007). If the groups are not balanced after matching, then
the goal of matching was not achieved, and the researcher should specify a different
propensity score model (Ho et al., 2007; Steiner et al., 2010; Stuart, 2010).
Step 5: Estimation of the Treatment Effect. When matching quality is good, a
researcher should select the matching method that results in the best group balance on the
covariates. After doing so, the researcher is able to use outcome scores from the resulting
matched sample to estimate the treatment effect (Bai, 2011; Stuart & Rubin, 2008). If
group means on the covariates are equal after matching, all of the selection bias will be
removed from the treatment effect for the covariates that were included in the model
(Rubin, 1973a; 1973b). In contrast, when matching does not work well (i.e., groups are
still unbalanced on the covariates), little to no selection bias will be removed from the
estimated treatment effect, or the direction of the bias may shift (Rubin, 1973a; 1973b).
When propensity score matching is conducted, there are three commonly
estimated treatment effects that researchers can choose from depending on the population
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to which they wish to make inferences. The choice between estimating the average
treatment effect (ATE), average treatment effect for the treated (ATT), or average
treatment effect for the control (ATC) is determined by which is most appropriate to
answer the research question (Austin, 2011; Ho et al., 2007; Pan & Bai, 2015; Stuart,
2010). The treatment effect that is estimated (i.e., ATE, ATT, or ATC) can be specified
via dummy coding of the groups, application of weights, or through research design and
randomization.
Average Treatment Effect. The average treatment effect (ATE) provides an
estimated treatment effect that would be observed if every individual in the population
both did and did not receive treatment (Austin, 2011; Ho et al., 2007; Pan & Bai, 2015).
The ATE is the treatment effect that is estimated when attempting to understand the
counterfactual in a randomized control trial (Rosenbaum & Rubin, 1983). Thus,
estimation of the ATE allows for the generalization of the treatment effect to the entire
population.
Average Treatment Effect for the Treated. The average treatment effect for the
treated (ATT) provides an estimated treatment effect only for those who received
treatment (Austin, 2011; Ho et al., 2007; Pan & Bai, 2015). The ATT is the treatment
effect that is estimated when attempting to understand the counterfactual for those who
received treatment. Thus, estimation of the ATT allows for the generalization of the
treatment effect to the treatment population. The ATT is frequently the treatment effect of
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interest in quasi-experimental studies, such as propensity score matching (Austin, 2011;
Cochran & Rubin, 1973; Ho et al., 2007; Rubin, 1973a, 1973b; Stuart, 2010).
Average Treatment Effect for the Control. The average treatment effect for the
control (ATC) provides an estimated treatment effect only for those who did not receive
treatment (comparison group members; Guo & Fraser, 2015; Pan & Bai, 2015). The ATC
is the treatment effect that is estimated when attempting to understand the counterfactual
for those who did not receive treatment. Thus, estimation of the ATC allows for the
generalization of the treatment effect to the comparison population. The ATC is rarely the
treatment effect of interest in quasi-experimental studies (Pan & Bai, 2015). The ATC
may be of interest when there are fewer comparison group members than treatment group
members; however, studies of this nature are infrequent (Pan & Bai, 2015).
Once matched treatment and comparison groups are created, the desired treatment
effect can be estimated using whatever statistical analysis is most appropriate to answer
the research question (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010; Stuart &
Rubin, 2008). Estimation of treatment effects is conducted in the same way as
randomized control studies or other observational studies where propensity score
matching methods are not used (Austin, 2011). The only difference is that the treatment
effect is estimated on the matched sample rather than the original sample. When there are
two groups (e.g., treatment group, comparison group), the estimated treatment effect is
often a comparison of group mean differences on the outcome of interest (Austin, 2011).
One consideration is whether the matched sample is an independent or dependent
sample; the answer to which guides the selection of either an independent or dependent
samples analysis. The matched sample may be considered a dependent sample because
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the groups were created by matching on the covariates. Because the covariates relate to
the outcome, it stands to reason that groups that are more similar on the covariates will
also be more similar on the outcome (Austin, 2011). When a matched sample is not
created (e.g., treatment assignment is randomized), the groups should be independent of
one another. In contrast, the matched sample may be considered an independent sample
because there should still be random differences between the distributions of the
covariates in both groups. Thus, the outcomes of two matched individuals should not be
related simply because the individuals are similar on the covariates (Schafer & Kang,
2008). Consideration must be given to whether the matched sample consists of
independent or dependent groups to guide the selection of an appropriate outcome
analysis model.
Many applications of matching methods in applied studies stop at this step
(estimation of the treatment effect; Caliendo & Kopeinig, 2008; Stuart, 2010; Stuart &
Rubin, 2008). That is, the researcher estimates the treatment effect according to the
research question that is being examined, then reports the results and moves on to a
discussion of the results. However, there is an additional step that provides validity
evidence for the claims regarding the estimated treatment effect. Sensitivity analysis is
used to determine the range of possible conclusions that could be made from a quasiexperimental study (Rosenbaum & Rubin, 1983a). Specifically, sensitivity analysis is
focused on how the estimated treatment effect would differ due to potential unmeasured
(and thus, not included in the propensity score model) covariates.
Step 6: Evaluation of Sensitivity Analysis. Sensitivity analysis was introduced
by Rosenbaum and Rubin (1983a) to determine how the treatment effect estimate is
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impacted by potentially unmeasured covariates. Sensitivity analysis allows the researcher
to speculate about what the estimated treatment effect would have been if there were any
unmeasured covariates that should have been included in the propensity score model. If
sensitivity analysis reveals that the estimated treatment effect would not differ with the
addition of unmeasured covariates, then there is additional evidence that the matching
method reduced the impact of selection bias (Rosenbaum & Rubin, 1983a). Although a
researcher can never be certain that all selection bias was removed, favorable sensitivity
analysis results strengthen the claims made regarding the outcome of interest (Caliendo &
Kopeinig, 2008; Rosenbaum & Rubin, 1983a; Stuart, 2010).
Generalized Boosted Modeling
Generalized Boosted Modeling (GBM) is a propensity score method that does not
require the creation of matched treatment and comparison groups. GBM is an iterative
method that builds off of classification and regression trees (McCaffrey et al., 2004). The
process of predicting the propensity scores is automated and data driven (Burgette et al.,
2015). As statistical programming software packages have become more robust over
time, GBM has become relatively simple to implement, with many models taking very
little time to iterate over thousands of replications (Sinharay, 2016).
Classification and Regression Trees. The goal of classification and regression
trees (CART) is to accurately predict a categorical (classification) or continuous
(regression) outcome by optimizing the use of predictor variables. Specifically, when a
binary variable is the outcome (e.g., treatment assignment), the variables that are most
useful for predicting the outcome are selected through a series of splits on the data.
Beginning with the full sample, the data are split into two subsets based on one variable.
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The split occurs at a single value of the variable and maximizes the subsets’ difference on
the outcome (McCaffrey et al., 2004). After the first split, each subset is split again on the
variable that again maximizes the subsets’ difference on the outcome. Each split can
either use a previously used variable (with the split occurring at a different value) or a
variable that was not previously used. The splitting process continues until the maximum
tree depth is reached (Burgette et al., 2015; McCaffrey et al., 2004). The maximum tree
depth is set by the researcher and specifies the maximum number of interactions or
largest polynomial terms that can be included in the model (Burgette et al., 2015;
McCaffrey et al., 2004; Sinharay, 2016). For example, a tree depth of 3 will allow for the
inclusion of 2-way interactions between variables, 3-way interactions between variables,
quadratic effects, and cubic effects in the model predicting treatment assignment. Thus,
the larger the specified tree depth, the more complex the model.
The classification tree is built using data from all participants. After the tree is
built, the predicted treatment assignment (0/1) can be determined for each individual by
starting at the top of the tree and following the splits based on the individual’s values on
the variables included in the tree (Burgette et al., 2015). Thus, a predicted treatment
assignment value will be estimated for each participant in the sample.
Boosting. Boosting is a procedure that combines information from multiple
CART models to improve prediction of the outcome variable (Burgette et al., 2015).
When boosting is added to a CART model, the first tree that is fit is a poorly fitting
model (i.e., classification error is only slightly smaller than chance classification). That
is, the first model performs marginally better at predicting treatment assignment than if
guessing was used to predict treatment assignment. After fitting the first classification
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tree, another tree is built on the residuals from the previous tree, with individuals who
were misclassified by the previous tree receiving a “boost” or larger weight (Burgette et
al., 2015; Guo & Fraser, 2015; McCaffrey et al., 2004). By boosting misclassified
individuals, there is a greater chance that misclassified individuals will be correctly
classified by the next tree (Sinharay, 2016).
Trees are successively built, boosting on the misclassified observations from the
previous tree until the algorithm reaches the optimal iteration (Guo & Fraser, 2015;
McCaffrey et al., 2004). When generalized boosted modeling is used to estimate
propensity scores, the optimal iteration is the one that results in the best covariate balance
between the treatment and comparison group. Two different stopping rules can be used to
determine which iteration results in the best covariate balance; the effect size stopping
rule or the Kolmogorov-Smirnov stopping rule (Burgette et al., 2015; McCaffrey et al.,
2004). The effect size stopping rule selects the best iteration as the one that minimizes the
standardized group differences across covariates. The Kolmogorov-Smirnov stopping
rule selects the best iteration as the one that maximizes the Kolmogorov-Smirnov
statistic. Propensity scores are estimated for all participants using the boosted iteration
that is determined to be the optimal iteration (based on the stopping rule; Burgette et al.,
2015; McCaffrey et al., 2004).
In summary, when generalized boosted modeling is used to estimate propensity
scores a series of regression trees are fit to the data. The residuals from each tree inform
the successive tree, with misclassified individuals receiving additional weight. Trees are
fit until the best covariate balance is reached between the treatment and comparison
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groups. The iteration that results in the best covariate balance between groups is used to
estimate the log odds of receiving treatment for each participant.
Treatment Effect Estimate Weighting. Instead of matching on the propensity
scores, in generalized boosted modeling, the propensity score is used to weight each
participants’ outcome score in the estimation of the treatment effect. The way in which
the propensity score is used to weight a participant’s outcome score depends on whether
the ATE or ATT is estimated. When the ATE is estimated, each comparison group
member is weighted by their propensity score and each treatment group member is
weighted by one divided by their propensity score (Ridgeway et al., 2015). When the
ATT is estimated, each comparison group member is weighted by their propensity score
divided by one minus their propensity score (their odds for treatment group assignment)
and each treatment group member receives a weight of 1 (Ridgeway et al., 2015). When
ATC coding is used, each treatment group member is weighted by their propensity score
divided by one minus their propensity score (their odds for comparison group
assignment) and each comparison group member receives a weight of 1. Thus,
information from all treatment and comparison group members is included in the
estimation of the treatment effect (McCaffrey et al., 2004).
Generalized boosted modeling is advantageous over traditional matching methods
because generalized boosted models can support a large number of covariates and can
model linear, nonlinear, and interaction effects when estimating the propensity score
(Guo & Fraser, 2015; McCaffrey et al., 2004). The propensity score model is less prone
to model misspecification when generalized boosted modeling is used (compared to
traditional regression models) because information from many CART models is
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combined to create the optimal propensity score model (McCaffrey et al., 2004).
Boosting on the misclassified individuals results in better final estimated propensity
scores than those estimated using a single regression model (McCaffrey et al., 2004).
Generalized boosted modelling is also advantageous over traditional matching methods
because the outcome analysis is conducted on the entire sample rather than on the
reduced, matched sample.
The Role of Comparison Group Size in Propensity Score Matching
A common feature of propensity score matching is a comparison pool that is
substantially larger than the treatment group sample. A large comparison group pool with
common support can ensure adequate matches and reduce or eliminate loss of treatment
group members (Pan & Bai, 2015; Rubin, 1979; Stuart, 2010; Stuart & Rubin, 2008). In
one of the seminal PSM articles, Rosenbaum and Rubin (1985) stated “In many
observational studies, there is a relatively small group of subjects exposed to a treatment
and a much larger group of control subjects not exposed.” (p. 33). When implementing a
treatment (e.g., a drug to treat cancer, rehabilitation services, drug/alcohol cessation
programs, etc.) the number of individuals who can receive treatment is often specified
during the study design phase because the treatment requires significant resources. Thus,
the researcher can at the same time determine how large a comparison pool from which
to collect data. However, within educational contexts, for example, the number of
students who take a class (i.e., receive treatment or an intervention) and who do not take
a class (i.e., do not receive treatment or an intervention) may be outside of the
researcher’s control.
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Specifically, in higher education, assessment practitioners and educational
researchers are interested in the extent to which students achieve student learning
outcomes. General education learning outcomes are of interest to multiple stakeholders
(e.g., students, university administration, accrediting bodies). Often researchers are
interested in comparing student knowledge in general education subject areas across
different course completion conditions. In these situations, the researcher is unable to
assign students to specific treatment conditions. In many instances, it would be unethical
to assign certain students to complete certain courses. Thus, researchers may find
themselves in the situation where they have a larger sample of individuals who received a
treatment than the sample of those who did not. One might wonder, “Why would the
researcher consider using propensity score methods in this scenario?” When there are
systematic group differences between students who have and have not completed certain
courses (which, there likely are), then statistical analyses that were designed for use with
randomly assigned groups would not be appropriate. One seemingly obvious solution is
to simply increase the comparison pool size by administering the assessment to students
who have not completed certain courses. However, this may not always be feasible
within higher education.
Lacking from the propensity score methods literature is empirically supported
advice for whether propensity score methods should be used when the treatment group is
larger than the comparison group. Some warnings against using propensity score methods
when the treatment group is larger than the comparison group can be found. Stuart (2010)
stated “If estimating the ATT and there are not (or not many) more control than treated
individuals, appropriate choices are generally subclassification, full matching, and
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weighting by the odds” (p. 19). Ho et al. (2007) provided two options when the treatment
group is larger than the comparison group: match with replacement or recode the
treatment and comparison groups.
Recoding of the groups (e.g., treatment group = 1 versus treatment group = 0, and
vice versa for the comparison group) changes the effect that is estimated. When the
treatment group is coded 1, the ATT is the estimated treatment effect of interest. In
contrast, when recoded (treatment group = 0 and comparison group = 1), the actual
estimated treatment effect will be the ATC (i.e., the average treatment effect for the
comparison group; Ho et al., 2007). When the coding of the groups is switched from
reflecting ATT coding to reflecting ATC coding, propensity score matching will result in
a treatment group that is similar to the comparison group on the covariates. Thus, the
ATC is the treatment effect for those who did not receive treatment relative to those who
did receive treatment, which may not be of interest to educational researchers. Said
another way, estimation of the ATC answers the question “what is the effect of receiving
the treatment for those who did not receive the treatment?”
In an applied study using empirical data, Perkins and Horst (2020) compared
results using ATT and ATC coding across nearest neighbor matching (with and without a
0.20 SD caliper) and generalized boosted modeling when the treatment group was larger
than the comparison group. For each method, there were differences in the magnitude and
direction of the estimated treatment effect between ATT and ATC coding. Specifically,
across all methods, the magnitude of the estimated treatment effect was larger for ATT
coding than for ATC coding. For nearest neighbor matching, the estimated treatment
effect was negative for ATT coding (indicating that the mean outcome score of the
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treatment group was less than the mean outcome score of the comparison group) and
positive for ATC coding. For nearest neighbor matching with a caliper and generalized
boosted modeling, the estimated treatment effect was positive for ATT coding (indicating
that the mean outcome score of the comparison group was less than the mean outcome
score of the treatment group) and negative for ATC coding. Moreover, there was
substantial treatment group member loss with nearest neighbor matching with a 0.20
caliper and ATT coding (Perkins & Horst, 2020).
Using a simulation study, Holzman and Horst (2019) examined the ATT with
varying treatment to comparison group ratios for nearest neighbor matching and nearest
neighbor matching with a 0.20 caliper. When the treatment group was larger than the
comparison group, there was weaker common support, greater loss of treatment
members, and poorer estimation of the treatment effect than when the comparison group
was larger than the treatment effect (Holzman & Horst, 2019).
The lack of supported guidance regarding how to conduct propensity score
matching when the treatment group is larger than the comparison group is a gap in the
quasi-experimental literature that must be filled. An understanding of whether propensity
score methods result in accurate treatment effect estimates and inferences when the
treatment group is larger than the comparison group is needed.
Purpose of the Current Study
As noted, there is limited research and guidance regarding what quasiexperimental methods work best for reducing selection bias when the treatment group is
larger than the comparison group. Therefore, the aim of this study is to examine how
quasi-experimental methods perform when the treatment group is larger than the
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comparison group. Specifically, a simulation study was conducted because the population
treatment effect can be defined, and the ability of each method to recover the population
treatment effect can be examined. In order to provide recommendations regarding the use
of propensity score methods when the treatment group is larger than the comparison
group, three research questions were examined.
1a. When the treatment group is larger than the comparison group, are there
differences in the bias in the estimated treatment effect for different coding
methods (e.g., ATT, ATC), different treatment to comparison ratios (e.g., 2:1,
4:3, 1:4), different treatment sample sizes (e.g., 200, 600, 1,000), and different
treatment effect sizes (e.g., Cohen’s d of 0, 0.20, 0.50, 0.80) across propensity
score methods (e.g., nearest neighbor matching, nearest neighbor matching
with a 0.20 SD caliper, generalized boosted modeling)?
1b. When the treatment group is larger than the comparison group, are there
differences in the estimated treatment effect inferences for different coding
methods (e.g., ATT, ATC) across propensity score methods (e.g., nearest
neighbor matching, nearest neighbor matching with a 0.20 SD caliper,
generalized boosted modeling)?
2. When the treatment group is larger than the comparison group, are there
differences in the covariate balance after matching or weighting for different
coding methods (e.g., ATT, ATC), different treatment to comparison ratios
(e.g., 2:1, 4:3, 1:4), different treatment sample sizes (e.g., 200, 600, 1,000),
and different levels of initial covariate balance (e.g., SMD of 0, 0.20, 0.50,
0.80, 1.20) across propensity score methods (e.g., nearest neighbor matching,

53

nearest neighbor matching with a 0.20 SD caliper, generalized boosted
modeling)?
3. When the treatment group is larger than the comparison group, are there
differences in the loss of treatment group members for different coding
methods (e.g., ATT, ATC), different treatment to comparison ratios (e.g., 2:1,
4:3, 1:4), and different treatment sample sizes (e.g., 200, 600, 1,000) for
nearest neighbor matching with a 0.20 SD caliper? Do conditions in which
there is loss of treatment group members also show greater bias in the
estimated treatment effect?
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CHAPTER 3
Method
The goal of the current study was to examine how well propensity score methods
reduce systematic differences between groups when the treatment group is larger than the
comparison group. Across various conditions, I evaluated bias in the estimated treatment
effect, balance obtained after matching/weighting, treatment sample loss, and whether
inferences regarding the treatment effect differed. The following conditions were varied:
coding of the treatment and comparison group (i.e., ATT vs. ATC coding), magnitude of
the treatment effect (i.e., no effect to large effect), treatment to comparison group ratio
(i.e., 1:4, 2:1, and 4:3), and treatment group sample size (i.e., 200, 600, and 1000; see
Table 1).
Conditions
Treatment Group Sample Size
Treatment group sample size varied across three levels: 200, 600, and 1,000.
Treatment group sample size was manipulated to mimic realistic treatment group sample
sizes that might be observed in educational research (e.g., Fan & Nowell, 2011; Jacovidis
et al., 2017; Powell et al., 2020). Propensity score methods have been applied to varyingsized treatment groups in educational contexts (e.g., Fan & Nowell, 2011; Jacovidis et al.,
2017; Perkins & Horst, 2020; Powell et al., 2020; Stone & Tang, 2013). The large
treatment group sample sizes (i.e., 1,000) were included to mimic the situation where an
educational researcher combines data collected from multiple cohorts (e.g., Perkins &
Horst, 2020).
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Treatment to Comparison Group Ratio
When the comparison group is larger than the treatment group, the overarching
recommendation is that the comparison group be much larger than the treatment group
(Bai & Clark, 2019; Rubin, 1979). By having a large ratio of comparison group members
from which to select matches for treatment group members, there is a better chance of
finding good matches for each treatment group member than otherwise. A commonly
suggested treatment to comparison ratio is 1:4 (Bai & Clark, 2019; Rubin, 1979). There is
no guidance regarding treatment to comparison group ratio when the treatment group is
larger than the comparison group. However, the 2:1 treatment to comparison group ratio
was examined in one simulation study (Holzman & Horst, 2019). The lack of guidance
may be due to concerns about only capturing treatment effects for the overlap between
the treatment and comparison groups or not capturing heterogeneous treatment effects
within the range of overlap between the treatment and comparison groups. That is, if only
a sample of treatment group members are examined, there may be a loss of information
regarding the treatment effect.
When matching with a larger comparison group than treatment group, the
maximum number of matched pairs possible for any method is the size of the treatment
group (unless using one-to-many matching). For example, if there were 400 comparison
group members and 100 treatment group members, then the maximum number of
matched pairs would be 100 (i.e., the size of the treatment group). Conversely, when the
treatment group is larger than the comparison group, the maximum number of matched
pairs possible is the size of the comparison group (unless matching with replacement).
For example, if there were 400 treatment group members and 100 comparison group
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members, then the maximum number of matched pairs would again be 100 (i.e., the size
of the comparison group). Thus, when the treatment group is larger than the comparison
group and matching is done without replacement, there will always be a loss of treatment
group members. In sum, with one-to-one matching without replacement, the number of
matched pairs can only be as many as the smallest group sample size.
If the typically recommended treatment to comparison group ratio (i.e., 1:4) were
reversed (i.e., a treatment to comparison ratio of 4:1), a maximum of 25% of the
treatment group will be retained in the matched sample. Thus, when the treatment group
is larger than the comparison group, there will always be a loss of treatment group
members. Treatment to comparison group ratios of 2:1 and 4:3, allow for a maximum of
50% or 75% of treatment group members to be retained in the matched sample,
respectively. In the current study, the treatment to comparison group ratio varied across
three levels: 2:1, 4:3, and 1:4. Treatment sample size was fully crossed with treatment to
comparison group ratio, which resulted in nine configurations (see Table 2). Total sample
size ranged from 300 to 5,000 depending on the treatment group sample size and
treatment to comparison group ratio.
Treatment Effect Size
Treatment effect size in the population varied across four levels: Cohen’s d of 0,
0.20, 0.50, and 0.80. The selected levels align with no, small, medium, and large effects,
respectively (Cohen, 1988). Although very large effect sizes (i.e., Cohen’s d greater than
1) were not included as a condition, small to moderate effect sizes have been shown to be
typical within educational research (Cheung & Slavin, 2016; Hill et al., 2008; Kraft,
2020).
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Group Dummy Coding
Coding varied based on the recommendation to switch the coding of the treatment
and comparison group when the treatment group is larger than the comparison group (Ho
et al., 2007), which has also been used empirically (e.g., Perkins & Horst, 2020). Coding
of the treatment and comparison groups varied across two levels: the first coding was
treatment group coded 1 and comparison group coded 0, and the second coding was
treatment group coded 0 and comparison group coded 1. When the treatment group is
coded as 1, the ATT reflects the average treatment effect of those who received treatment
because comparison group members are selected if they resemble treatment group
members on the covariates. This results in a comparison group sample that is similar to
the treatment group sample on the covariates. Calling back to the counterfactual, the ATT
reflects whether comparison group members with propensity scores similar to treatment
group members score the same on the outcome.
In contrast, when the comparison group is coded as 1, the comparison group is
essentially being treated how we typically think of the treatment group, and vice versa.
Propensity scores are now the probability of comparison group assignment, conditional
upon the covariates in the model. As a result of coding the treatment group 0, there will
be a larger pool from which to select matches for each comparison group member
because the original treatment group is now considered to be the comparison group.
Accordingly, the coding will result in estimation of the ATC, reflecting the average
treatment effect of those who did not receive treatment. Thus, treatment group members
are selected if they resemble comparison group members on the covariates, resulting in a
treatment group sample that is similar to the comparison group on the covariates. Calling

58

back to the counterfactual, the ATC reflects whether treatment group members with
propensity scores similar to comparison group members score the same on the outcome.
Simulation of Data
Data were simulated and analyzed using RStudio version 3.6.1 (RStudio Team,
2018). Using the mvtnorm package (Genz et al., 2019), data were simulated for nine
configurations of treatment sample size and treatment to comparison group ratio (see
Table 2 and Appendix) across 1,000 replications. Total simulees for which data were
generated ranged from 300 (Configuration A) to 5,000 (Configuration I; see Table 2).
Data for each configuration were simulated via four steps, following the simulation
process used by Harris (2018),
1. Generate values for five continuous covariates from a random multivariate
normal distribution with means of zero and standard deviations of one.
2. Calculate true propensity scores for each simulee from the values of the
covariates. True propensity scores were first calculated on the probit metric,
then centered according to the treatment to comparison group ratio, and finally
converted to the probability metric.
3. Assign simulees to the treatment or comparison group based on whether the
value of a random draw between zero and one was greater than or less than
their true propensity score.
4. Simulate outcome scores based on a linear combination of treatment
assignment and the covariates (plus a random error term). Four outcome
scores were generated for each sample in order to vary the magnitude of the
true treatment effect (Cohen’s d of 0, 0.20, 0.50, and 0.80).
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First, values for X1-X5 (the continuous covariates) were generated from a
multivariate normal distribution (M = 0, SD = 1). The correlations between the five
continuous covariates ranged from 0.10 to 0.65 (see Table 3) to reflect the relations
typically seen between variables in educational psychology (Osbourne, 2002). The
covariates were also differentially related to treatment assignment to reflect different
levels of baseline balance between the groups on the covariates. The following
correlations were specified between the propensity score and each covariate (rX1 = -0.02,
rX2 = 0.15, rX3 = 0.40, rX4 = 0.70, rX5 = 0.90) in order to set specific group balance on the
covariates prior to matching or weighting (SMDX1 = 0, SMDX2 = 0.20, SMDX3 = 0.50,
SMDX4 = 0.80, SMDX5 = 1.20), respectively.
Second, true propensity scores were calculated for each simulee using matrix
algebra. A vector of weights (B) was calculated via:
̂𝑔𝑟𝑜𝑢𝑝
𝑩 = (𝑿′𝑿)−1 𝑿′𝒀

(2)

̂𝑔𝑟𝑜𝑢𝑝 is a vector of the
where 𝑿 is a matrix of correlations between the covariates, 𝑿′𝒀
correlations between each covariate and propensity for treatment. The vector of weights
(B) was then multiplied by the simulated covariate values (X1 through X5) for each
simulee, which were summed to produce a predicted Y score for each simulee on the
̂𝑔𝑟𝑜𝑢𝑝 ). To set each specific treatment to comparison group ratio, the
probit metric (𝒀
predicted Y probit scores were rescaled by subtracting the intercept from each predicted
Y probit scores (a linear transformation). The probit intercept was calculated via:
𝑧
𝑩′ 𝑹𝑩

√(1−( ′
))
𝑩 𝑹𝑩+1

were 𝑧 is value from a standard, normal distribution corresponding to one minus the
proportion of each sample that received treatment (i.e., 1 − 0.667, 1 − 0.571, and 1 −

(3)
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𝑩′ 𝑹𝑩

0.200 for 2:1, 4:3, and 1:4 treatment to comparison group ratios, respectively) and 𝑩′ 𝑹𝑩+1
is the variance explained in propensity for treatment by the covariates (where 𝑹 is the
matrix of correlations between the covariates). After rescaling, the propensity scores were
transformed from the probit metric to the probability metric. For each simulee, the
′
proportion of scores that fell at or below the rescaled value of 𝒀𝑔𝑟𝑜𝑢𝑝
on a normal curve

with 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 = 𝑩′ 𝑹𝑩 + 1 indicated the true propensity for treatment on the
probability metric (0 to 1).
Third, each simulee was assigned a random value from 0 to 1 from a uniform
distribution. To assign treatment membership to each simulee, their random value was
compared to their true propensity score. If the random value was less than or equal to the
true propensity score, the simulee was assigned to the comparison group (group = 0).
Conversely, if the random value was greater than the true propensity score, the simulee
was assigned to the treatment group (group = 1). Due to the rescaling of the propensity
scores, treatment membership was assigned for each sample according to the specified
treatment to comparison group ratio.
Fourth, in order to vary the magnitude of the treatment effect, values for four
outcome variables were generated for each simulee via linear regression:
𝑌1 = 0(𝑔𝑟𝑜𝑢𝑝) + 0.05𝑋1 + 0.05𝑋2 + 0.05𝑋3 + 0.05𝑋4 + 0.05𝑋5 + 𝑣

(4)

𝑌2 = 0.11(𝑔𝑟𝑜𝑢𝑝) + 0.05𝑋1 + 0.05𝑋2 + 0.05𝑋3 + 0.05𝑋4 + 0.05𝑋5 + 𝑣

(5)

𝑌3 = 0.28(𝑔𝑟𝑜𝑢𝑝) + 0.05𝑋1 + 0.05𝑋2 + 0.05𝑋3 + 0.05𝑋4 + 0.05𝑋5 + 𝑣

(6)

𝑌4 = 0.45(𝑔𝑟𝑜𝑢𝑝) + 0.05𝑋1 + 0.05𝑋2 + 0.05𝑋3 + 0.05𝑋4 + 0.05𝑋5 + 𝑣

(7)

where the magnitude of the treatment effect varied across the four outcome variables (𝑌1
through 𝑌4 ). To introduce random error into each outcome variable, a random error term
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(𝑣) was generated for each simulee from a normal distribution with a mean of 0 and
standard deviation of 0.5. To specify the magnitude of the treatment effect when there are
no systematic group differences on the covariates, the regression weight for the grouping
variable was set as follows; 𝑏1 = 0, 𝑏2 = 0.11, 𝑏3 = 0.28, 𝑏4 = 0.45. Specifically, if
every simulee were the same on the covariates (X1 through X5), the estimated treatment
effect (on a Cohen’s d metric) for the simulated Y scores should be; 𝑑1 = 0, 𝑑2 = 0.20,
𝑑3 = 0.50, 𝑑4 = 0.80. The regression weights for each covariate resulted in correlations
between the covariates and each outcome variable that ranged from 0.15 to 0.45, which is
typical within educational contexts (Osbourne, 2002). Each of the four true treatment
effects were simulated to be homogeneous across levels of the propensity score. Thus, the
magnitude of the true treatment effect was the same across ATT, ATC, and ATE coding.
Following the simulation of data, propensity score matching (nearest neighbor
and nearest neighbor with a 0.20 SD caliper) and generalized boosted modeling were
conducted for each of the 1,000 replications across 8 combinations of group coding and
true treatment effect size (2 coding schemes * 4 true treatment effect sizes). All
conditions were fully crossed (see Table 1), resulting in 216 unique combinations of 3
treatment sample sizes, 3 treatment to comparison group ratios, 4 true treatment effect
sizes, 3 propensity score methods, and 2 group coding schemes (3 ∗ 3 ∗ 4 ∗ 3 ∗ 2 = 216).
Propensity Score Matching
For nearest neighbor matching and nearest neighbor matching with a 0.20 SD
caliper, propensity scores were estimated using the MatchIt package in R (Ho et al.,
2011). Propensity scores were estimated via a logistic regression model with the five
covariates (X1, X2, X3, X4, and X5) as predictors of treatment assignment (0, 1). When
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the treatment group is larger than the comparison group, the matchit function sorts the
treatment group members by the propensity score from largest to smallest by default.
However, random ordering of treatment group members by the propensity score resulted
in better matches than high to low or low to high ordering (Austin, 2013). Thus, treatment
group member ordering was specified to be random prior to matching. Nearest neighbor
matching and nearest neighbor matching with a 0.20 SD caliper were selected, as these
matching methods are frequently employed in the propensity score matching literature
(e.g., Austin, 2011, 2013; Caliendo & Kopeinig, 2008; Cochran & Rubin, 1973; Stuart,
2010; Stuart & Rubin, 2008). Additionally, both nearest neighbor and nearest neighbor
with a SD caliper have been used in the limited simulation (Austin & Cafri, 2020;
Holzman & Horst, 2019) and empirical studies (Lechner, 2000; Perkins & Horst, 2020)
where the treatment group was larger than the comparison group.
Generalized Boosted Modeling
Generalized boosted modeling was conducted using the Twang package in R
(Ridgeway et al., 2020). Propensity scores were estimated via a logistic regression model
with the five covariates (X1, X2, X3, X4, and X5) as predictors of treatment assignment
(0, 1).
For each replication, the following tuning parameters were selected: 10,000 trees,
interaction depth of 3, and shrinkage of .01. These values were selected based on the
recommendations by Ridgeway et al. (2020). To ensure that the optimal iteration was not
too close to the specified number of trees, 10,000 trees were specified (Ridgeway et al.,
2020). The optimal iteration was identified as the iteration that resulted in the smallest
mean standardized effect size across the five covariates. After generalized boosted
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modeling was performed, the ATT weights were estimated using the Twang package
(Ridgeway et al., 2020).
Treatment Effect Estimation
For nearest neighbor and nearest neighbor with a 0.20 SD caliper, the treatment
effect was estimated from the matched group samples via linear regression:
𝑌𝑖 = 𝑏0 + 𝑏1 (𝑔𝑟𝑜𝑢𝑝) + 𝑒𝑖

(8)

where 𝑏1 indicates the treatment effect, 𝑏0 is the comparison group mean on the outcome
variable, and 𝑒𝑖 is the error term, estimated for each of the four simulated outcome
variables (𝑖 = 1 𝑡ℎ𝑟𝑜𝑢𝑔ℎ 4). For generalized boosted modeling, the ATT weights were
applied during treatment effect estimation. The effect size (Cohen’s d) of the mean
difference between the treatment and comparison group was calculated for each
replication by dividing the mean difference between groups by the SD pooled across both
groups.
Criteria for Evaluating Research Questions
A summary of the values that were saved from the simulated data is provided in
Table 4. Each research question was evaluated over a different number of combinations
of the simulation conditions. Specifically research questions 1, 2, and 3 were evaluated
over 216, 270, and 36 combinations of conditions, respectively. After collapsing across
replications, bias in the estimated treatment effect, balance after matching or weighting,
loss of treatment group members, and the estimated treatment effect inference were
examined.
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Research Question 1a: When the Treatment Group is Larger Than the Comparison
Group, Can Propensity Score Methods Accurately Recover the True Treatment Effect?
To answer this research question, bias in the estimated treatment effect was
examined. Bias in the estimated treatment effect is the extent to which the estimated
treatment effect differs from the population treatment effect (Feinberg & Rubright, 2016).
If the estimated treatment effect is unbiased, across repeated sampling, there should be
little to no deviation from the population treatment effect (Feinberg & Rubright, 2016).
Values different than zero indicate that the estimated treatment effect is biased, with large
values indicating large bias. Bias was calculated as:
𝐵𝑖𝑎𝑠 =

̂
∑𝑛
𝑖=1(𝜃𝑖 −𝜃𝑇𝑟𝑢𝑒 )
𝑛

(9)

where the numerator is the sum of the deviation between the estimated treatment effect
(𝜃̂) from the population treatment effect (𝜃𝑇𝑟𝑢𝑒 ) for each replication (𝑖), averaged across
𝑛 replications (Feinberg & Rubright, 2016). The summed deviations were then averaged
by dividing the numerator by the number of replications (𝑛). Bias in the estimated
treatment effect (on the Cohen’s d standardized effect size metric) was evaluated for each
propensity score method across coding methods, treatment to comparison ratios,
treatment sample sizes, and true treatment effect sizes via a 3x2x3x3x4 ANOVA.
Research Question 1b: Does the Magnitude and Direction of the Estimated Treatment
Effect Differ Across Propensity Score Methods Depending on Group Coding?
The magnitude and direction of the estimated treatment effect using ATC coding
was compared to the magnitude and direction of the estimated treatment effect using
ATT coding. If the magnitude and/or direction of the treatment effect differed across
conditions, the inference made regarding treatment effectiveness differed. The magnitude
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and direction of the estimated treatment effect using different coding methods was
examined across treatment to comparison ratios, treatment sample sizes, and true
treatment effect sizes.
Research Question 2: When the Treatment Group is Larger Than the Comparison
Group, Can Propensity Score Methods Achieve Adequate Group Balance on the
Covariates?
Balance after matching or weighting was examined numerically by obtaining the
standardized mean difference and percent in bias reduction for each covariate and the
propensity score. Examining group balance on the covariates after matching or weighting
provides an indication of how well each method works at reducing systematic group
differences on the covariates. Additionally, the ratio of treatment group propensity score
variance to comparison group propensity score variance was evaluated to examine group
balance.
Standardized mean differences are an effect size for the lack of balance between
groups, with a zero value indicating no mean difference between the groups on the
covariate (Austin, 2011; Caliendo & Kopeinig, 2008; Stuart, 2010; Stuart & Rubin,
2008). Guidelines have been provided for what standardized mean difference value
indicates acceptable group balance, ranging from 0.05 (What Works Clearinghouse,
2017) to 0.25 (Rubin, 2001). For this study, the standardized mean differences will be
reported, and values ≤ |0.10| will indicate that the groups are adequately balanced after
matching or weighting. This value was chosen as it is not too stringent or lenient and has
been used as a guideline for group balance in other simulation studies (Austin 2009,
2011, 2013).
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Percent in bias reduction quantifies the extent to which bias in each covariate is
reduced relative to initial balance (Pan & Bai, 2015). A percent in bias reduction of 100
would indicate that group means on the covariate were equal after matching or weighting,
and that 100% of the original covariate imbalance was corrected. For this study, the
percent in bias reduction was reported, and values ≥ 80% indicated that the groups were
adequately balanced after matching or weighting (Pan & Bai, 2015)
The ratio of the groups’ propensity score variance provides an indication of the
quality of balance for matching methods (Rubin, 2001; Stuart, 2010). Ratios close to 1
indicate that the variance of the propensity score is similar across the treatment and
comparison group.
Visual examination of group balance on the propensity score is important for
evaluating common support, or the extent to which the group distributions of the
propensity score are similar. Typically, when using propensity score methods, balance is
evaluated visually using jitter plots and histograms (Austin, 2011; Ho et al., 2007; Stuart,
2010). Examination of jitter plots for each replication of each condition is not feasible,
thus, jitter plots were examined for validation datasets. In sum, for research question two,
group balance on the covariates and the propensity score after matching or weighting was
evaluated via standardized mean differences and percentage in bias reduction for each
propensity score method across coding methods, treatment to comparison ratios,
treatment sample sizes, and initial covariate balance between the groups.
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Research Question 3: When the Treatment Group is Larger Than the Comparison
Group, Does the Loss of Treatment Group Members Differ Across Conditions?
Loss of treatment group members was examined for nearest neighbor and nearest
neighbor with a caliper across coding methods, treatment to comparison ratios, and
treatment sample sizes. Loss of treatment group members was quantified as the percent of
treatment group members not retained in the matched sample (for nearest neighbor and
nearest neighbor with 0.20 SD caliper). For generalized boosted modeling, there is no
loss of treatment group members because when estimating the treatment effect, the full
treatment and comparison group samples are retained, and each individual receives a
weight based on their propensity score. In addition to examination of sample size, the
average propensity score for matched and unmatched treatment group members were
compared to determine whether the unmatched treatment group members qualitatively
differed from the matched treatment group members.
Summary
In summary, each research question was answered using a different criterion. By
examining bias in the estimated treatment effect (RQ1a), the estimated treatment effect
inference (RQ1b), balance after matching or weighting (RQ2), and loss of treatment
group members (RQ3) across the varied conditions, this study will expand the current
understanding of whether propensity score methods are appropriate to use when the
treatment group is larger than the comparison group.
Validation Data Sets
To evaluate whether the data were simulated correctly, one replication was
examined for each configuration (samples A through I). First, the relations among the
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covariates, propensity score, and treatment assignment, and initial covariate balance
between the groups were examined to evaluate whether the data were correctly simulated.
Next, the treatment group sample size and treatment to comparison group ratio were
examined to evaluate whether treatment assignment was correctly simulated. Finally, the
true treatment effect for each of the four outcome variables was examined to evaluate the
magnitude of the treatment effect if groups were not systematically different on the
covariates. The validation data sets also allowed for the visual examination of the overlap
between the treatment and comparison group propensity score distributions (before
matching or weighting) via jitter plots.
Validation of Covariate Values
The standardized group mean differences and correlations between the covariates
and latent propensity for treatment were evaluated for samples A through I. The results
for each validation sample were compared to Table 3 to evaluate whether the values of
the simulated data matched the specified values.
Across all nine validation samples, the standardized group mean differences and
correlations between the covariates and latent propensity for treatment were consistent
with the values that were specified (see Table 5). Of note, for validation sample D, the
correlation between X1 and X2 was inflated. Additionally, the correlations between X1
and treatment selection and X1 and propensity scores were stronger than specified. Not
surprisingly, the standardized mean difference for X1 was larger than specified (-0.21
instead of 0). These values were considered a product of sampling variability, yet
maintained the patterns specified in the simulation.
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Validation of Treatment Assignment and True Treatment Effect
Group sample sizes and treatment to comparison group ratio were examined for
samples A through I to evaluate whether treatment assignment was correctly specified.
The group sample sizes for each validation sample were compared to Table 2 to
determine accuracy. The magnitude of the true treatment effect (e.g., the group difference
on the outcome if there were no group imbalance on the covariates) was examined in
each sample to evaluate whether the values for the outcome variables were simulated
correctly.
Across all nine validation samples, the group sample sizes, the treatment to
comparison group ratio, and the true treatment effect were consistent with the specified
values (see Table 6). Of note, the treatment group was slightly larger than intended in
validation sample A, however the true treatment effect was simulated well. For validation
sample G, the true treatment effect was stronger than specified across all four outcome
variables. These minor deviations were considered a product of sampling variability, yet
maintained the patterns specified in the simulation.
Evaluation of Common Support
Examination of the overlap between the groups’ propensity score distributions
provided an indication of whether there was common support between the groups on the
propensity scores. Across all nine validation samples, there appeared to be adequate
common support between the treatment and comparison groups on the propensity scores
(see Figure 2). For samples where the treatment group was larger than the comparison
group (samples A through F), the propensity score distribution was more dense at higher
propensity score values for the treatment group. Conversely, for samples where the
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comparison group was larger than the treatment group (samples G through I), the
propensity score distribution was denser at lower propensity score values for the
comparison group.
In summary, the results from the nine validation samples indicated that the data
were simulated as specified.
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CHAPTER 4
Results
Evaluation of Simulated Data
Simulated covariate and true propensity score means and standard deviations for
each scenario are presented in Table 7. Means and standard deviations for each covariate,
collapsed across treatment and comparison groups, were approximately 0 and 1,
respectively. Additionally, the small standard errors for the means and standard
deviations for each covariate indicated that there was a small amount of variability in
these values across the 1,000 replications for each scenario. The mean true propensity
score, prior to matching or weighting, collapsed across treatment and comparison groups,
matched the proportion of individuals assigned to the treatment group as specified by the
treatment to comparison group ratio set for each scenario. For all scenarios, the treatment
group had a higher mean propensity score than the comparison group, indicating a higher
propensity for treatment.
Average correlations between covariates and the true propensity score for each
scenario are presented in Table 8. All values aligned with those in the simulation code,
indicating that the relations between the covariates and true propensity score were
simulated well across the 1,000 replications for each scenario.
Simulated treatment and comparison group outcome means and standard
deviations for each scenario are presented in Table 9. For all four outcome variables
(representing different true treatment effects; Cohen’s d of Y1 = 0, Y2 = 0.20, Y3 = 0.50,
and Y4 = 0.80), the treatment group had a higher mean outcome score than the
comparison group. As intended, there was a difference in the average outcome between
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treatment and comparison groups prior to applying propensity score methods to reduce
systematic group differences, allowing for the examination of research question one
across different true treatment effects.
Cohen’s d effect sizes for each average true treatment effect are presented by
scenario and coding method in Table 10. First, across all scenarios, the true treatment
effect aligned with the values specified in the simulation. Specifically, on average, the
simulated true treatment effect sizes approached the specified Cohen’s d effect sizes of 0,
0.20, 0.50, and 0.80 for Y1, Y2, Y3, and Y4, respectively. As would be expected, for
scenarios with smaller sample sizes (i.e., scenarios A, D, and G), the standard errors of
the mean true treatment effect were larger than for scenarios with larger sample sizes
(i.e., scenarios B, C, E, F, H, and I). Note that for each scenario, each true treatment
effect was of the same magnitude for ATT and ATC coding. However, the direction of
the effect differed across ATT and ATC coding. That is, if the true treatment effect was
positive for ATT coding, the true treatment effect was negative for ATC coding. This
indicated that regardless of coding method, the magnitude of the estimated treatment
effect was the same, with only a directional difference. The results presented in Tables 8,
9, and 10, together indicated that the data were simulated as specified.
To evaluate convergence of the generalized boosted models, the mean, median,
minimum, and maximum optimal iterations are presented in Table 11. Overall, the
models reached the optimal iteration with relatively few iterations. For scenarios B
through F, in which the treatment group was larger than the comparison group,
generalized boosted modeling required more iterations to achieve the optimal iteration for
ATT coding than for ATC coding. For scenarios G through I, in which the comparison
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group was larger than the treatment group, generalized boosted modeling took more
iterations to achieve the optimal iteration for ATC coding than for ATT coding. Thus,
when the group coded “1” was larger than the group coded “0” (except for scenario A,
which had the smallest total sample size), on average it took more iterations to achieve
the optimal iteration.
Evaluation of Research Questions
Given that the data were simulated as intended and that generalized boosted
models converged in fewer iterations than the maximum number of specific iterations,
the research questions could be evaluated. Results are presented by research question.
Research Question 1
The first research question focused on the ability of each propensity score method
to accurately recover the true treatment effect across coding methods, treatment to
comparison ratios, treatment sample sizes, and true treatment effect sizes. Bias in the
estimated treatment effect was evaluated for each replication for each scenario, then
averaged across the 1,000 replications for each scenario. Bias values other than 0
indicated that the true treatment effect was not accurately recovered. Additionally, bias
was evaluated via a 3x2x3x3x4 ANOVA. Given the large number of replications,
statistical significance tests were overpowered. Thus, more weight was given to practical
significance (partial eta squared) to determine whether there were significant effects for
the five conditions and all interactions among conditions.
The average Cohen’s d effect size, average bias, and standard errors are presented
for each true treatment effect (Y1 through Y4) in Table 12. First, the baseline values
show the amount of bias in the estimated treatment effect for the unmatched or
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unweighted sample. Across all scenarios, the amount of bias in each baseline estimated
treatment effect was fairly consistent, with the amount of bias increasing slightly as the
true treatment effect increased. Looking at the bolded values in Table 12, three noticeable
patterns emerge.
First, notice that for scenarios where the treatment group was larger than the
comparison group (scenarios A through F), nearest neighbor matching always resulted in
a large amount of bias in the estimated treatment effect. For ATT coding, the estimated
treatment effect after nearest neighbor matching differed very little from the baseline
treatment effect. Although there was a reduction in bias in the estimated treatment effect
from baseline after nearest neighbor matching for ATC coding, a non-negligible amount
of bias remained. Conversely, when the treatment group was smaller than the comparison
group (scenarios G through I), nearest neighbor matching using ATT coding resulted in
substantially less bias for Y1, Y2, and Y3 than when the treatment group was larger than
the comparison group. For scenarios G through I, nearest neighbor matching using ATC
coding (which, because of the 1:4 ratio, resulted in the group that was coded 0 being
smaller than the group that was coded as 1) resulted in substantially more bias than for
ATT coding. In fact, for scenarios G through I, the bias in the estimated treatment effect
for ATC coding was very similar to the baseline bias in the estimated treatment effect.
Thus, for nearest neighbor matching, using a coding scheme in which the largest group
was coded “1” resulted in very little to no difference in the estimated treatment effect
when compared to the baseline treatment effect.
Second, notice that for nearest neighbor matching with a 0.20 SD caliper, the
amount of bias in estimated treatment effect was small for all scenarios, all true treatment
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effects, and all coding methods. Across all scenarios and coding methods, the amount of
bias in the estimated treatment effect increased as the true treatment effect increased.
That is, although there was little bias in the estimated treatment effect for Y1 and Y2
(true treatment effect sizes of 0 and 0.20, respectively), there was a larger, but still
relatively small, amount of bias in the estimated treatment effect for Y3 and Y4 (true
treatment effect sizes of 0.50 and 0.80, respectively). These results suggested that nearest
neighbor with a 0.20 caliper resulted in a generally unbiased estimate of the treatment
effect when the treatment group was larger than the comparison group.
Third, for generalized boosted modeling, the amount of bias in the estimated
treatment effect was relatively small for all scenarios and all coding methods for Y1 and
Y2. For Y3 and Y4, bias in the estimated treatment effect after generalized boosted
modeling was larger than for Y1 and Y2. Additionally for all true treatment effects, bias
after generalized boosted modeling was larger than after nearest neighbor matching with
a caliper, except for Y2 (scenarios A, D, and H with ATT coding, and B, C, and D with
ATC coding) and Y3 (scenarios D with ATC coding, and G with ATT coding). Thus, it
appeared that generalized boosted modeling using either ATT or ATC coding resulted in
a larger amount of bias in the estimated treatment effect than nearest neighbor matching
with a caliper and a substantially smaller amount of bias in the estimated treatment effect
than nearest neighbor matching.
Additionally, across all scenarios, when comparing bias across ATT and ATC
coding, the direction of the bias differed consistently. That is, if the average bias was
positive for ATT coding, it was negative for ATC coding, and vice versa. This pattern
was not surprising given that the true treatment effect differed in sign across ATT and
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ATC coding. However, the pattern of differences in the magnitude of bias was less clearcut than the pattern of directional differences and did not solely differ across coding
method.
To better understand differences in the amount of bias in the estimated treatment
effect across propensity score method, coding method, treatment to comparison ratios,
treatment sample sizes, and true treatment effect sizes a 3x2x3x3x4 ANOVA was
conducted1. Given the large sample size due to the large number of replications for each
scenario, statistical significance was reported and effects that were practically significant
were interpreted. Meaningful practically significant effects were identified as those that
explained greater than or equal to 2% of the variance in bias. That is, partial-eta squared
values greater than or equal to .02 indicated a small meaningful effect (Cohen, 1988).
ANOVA results are presented in Table 13. Four effects were both statistically significant
and accounted for greater than or equal to 2% of the variance in bias: propensity score
method (ηp2 = 0.551), the interaction between propensity score method and effect size
(ηp2 = 0.187), the interaction between coding method and treatment to comparison ratio
(ηp2 = 0.024), and the interaction between propensity score method, coding method, and
treatment to comparison ratio (ηp2 = 0.159). As is standard practice, main effects were not

1

Given that the direction of bias differed consistently across ATT and ATC coding, the
direction of bias observed for ATC coding was reversed prior to conducting the ANOVA.
That is, if the ATC bias value was negative, it was made to be positive and if the ATC
bias value was positive, it was made to be negative. The difference in sign across ATT
and ATC coding accurately reflects that the original treatment group outcome mean was
higher than the original comparison group outcome mean. Reversing the sign for only
ATC coding retained information regarding the magnitude of bias in the estimated
treatment effect, allowing for examination of differences in the magnitude of bias in the
estimated treatment effect via statistical significance tests and effect sizes.
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interpreted for conditions for which there was a statistically significant and meaningful
interaction (Cohen, 2013). Therefore, because there was a statistically significant and
meaningful three-way interaction between propensity score method, coding method, and
treatment to comparison ratio, the main effect for propensity score method and the twoway interaction between coding method and treatment to comparison ratio were not
interpreted.
The three-way interaction between propensity score method, coding method, and
treatment to comparison ratio accounted for 15.90% of the variance in bias. Mean bias for
each combination of propensity score method, coding method, and treatment to
comparison group ratio are presented in Table 14. Generalized boosted modeling with
ATT coding and a 1:4 ratio, generalized boosted modeling with ATC coding and a 2:1 or
4:3 ratio, and nearest neighbor matching with a caliper (for all coding methods and all
ratios) had the lowest mean bias. The observation of low bias in the estimated treatment
effect for generalized boosted modeling and nearest neighbor matching with a caliper
with ATT coding and a 1:4 ratio were not surprising given that these conditions replicate
previous research recommendations (e.g., Rubin, 1979).
The statistically significant and meaningful three-way interaction between
propensity score method, coding method, and treatment to comparison ratio indicated that
the interaction between coding method and treatment to comparison ratio depended on
propensity score method. Said another way, there was a different pattern of interaction
between coding method and treatment to comparison ratio for each propensity score
method. To better understand this effect, three two-way interaction models between
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coding method and treatment to comparison ratio were examined (one for each
propensity score method).
The interaction between coding method and treatment to comparison ratio was
statistically significant and meaningful for nearest neighbor matching (F(2, 71994) =
22436.553, p < .001, partial η2 = .384) and generalized boosted modeling (F(2, 71994) =
1912.556, p < .001, partial η2 = .050). However, for nearest neighbor matching with a
caliper, the interaction between coding method and treatment to comparison ratio was
statistically significant but not meaningful (F(2, 71994) = 13.052, p = <.001, partial η2 <
.001). The statistically significant and meaningful interactions between coding method
and treatment to comparison ratio were further examined for nearest neighbor matching
and generalized boosted modeling.
For both nearest neighbor matching and generalized boosted modeling, there were
statistically significant and meaningful differences in bias between ATT coding and ATC
coding for each treatment to comparison ratio (see Table 14 and Figure 3). For both
nearest neighbor matching and generalized boosted modeling with a treatment to
comparison ratio of 1:4, bias in the estimated treatment effect was larger in magnitude for
ATC coding than for ATT coding. Conversely for both nearest neighbor matching and
generalized boosted modeling with a treatment to comparison ratio of 2:1 or 4:3, bias in
the estimated treatment effect was larger in magnitude for ATT coding than for ATC
coding. Overall, generalized boosted modeling resulted in a lower magnitude of bias
across all coding methods and treatment to comparison group ratios than nearest neighbor
matching. Additionally, generalized boosted modeling overcorrected bias in the estimated
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treatment effect as evidenced by the negative average bias values for all coding methods
and treatment to comparison group ratios.
For nearest neighbor matching with a caliper, average bias was consistently low
across coding method and treatment to comparison group ratio. Thus, there was no effect
for coding method or treatment to comparison group ratio on bias in the estimated
treatment effect after nearest neighbor matching with a 0.20 SD caliper.
After accounting for the three-way interaction, there was a statistically significant
and meaningful two-way interaction between propensity score method and true treatment
effect size. The two-way interaction between propensity score method and true treatment
effect size accounted for an additional 18.70% of the variance in bias.
Further examination of the two-way interaction between propensity score method
and true treatment effect size revealed that for all true treatment effect sizes, there were
statistically significant and meaningful differences in bias in the estimated treatment
effect across propensity score methods (see Table 15 and Figure 4). The lowest
magnitude of mean bias was observed when there was no true treatment effect (i.e., Y1,
SMD = 0) or when the true treatment effect was small (i.e., Y2, SMD = 0.20), for both
nearest neighbor matching with a caliper and generalized boosted modeling. Nearest
neighbor matching with a caliper was the only method that resulted in average bias less
than |0.10| for all four true treatment effect sizes. Across all four true treatment effect
sizes nearest neighbor matching (with no caliper) resulted in the highest levels of average
bias compared to nearest neighbor matching and generalized boosted modeling.
For all true treatment effects, the magnitude of bias in the estimated treatment
effect was largest for nearest neighbor matching, followed by generalized boosted
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modeling, with the least bias observed for nearest neighbor matching with a caliper. All
three propensity score methods resulted in a reduction in bias from that observed at
baseline, however bias remained large after nearest neighbor matching (for all true
treatment effects) and generalized boosted modeling (for treatment effects of 0.50 and
0.80).
The smallest differences in bias (although still statistically significant and
meaningful) were observed between nearest neighbor matching with a caliper and
generalized boosted modeling for no true treatment effect and a small true treatment
effect. The magnitude of differences in bias between nearest neighbor matching with a
caliper and generalized boosted modeling increased for a medium and large true
treatment effect. That is, for Y3 and Y4, generalized boosted modeling resulted in a
higher average magnitude of bias than nearest neighbor matching with a caliper, and
there was a larger difference in bias between the two propensity score methods than was
observed for Y1 and Y2.
In summary, bias in the estimated treatment effect did not differ much between
generalized boosted modeling and nearest neighbor matching with a caliper when the true
treatment effect was 0 or 0.20 (Y1 and Y2, respectively). In these instances, nearest
neighbor matching with a caliper performed the best, followed by generalized boosted
modeling. There was substantially more bias for generalized boosted modeling when the
true treatment effect was 0.50 or 0.80 (Y3 and Y4, respectively). Across all true treatment
effect sizes, nearest neighbor matching had the highest bias in the estimated treatment
effect.
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Research Question 2
The second research question focused on the extent to which group balance was
achieved on the covariates across propensity score method, coding method, treatment to
comparison ratio, treatment sample size, and initial covariate balance between the groups.
Balance was evaluated via the standardized mean difference (values ≤ |0.10| indicated
adequate balance; Austin, 2009, 2011, 2013), percentage in bias reduction (values ≥
80.00 indicated adequate reduction in bias; Pan & Bai, 2015), and the propensity score
variance ratio (values close to 1.00 indicated similar variances; Rubin, 2001).
Average (mean) standardized mean differences and median percentage in bias
reduction for each covariate and the estimated propensity scores are presented by
scenario in Table 16. The baseline standardized mean differences for each of the five
covariates were consistent across all scenarios and coding methods. The baseline
standardized mean differences aligned with the values specified of 0, 0.20, 0.50, 0.80,
and 1.20 for X1, X2, X3, X4, and X5, respectively. Thus, each covariate had a different
level of baseline group balance, which allowed for the examination of balance obtained
across different initial levels of baseline covariate balance. Additionally, across coding
method (i.e., ATT or ATC), initial covariate balance differed in sign, with small
differences in magnitude for all scenarios. Examination of Table 16 revealed three main
patterns for the average standardized mean difference.
First, notice that for nearest neighbor matching, the only covariate that was
adequately balanced across all coding methods and scenarios was X1. This covariate was
balanced in the baseline sample, so nearest neighbor matching did not improve this
balance, but also did not result in a larger imbalance. For scenarios A, B, and C with
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ATC coding, nearest neighbor matching also resulted in adequate group balance on X2.
Conversely, for scenarios G, H, and I with ATT coding, nearest neighbor matching
resulted in adequate group balance on X2 and X3. These results indicated that nearest
neighbor worked well to create adequate group balance on covariates with small and
medium magnitudes of initial lack of balance when the treatment to comparison ratio was
2:1 and ATC coding was used (scenarios A, B, C) or when the treatment to comparison
ratio was 1:4 and ATT coding was used (scenarios G, H, I).
Second, nearest neighbor matching with a 0.20 SD caliper resulted in the best
group balance on all five covariates and the propensity score for both ATT and ATC
coding across all nine scenarios. Adequate balance was obtained on all covariates and the
propensity score for nearest neighbor matching with a caliper, indicating that when the
treatment group was larger than the comparison group, nearest neighbor matching with a
caliper worked well at creating treatment and comparison groups that were balanced on
the covariates, across five magnitudes of initial imbalance.
Third, notice that generalized boosted modeling resulted in adequate group
balance on X1 and X2 (i.e., covariates with the best balance at baseline) across all coding
methods and scenarios, and on X3 across all coding methods for scenarios C, E, F, H, and
I. Generalized boosted modeling did not result in adequate balance on X4 or X5 (i.e.,
covariates with the worst balance at baseline) for any coding method or scenario,
however balance was improved over baseline. These results indicated that when the
treatment group was larger than comparison group, generalized boosted modeling
resulted in adequate balance for covariates that had low baseline standardized mean
differences. For the covariate with a medium standardized mean difference (X3, SMD =
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0.50), generalized boosted modeling resulted in adequate balance in scenarios with a
large treatment sample size (600 or 1,000).
To better understand the standardized mean difference across all conditions, the
average absolute value of standardized mean difference was graphed for each covariate
by propensity score method, coding method, and treatment to comparison ratio (see
Figure 5). The average standardized mean difference was low for all covariates and the
propensity score after nearest neighbor matching with a caliper. Even the covariates that
were unbalanced at baseline (X3, X4, and X5) were well balanced after nearest neighbor
matching with a caliper. This suggested that nearest neighbor matching with a caliper
resulted in adequate group balance on the covariates regardless of the initial balance on
the covariate. Additionally, for nearest neighbor matching with a caliper, there were
minimal differences in average standardized mean difference for each covariate across
coding methods and treatment to comparison ratio.
After generalized boosted modeling, there was a slightly different pattern. The
average standardized mean difference was low for X1 and X2 after weighting, however,
the average standardized mean difference was higher as the covariate’s baseline
standardized mean difference was higher (i.e., X3, X4, and X5). Although the average
standardized mean difference was not ideal for X3, X4, and X5, generalized boosted
modeling always resulted in a reduction in average standardized mean difference when
compared to the baseline standardized mean difference. Additionally, for generalized
boosted modeling, there were minimal differences in the average standardized mean
difference for each covariate across coding methods and treatment to comparison ratio.
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A noticeably different pattern emerged for nearest neighbor matching. When the
baseline standardized mean difference was 0 (X1), the average standardized mean
difference after nearest neighbor matching was low, and minimally differed across coding
methods and treatment to comparison ratio. As the baseline standardized mean difference
increased across covariates, the average standardized mean difference increased. That is,
covariates with large initial standardized mean differences (large initial group imbalance)
had larger standardized mean differences after nearest neighbor matching, relative to
covariates with smaller initial standardized mean differences. Additionally, for nearest
neighbor matching, there were noticeable differences in the average standardized mean
difference for each covariate across coding method and treatment to comparison ratio.
For X2, X3, X4, and X5, when the treatment group was larger than the comparison group
(ATT coding with a ratio of 2:1 or 4:3 and ATC coding with a ratio of 1:4), the average
standardized mean difference after nearest neighbor matching was similar to the baseline
average standardized mean difference. For example, note that for X4, the average
standardized mean difference after nearest neighbor matching with ATT coding for the
treatment to comparison ratio of 4:3 is close to the initial standardized mean difference of
0.80. When coding was reversed (ATC coding with a ratio of 2:1 or 4:3 and ATT coding
with a ratio of 1:4), the average standardized mean difference after nearest neighbor
matching was smaller than the baseline standardized mean difference. In other words,
when the treatment group was larger than the comparison group, balance was improved
over that at baseline when nearest neighbor matching was used with ATC coding. In the
typical scenario where the comparison group was larger than the treatment group (ratio of
1:4 with ATT coding), balance was improved over baseline when nearest neighbor
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matching was used. Although nearest neighbor matching with a 1:4 ratio and ATT coding
and nearest neighbor matching with a 2:1 or 4:3 ratio and ATC coding was more
balanced than the other nearest neighbor matching conditions, balance was not ideal.
In addition to the standardized mean difference as an indicator of covariate and
propensity score group balance, percentage in bias reduction was evaluated. The median
percentage in bias reduction values indicated the extent to which balance was improved
(or worsened, as indicated by negative values) when compared to the baseline group
balance for each covariate and the propensity score (see Table 16). Thus, for covariates
that were well balanced initially, there was little to no room for improvement. Although
values greater than or equal to 80.00 can be used to indicate adequate reduction in initial
imbalance, the percentage in bias reduction value must be evaluated in light of the initial
group balance for each covariate (Pan & Bai, 2015).
The majority of the median percentage in bias reduction values were greater than
60.00, indicating that in general, balance improved after matching or weighting compared
to baseline balance for initially unbalanced covariates (X2, X3, X4, X5, and the
propensity score). When the treatment group was larger than the comparison group
(scenarios A through F), nearest neighbor matching with ATT coding resulted in group
balance on the covariates that did not differ from baseline covariate balance (i.e., low
PBR values, ranging from -13.15 to 0.89). The same pattern was observed for nearest
neighbor matching with ATC coding for scenarios G through I (which resulted in the
group coded 0 being smaller than the group coded 1). Thus, nearest neighbor matching
did not improve group balance when the treatment group was larger than the comparison
group. Conversely, when ATC coding was used for scenarios A through F and ATT
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coding for scenarios G through I, group balance on the covariates was improved after
nearest neighbor matching compared to baseline (i.e., values ranging from 19.16 to
80.84).
The propensity score variance ratios are presented in Table 16. For all scenarios
and coding methods, nearest neighbor matching with a 0.20 SD caliper resulted in
average propensity score variance ratios close to 1.00. Nearest neighbor matching either
resulted in no change relative to baseline in the propensity score variance ratio (ATT
coding for scenarios A through F, and ATC coding for scenarios G through I), a small
improvement relative to baseline in the propensity score variance ratio (ATT coding for
scenarios G through I), or a propensity score variance ratio that was farther away from
1.00 than at baseline (ATC coding for scenarios A through F).
Research Question 3
The third research question focused on the loss of treatment group members for
nearest neighbor matching and nearest neighbor matching with a caliper across coding
methods, treatment to comparison ratios, and treatment sample sizes. Loss of treatment
group sample size was quantified as the percentage of treatment group members (i.e.,
simulees) not retained in the matched sample (unmatched). Additionally, the average
propensity score for the matched and unmatched treatment groups were compared to the
average propensity score for the baseline treatment group to determine if the matched
treatment group was similar to the baseline treatment group.
Group sample sizes for baseline, matched, and unmatched treatment and
comparison groups, mean propensity score by group, and treatment loss for each scenario
are presented in Table 17. The treatment loss percentages for nearest neighbor matching
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aligned with the expected values given the treatment to comparison ratio. That is, when
the treatment group was larger than the comparison group, nearest neighbor matching
resulted in a loss of treatment sample of approximately 50% for a ratio of 2:1 (scenarios
A through C) and 25% for a ratio of 4:3 (scenarios D through F). For the ratio of 1:4,
there was no treatment sample loss because there were more comparison group members
than treatment group members.
After nearest neighbor matching with a caliper, treatment sample loss was larger
than that after nearest neighbor matching. With a ratio of 2:1 (scenarios A through C),
treatment sample loss ranged from 66.76% to 67.92%, with no differences across coding
method. With a ratio of 4:3 (scenarios D through F), treatment sample loss ranged from
56.78% to 58.05%, with no differences across coding method. With a ratio of 1:4
(scenarios G through H), treatment sample loss ranged from 19.43% to 21.12%, with no
differences across coding method.
To better understand whether the matched treatment group had similar average
propensity scores as the baseline treatment group, average propensity score was graphed
by propensity score method, coding method, and treatment to comparison ratio (see
Figure 6). Note that the treatment group’s baseline average propensity score was higher
than the comparison group’s for ATT coding. For ATC coding, this pattern was reversed
such that the treatment group’s baseline average propensity score was lower than the
comparison group’s.
When the treatment group was larger than the comparison group (treatment to
comparison ratios of 2:1 and 4:3), there were different patterns observed between ATT
and ATC coding. Specifically, nearest neighbor matching resulted in a matched treatment
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group with the same propensity score mean as the baseline treatment group (and the same
for the comparison group mean). Conversely, nearest neighbor matching with a caliper
resulted in a matched treatment group propensity score mean that was lower than the
baseline treatment group mean, but also a matched comparison group mean that was
higher than the baseline comparison group mean. In other words, the matched treatment
and comparison group met in roughly the middle of the propensity score range. For ATC
coding, nearest neighbor matching with a caliper also resulted in matched treatment and
comparison group means that were similar to each other (with a higher matched treatment
group mean than baseline treatment group mean and a lower matched comparison group
mean than baseline comparison group mean). For nearest neighbor matching, the
matched treatment group mean was higher than the baseline treatment group mean,
however, there was no difference between the matched comparison group mean and the
baseline comparison group mean.
When the comparison group was larger than the treatment group (treatment to
comparison ratio of 1:4), nearest neighbor matching with ATT coding resulted in no
difference between the matched treatment group propensity score mean and the baseline
treatment group propensity score mean. The matched comparison group mean was higher
than the baseline comparison group mean (and similar to the baseline treatment group
mean). For nearest neighbor matching with a caliper with ATT coding, the matched
treatment group mean was lower than the baseline treatment group mean, but more
similar to the baseline treatment group mean than to the baseline comparison group mean.
Additionally, the matched treatment and comparison group means were nearly identical
for nearest neighbor matching with a caliper, whereas with nearest neighbor matching the
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matched treatment group mean was still higher than the matched comparison group
mean.
When nearest neighbor matching with ATC coding was used, there was no
difference between the matched treatment group mean and baseline treatment group
mean. Likewise, there was no difference between the matched comparison group mean
and baseline comparison group mean. For nearest neighbor matching with a caliper with
ATC coding, the matched treatment group mean was higher than the baseline treatment
group mean and the matched comparison group mean was lower than the baseline
comparison group mean. Additionally, the matched treatment and comparison group
propensity score means were nearly identical for nearest neighbor matching with a
caliper, whereas with nearest neighbor matching the matched treatment group propensity
score mean was still lower than the matched comparison group propensity score mean. In
sum, for nearest neighbor matching, coding method determined whether the matched
treatment group resembled the original treatment or original comparison group. For
nearest neighbor matching with a caliper, the matched treatment group always resembled
the matched comparison group, regardless of coding method.
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CHAPTER 5
Discussion
The performance of three propensity score methods when the treatment group was
larger than the comparison group was evaluated in the current study. Several conditions
were simulated to examine the function of each propensity score method under different
situations that researchers may encounter. Specifically, two coding methods, four true
treatment effects, three treatment sample sizes, three treatment to comparison group
ratios, and five levels of baseline covariate balance were simulated.
Data were simulated for nine scenarios with 1,000 replications per scenario. Each
scenario represented a unique combination of treatment sample size and treatment to
comparison group ratio2. Across all scenarios, covariate baseline imbalance was varied
by specifying a different amount of imbalance (SMD) for each of the five covariates
(SMD for X1 = 0, X2 = 0.20, X3 = 0.50, X4 = 0.80, X5 = 1.20). Additionally, for all
scenarios, four true treatment effect sizes were simulated (Cohen’s d for Y1 = 0, Y2 =
0.20, Y3 = 0.50, and Y4 = 0.80). After data were simulated for each scenario, three
propensity score methods were evaluated (nearest neighbor matching, nearest neighbor
matching with a 0.20 SD caliper, and generalized boosted modeling) using two coding
methods (ATT coding and ATC coding) for each true treatment effect.

2

Each scenario represented a unique combination of treatment sample size and treatment
to comparison group ratio as follows: scenario A (N Treatment = 200, T:C = 2:1), scenario B
(NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C = 2:1), scenario D
(NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F (NTreatment
= 1,000, T:C = 4:3), scenario G (NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600,
T:C = 1:4), and scenario I (NTreatment = 1,000, T:C = 1:4).
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When the treatment group is larger than the comparison group, one
recommendation is to use ATC coding (instead of ATT coding; Ho et al., 2007). Using
ATC coding when the treatment group is larger than the comparison group results in
coding that is equivalent to using ATT coding when the treatment group is smaller than
the comparison group. That is, ATC coding when the treatment group is larger than the
comparison group results in the more ideal situation where the group coded “1” is smaller
than the group coded “0” (i.e., a smaller “treatment” group than “comparison” group).
The current study is the first simulation study (to my knowledge) to examine the effect of
coding method on bias when the treatment group is larger than the comparison group.
Specifically, three research questions were examined to evaluate the performance of
propensity score methods when the treatment group was larger than the comparison
group.
Bias in Estimated Treatment Effect: Research Question 1
The first research question regarded the magnitude and direction of bias in the
estimated treatment effect across propensity score methods, coding methods, true
treatment effect size, treatment sample size, and treatment to comparison group ratio.
Specifically, the first research question was two-fold: 1a. When the treatment group is
larger than the comparison group, can propensity score methods accurately recover the
true treatment effect and 1b. Does the magnitude and direction of the estimated treatment
effect differ across propensity score methods depending on group coding? Bias in the
estimated treatment effect was quantified as the average deviation from the true treatment
effect across 1,000 replications. Additionally, a 3x2x3x3x4 ANOVA was conducted to
determine whether there were statistically significant and practically meaningful
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differences in bias across conditions (i.e., propensity score method, coding method,
treatment to comparison group ratio, treatment sample size, and true treatment effect
size). The magnitude and direction of the estimated treatment effect (averaged across
1,000 replications) was compared across propensity score method, treatment to
comparison group ratio, treatment sample size, and true treatment effect size for both
coding methods (i.e., ATT and ATC coding). In sum, bias depended on two effects: the
three-way interaction between propensity score method, coding method, and treatment to
comparison group ratio and the two-way interaction between propensity score method
and true treatment effect size.
To facilitate understanding, the three-way interaction will be discussed in two
sections: the “typical” scenario (i.e., treatment group smaller than the comparison group)
and the “atypical” scenario (i.e., treatment group larger than the comparison group).
Within each section, differences in bias across propensity score methods and coding
methods are explored.
Treatment Group Smaller Than Comparison Group: Traditional 1:4 Ratio
Under traditional conditions where the treatment group is smaller than the
comparison group, propensity score methods have been shown to result in minimally
biased estimates of the treatment effect (e.g., Rubin, 1973a, 1973b, 1979). For nearest
neighbor matching and generalized boosted modeling, bias was lower for ATT coding
than for ATC coding when the treatment to comparison group ratio was 1:4. However,
when comparing across the two methods, bias was higher for nearest neighbor matching
than for generalized boosted modeling. In sum, for conditions that simulated the “typical”
propensity score scenario, using ATT coding replicated previous findings of minimally
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biased treatment effect estimates for generalized boosted modeling. In contrast, when
using ATC coding, bias was high for both nearest neighbor matching and generalized
boosted modeling. Thus, when the “typical” scenario was reversed (via the use of ATC
coding) so that group coded “1” was larger than the group coded “0”, nearest neighbor
matching and generalized boosted modeling did not result in a minimally biased
treatment effect estimate.
Unlike the other two methods, nearest neighbor matching with a caliper did result
in minimally biased treatment effect estimates for both ATT and ATC coding. Moreover,
for ATT coding, nearest neighbor matching with a caliper resulted in substantially lower
bias than nearest neighbor matching and slightly lower bias than generalized boosted
modeling. For ATC coding, however, nearest neighbor matching with a caliper resulted
in substantially lower bias than both nearest neighbor matching or generalized boosted
modeling. In the current study, coding did not matter for nearest neighbor matching with
a caliper under the “typical” scenario where the comparison group was larger than the
treatment group.
Treatment Group Larger Than Comparison Group: 2:1 and 4:3 Ratios
Under conditions where the treatment group is larger than the comparison group,
the use of ATC coding is one recommendation (Ho et al., 2007). Indeed, for nearest
neighbor matching and generalized boosted modeling, bias was lower for ATC coding
than for ATT coding when the treatment to comparison group ratio was 2:1 or 4:3.
However, like the 1:4 ratio findings, bias was higher for nearest neighbor matching than
for generalized boosted. In contrast, for nearest neighbor matching and generalized
boosted modeling, bias was highest for ATT coding. Like the ATC coding findings, bias
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was higher for nearest neighbor matching than for generalized boosted modeling. Thus,
for nearest neighbor matching and generalized boosted modeling in the “atypical”
scenario, the current study findings support the Ho et al. (2007) recommendation to use
ATC coding.
Unlike the other two methods, nearest neighbor matching with a caliper resulted
in low bias for both ATT and ATC coding. The observation of low bias for nearest
neighbor matching with a 0.20 SD caliper and ATT coding when the treatment group was
larger than the comparison group provides new information regarding the application of
propensity score methods. In the current study, coding did not matter for nearest neighbor
matching with a caliper under the “atypical” scenario where the treatment group was
larger than the comparison group. Thus, the recommendation to reverse the coding when
the treatment group is larger than the comparison group (Ho et al., 2007) may not be
necessary when nearest neighbor matching with a caliper is implemented. Therefore,
researchers interested in examining the effect of the treatment on those who received
treatment (ATT), may not need to alter the question of interest if the treatment group is
larger than the comparison group.
Not only did bias differ by propensity score method, coding method, and
treatment to comparison group ratio, bias also differed by propensity score method and
true treatment effect size. Averaging across coding method and treatment to comparison
group ratio, nearest neighbor matching with a caliper resulted in low bias for all four true
treatment effect sizes. Generalized boosted modeling resulted in low bias when there was
no true treatment effect or a small true treatment effect. Nearest neighbor matching,
however, resulted in high bias for all four true treatment effects. Thus, recovery of the
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true treatment effect depended on the true treatment effect size to a greater extent for
generalized boosted modeling than for nearest neighbor matching with a caliper or
nearest neighbor matching.
Averaging across coding method and treatment to comparison group ratio, all
three propensity score methods resulted in a reduction in bias over baseline bias. This
was not surprising, as propensity score methods aim to reduce bias by reducing
systematic group differences (Austin, 2011; Cochran & Rubin, 1973; Ho et al., 2007;
Rosenbaum & Rubin, 1983b; Rubin, 1973a, 1973b, 1974; Shadish et al., 2008). However,
the three propensity score methods did not reduce bias in the estimated treatment effect to
the same extent. Nearest neighbor matching resulted in bias in the estimated treatment
effect that was not largely different from initial, unmatched baseline bias. Generalized
boosted modeling reduced bias but resulted in an overcorrection, in which the estimated
treatment effect was less than the true treatment effect. Nearest neighbor matching with a
caliper reduced bias to the greatest extent and resulted in lowest bias in the estimated
treatment effect.
Direction and Magnitude of Bias
For each scenario (i.e., each unique combination of treatment to comparison
group ratio and treatment sample size), the direction of bias consistently differed across
ATT and ATC coding. As might be expected, if the estimated treatment effect for a
certain propensity score method was positive for ATT coding it was negative for the
same propensity score method for ATC coding (and vice versa).
When the treatment group was larger than the comparison group, the magnitude
of bias across ATT and ATC coding method differed for each propensity score method.
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For nearest neighbor matching, the magnitude of bias for ATC coding was consistently
smaller than for ATT coding. For generalized boosted modeling, the magnitude of bias in
the estimated treatment effect for ATC coding was similar to or smaller than that for ATT
coding. For nearest neighbor matching with a caliper, the magnitude of bias in the
estimated treatment effect did not meaningfully differ across ATT and ATC coding. In
sum, nearest neighbor matching with a caliper resulted in the least amount of bias of the
three methods, and resulted in low bias for both ATT and ATC coding regardless of
which group was larger (i.e., treatment or comparison group) for all true treatment effect
sizes.
Covariate Balance: Research Question 2
The second research question regarded covariate balance obtained across
propensity score methods, coding methods, treatment sample size, treatment to
comparison group ratio, and baseline covariate balance: When the treatment group is
larger than the comparison group, can propensity score methods achieve adequate group
balance on the covariates? Balance on the covariates after the application of propensity
score matching was quantified as the standardized mean difference between the treatment
and comparison groups on each covariate. Additionally, the percentage in bias reduction
was examined to supplement the information provided by the standardized mean
difference. Each of the five covariates had a different level of baseline balance (SMD X1
= 0, X2 = 0.20, X3 = 0.50, X4 = 0.80, and X5 = 1.20), which allowed for the comparison
of each propensity score method across differing levels of baseline group covariate
balance. In sum, balance differed depending on propensity score method and initial
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covariate balance. Balance also differed depending on coding method for nearest
neighbor matching.
The three propensity score methods differed in terms of covariate balance after
matching or weighting. Across all five covariates and the propensity score, nearest
neighbor matching with a caliper resulted in the lowest standardized mean differences.
Even for covariates with large baseline standardized mean differences (X4 and X5),
nearest neighbor matching with a caliper resulted in low standardized mean differences.
Recall that nearest neighbor matching with a caliper was also the method that resulted in
the least bias in the treatment effect. That is, nearest neighbor matching with a caliper
achieved both the best balance and least bias of the three propensity score methods.
Generalized boosted modeling resulted in low standardized mean differences for
covariates that had medium, low, or no baseline standardized mean differences (X3, X2,
and X1, respectively). For covariates with large standardized mean differences (X4 and
X5), generalized boosted modeling resulted in a reduction in the standardized mean
difference from that at baseline; however, systematic group differences remained on these
covariates. Recall that generalized boosted modeling resulted in slightly larger bias than
nearest neighbor matching with a caliper. That is, slight bias in the estimated treatment
effect remained likely because ideal covariate balance was not achieved for all covariates.
Nearest neighbor matching, on the other hand, had the most imbalance, with the
exception of the covariate that was balanced at baseline (X1). Recall that nearest
neighbor matching consistently resulted in the highest bias. That is, nearest neighbor
matching resulted in the least reduction of systematic group differences on the covariates
and had the highest bias of the three propensity score methods.
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For nearest neighbor matching with a caliper and generalized boosted modeling,
there were no meaningful differences in covariate balance across coding method.
Conversely, for nearest neighbor matching, coding method mattered. When coding
resulted in a larger comparison group than treatment group, after nearest neighbor
matching there was a reduction in standardized mean differences from that at baseline for
X2, X3, X4, and X5. However, when coding resulted in a larger treatment group than
comparison group, there was no change in the standardized mean difference from that at
baseline for X2, X3, X4, and X5. That is, the covariates remained imbalanced, and
selection bias was still present.
The removal of systematic group differences results in the reduction of bias in the
estimated treatment effect (Austin, 2011; Cochran & Rubin, 1973; Ho et al., 2007;
Rosenbaum & Rubin, 1983b; Rubin, 1973a, 1973b, 1974; Shadish et al., 2008). Thus, it
was not surprising that the propensity score methods that resulted in low standardized
mean differences also resulted in low bias in the estimated treatment effect.
Treatment Group Loss: Research Question 3
The third research question regarded similarity between the matched and baseline
treatment groups for matching methods (i.e., nearest neighbor matching and nearest
neighbor matching with a caliper): When the treatment group is larger than the
comparison group, does the loss of treatment group members differ across conditions?
Loss of treatment group members was quantified as the percentage of treatment group
members not retained in the matched sample. Additionally, the average propensity scores
were compared for baseline and matched treatment and comparison groups to determine
similarity between the matched and baseline treatment groups. The percent of treatment
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group loss differed across nearest neighbor matching and nearest neighbor matching with
a caliper. Additionally, for nearest neighbor matching, whether the average matched
treatment group propensity score resembled the average baseline treatment group
propensity score differed across coding method.
Nearest Neighbor Matching
For nearest neighbor matching, the percentage of unmatched treatment group
members aligned with expectations. That is, when using one-to-one matching with a
larger treatment group than comparison group, the maximum number of retained
treatment group members is the number of comparison group members. When the
comparison group was larger than the treatment group, there was no loss of treatment
group members. However, the matched treatment group did not always resemble the
baseline treatment group with regards to the propensity score.
After nearest neighbor matching when the treatment group was larger than the
comparison group with ATT coding, there was no change in the average propensity score
compared to baseline. However, recall that nearest neighbor matching with ATT coding
always resulted in the largest bias in the estimated treatment effect and worst covariate
balance. When the treatment group was larger than the comparison group and ATC
coding was used, the average matched treatment group propensity score was similar to
the average baseline comparison group propensity score. Recall that nearest neighbor
matching with ATC coding resulted in small improvements in covariate balance over that
at baseline and slightly less bias in the estimated treatment effect than at baseline.
Although there was minimal loss of treatment group members, selection bias remained
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after nearest neighbor matching when the treatment group was larger than the comparison
group for both ATT and ATC coding.
Conversely, after nearest neighbor matching when the comparison group was
larger than the treatment group with ATT coding (i.e., the typical scenario where the
comparison group is larger than the treatment group), the matched comparison group was
selected to resemble the baseline (and matched) treatment group. When ATC coding was
used, there was no change in the average propensity score compared to baseline. In short,
matched propensity scores resembled whichever group was coded “1”, yet initial
selection bias remained.
Nearest Neighbor Matching With a 0.20 SD Caliper
For nearest neighbor matching, the percentage of unmatched treatment group
members was slightly larger than for nearest neighbor matching. For nearest neighbor
matching with a caliper, when the treatment group was larger than the comparison group,
the matched treatment group and matched comparison group resembled neither the
baseline treatment group nor the baseline comparison group regardless of coding method.
In these cases, the propensity scores of the matched groups met midway between the
baseline propensity scores of the two groups. Conversely, when the treatment group was
smaller than the comparison group, there was little change in the average treatment group
propensity score after matching regardless of coding method. Under the “typical”
scenario, the matched comparison group was created to resemble the original treatment
group.
Despite the lack of similarity between the matched and baseline treatment group
propensity scores for nearest neighbor matching with a caliper, adequate group balance
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was achieved on all covariates and bias in the estimated treatment effect was lowest. Loss
of treatment representation and the smaller matched sample size that occurred after
nearest neighbor matching with a caliper did not impact recovery of the true treatment
effect, contrary to the suggestion by Jacovidis et al. (2017). Despite a loss of treatment
group sample of 19-68%, nearest neighbor matching with a caliper resulted in adequate
group balance on the covariates and low bias in all four estimated treatment effects.
Although loss of treatment representation did not impact recovery of the true
treatment effect for nearest neighbor matching with a caliper, there may be additional
concerns regarding loss of representativeness of the matched treatment group in terms of
diversity and equity. Thus, if the matched treatment group differs from the baseline
treatment group, researchers may have additional concerns regarding treatment group
representation for the matched treatment group.
Future Research and Limitations
There are several limitations to the current study worth noting. These limitations
center around the limited number of conditions examined and the well-known
disadvantage that simulation studies may not represent applied practice.
First, the aim of the current study was to examine commonly used propensity
score methods under varying, realistic conditions. However, without examination of
additional methods it is difficult to make broad recommendations regarding the reduction
of selection bias when the treatment group is larger than the comparison group.
Additional recommendations when the treatment group is larger than the comparison
group include subclassification, full matching, weighting by the odds (Stuart, 2010), and
matching with replacement (Ho et al., 2007). The current study focused on the
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recommendation to switch the coding of the treatment and comparison group (Ho et al.,
2007). Although bias was the lowest for nearest neighbor matching with a caliper (for
both ATT and ATC coding), bias was not always zero. That is, a minimal amount of bias
remained in the estimated treatment effect for the best performing method in the current
study. Examination of subclassification, full matching, weighting by the odds, and
matching with replacement is necessary to provide comprehensive guidance to
researchers.
Second, each of the four true treatment effects were simulated to be homogeneous
across all levels of the propensity score. Thus, the magnitude of the true treatment effect
was the same across ATT, ATC, and ATE coding. In applied practice, treatment effects
are likely to be heterogeneous. That is, some participants may be more responsive to an
intervention than others. In this case, the true treatment effect will not be the same across
ATT, ATC, and ATE coding. When treatment effects are heterogeneous across levels of
the propensity score, subclassification may be preferred over the methods examined in
the current study.
Third, for nearest neighbor matching and nearest neighbor matching with a
caliper, treatment group members were randomly ordered by propensity score before
selecting matches. Although random ordering is recommended over high to low or low to
high ordering (Austin, 2013) the default ordering for the MatchIt package in R is high to
low. The order in which comparison group members are selected for treatment group
members can impact balance between the matched groups. Although random ordering is
recommended when using matching methods, ordering of treatment group members has
not been examined when the treatment group is larger than the comparison group. The
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current study demonstrated that adequate group balance was obtained after nearest
neighbor matching with a 0.20 SD caliper with random ordering. However, multiple
ordering methods were not examined. Future studies should examine balance obtained
and bias in the estimated treatment effect after matching using different methods for
ordering treatment group members when the treatment group is larger than the
comparison group.
Fourth, only one caliper width was employed with nearest matching (SD of 0.20).
Although this is a recommended caliper width (Austin, 2009), the results from this study
may not extend to nearest neighbor matching using different caliper widths. That is,
although the best group balance and lowest bias was observed for nearest neighbor
matching with a 0.20 SD caliper, the same might or might not be true for nearest neighbor
matching using other caliper widths. Future studies should examine whether performance
differs depending on the selected caliper.
Fifth, there is a lack of sample size guidelines for the use of propensity score
methods when the treatment group is larger than the comparison group. In the current
study, three treatment group sample sizes were examined (treatment group sample size of
200, 600, and 1,000), however these sample sizes do not represent all possible treatment
group sample sizes that may occur in applied research. In the current study, sample size
did not relate to bias in the estimated treatment effect or balance obtained after matching
or weighting. Thus, future research regarding the performance of propensity score
matching when the treatment group is larger than the comparison group using different
sample sizes would fill a gap in the literature.
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Sixth, a small number of covariates (5) were simulated in the current study, all of
which were continuous covariates. In applied research, more than five covariates is
typical, and the covariates may be a mix of categorical and continuous variables. Future
studies should examine the performance of propensity score methods when the treatment
group is larger than the comparison group using different numbers of covariates and both
categorical and continuous covariates.
Finally, there is always a trade-off between applied and simulation studies.
Simulation studies allow for the specification of “truth”; however, it may not be clear
whether that truth is realistic. Although applied studies allow for the examination of
research questions under realistic circumstances, “truth” cannot be known. In the current
study, conditions were selected to represent realistic scenarios; however, all possible
scenarios cannot be examined in a single study.
Practical Implications
The recommendation to reverse the coding of the groups when the treatment
group is larger than the comparison group (Ho et al., 2007) may not be necessary for all
propensity score methods. For nearest neighbor matching with a caliper, there was little
difference in the estimated treatment effect between ATT and ATC coding when the
treatment group was larger than the comparison group. When nearest neighbor matching
with a caliper was used, both ATT and ATC coding resulted in estimated treatment
effects of similar magnitude, differing only in direction. Simply put, coding method did
not matter for nearest neighbor matching with a caliper.
For generalized boosted modeling and nearest neighbor matching, coding
mattered depending on the treatment to comparison group ratio. Specifically, when the
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treatment to comparison group ratio was 1:4 (i.e., comparison group larger than the
treatment group), bias in the estimated treatment effect was lower for ATT coding than
for ATC coding. Conversely, when the treatment to comparison group ratio was 2:1 or
4:3 (i.e., treatment group larger than the comparison group), bias in the estimated
treatment effect was lower for ATC coding than for ATT coding. Nearest neighbor
matching differed from generalized boosted modeling in that a high amount of bias was
observed for all coding methods and ratios (except for ATT coding when the treatment to
comparison group ratio was 1:4). Thus, when the treatment group is larger than the
comparison group, reversing the coding may not be necessary if using nearest neighbor
matching with a 0.20 SD caliper but should be considered for other methods.
The differences in bias that were observed across propensity score methods for
the simulated true treatment effect sizes also provide meaningful information for practice
when the treatment group is larger than the comparison group. Although researchers
never know the true treatment effect when conducting applied research, two
recommendations emerge from this study. First, if prior research indicates that a small
treatment effect is expected, nearest neighbor matching with a caliper and generalized
boosted modeling with ATT coding may be methods to consider. Second, if prior
research indicates that a medium or large treatment effect is expected, nearest neighbor
matching with a caliper with ATT coding may be a method to consider. For larger true
treatment effects, generalized boosted modeling overcorrected, resulting in a lower
estimated treatment effect than true treatment effect. This overcorrection was most likely
observed because the covariates that were most unbalanced at baseline had the strongest
relation with latent propensity for treatment and with one another. For all true treatment
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effects, nearest neighbor matching is not recommended when the treatment group is
larger than the comparison group. Nearest neighbor matching resulted in a reduction in
bias over that at baseline; however, the bias in the estimated treatment effect was still
large. Thus, consulting prior research could provide guidance for which propensity score
methods to audition when the treatment group is larger than the comparison group.
Propensity score methods that resulted in the best balance were those that resulted
in the least bias in the estimated treatment effect. Thus, when the treatment group was
larger than the comparison group, examination of group balance after matching or
weighting provided useful information regarding potential reduction in bias in the
estimated treatment effect. Researchers who wish to employ propensity score matching
when the treatment group is larger than the comparison group should use the balance
checking methods that are recommended in the propensity score literature to determine
whether systematic group differences are reduced and whether treatment effects should
be estimated using the matched or weighted data. However, researchers are cautioned
against equating adequate covariate balance on all covariates with the complete removal
of selection bias. Given the use of a simulation study, the current study was conducted
under ideal conditions. That is, all covariates related to treatment selection were used for
the estimation of the propensity score and creation of matched groups. Thus, the
assumption of no unmeasured confounders has been met. However, in practice, there may
be covariates related to selection bias that are not measured. If there are unmeasured
confounders, all selection bias may not be removed from the estimated treatment effect
even if adequate balance is obtained on all covariates.
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As illustrated by the findings, nearest neighbor matching with a caliper can result
in a larger loss of treatment group representation than nearest neighbor matching. Of
particular interest was whether loss of treatment representation related to recovery of the
true treatment effect. Loss of treatment representation (due to the inclusion of a caliper
for nearest neighbor matching) did not impact the recovery of the true treatment effect.
Conversely, nearest neighbor matching (which resulted in less loss of treatment
representation than nearest neighbor matching with a caliper) resulted in poor recovery of
the true treatment effect. Nearest neighbor matching was not able to obtain adequate
group balance on the covariates (except for the covariate for which groups were balanced
at baseline). Additionally, there was a large amount of bias in the estimated treatment
effect despite the matched treatment group resembling the baseline treatment group.
Thus, covariate balance after matching or weighting was a better indicator of bias
reduction than was the similarity between the matched and baseline treatment group
propensity scores.
Conclusion
To draw appropriate causal inferences from quasi-experimental studies,
researchers must be cognizant of and account for selection bias. Although additional
research is needed to understand how to best reduce selection bias when the treatment
group is larger than the comparison group, the current study adds to the limited existing
research. In educational research, if selection bias is present, practitioners have little
evidence for causal claims. However, reducing selection bias strengthens the validity of
inferences made regarding the treatment effect when random assignment is not feasible.
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Table 1
Simulation Conditions (Repeated Across Nearest Neighbor Matching, Nearest Neighbor
Matching with 0.20 SD Caliper, and Generalized Boosted Modeling)
ATT Coding (Treatment = 1)
T:C
True Treatment
Ratio
NT/NC
Effect (Cohen's d)
2:1
200/100
0
0.20
0.50
0.80
600/300
0
0.20
0.50
0.80
1000/500
0
0.20
0.50
0.80
4:3
200/150
0
0.20
0.50
0.80
600/450
0
0.20
0.50
0.80
1000/750
0
0.20
0.50
0.80
1:4
200/800
0
0.20
0.50
0.80
600/2400
0
0.20
0.50
0.80
1000/4000
0
0.20
0.50
0.80

ATC Coding (Treatment = 0)
T:C
True Treatment
Ratio
NT/NC
Effect (Cohen's d)
2:1
200/100
0
0.20
0.50
0.80
600/300
0
0.20
0.50
0.80
1000/500
0
0.20
0.50
0.80
4:3
200/150
0
0.20
0.50
0.80
600/450
0
0.20
0.50
0.80
1000/750
0
0.20
0.50
0.80
1:4
200/800
0
0.20
0.50
0.80
600/2400
0
0.20
0.50
0.80
1000/4000
0
0.20
0.50
0.80
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Table 2
Treatment Group, Comparison Group, and Total Sample Sizes for
Configurations A through I
Sample
T:C Ratio
Configuration A
2:1
Configuration B
2:1
Configuration C
2:1
Configuration D
4:3
Configuration E
4:3
Configuration F
4:3
Configuration G
1:4
Configuration H
1:4
Configuration I
1:4

Treatment N Comparison N
200
100
600
300
1000
500
200
150
600
450
1000
750
200
800
600
2400
1000
4000

Total N
300
900
1500
350
1050
1750
1000
3000
5000
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Table 3
Specified Standardized Group Mean Differences and
Correlations between Covariates and Latent Propensity Scores
Variable
X1
X2
X3
X4
X5
Latent Propensity
SMD

X1
1.00
0.10
0.20
0.30
0.30
-0.02
0.00

X2

X3

X4

X5

1.00
0.30
0.30
0.35
0.15
0.20

1.00
0.30
0.45
0.40
0.50

1.00
0.65
0.70
0.80

1.00
0.90
1.20

Table 4
Method of Evaluation, Conditions Examined, and Values Saved from Simulated Data for Each Research Question
Research Question
Method of Evaluation
RQ1a: When the treatment group is  Bias - the extent to which the
larger than the comparison group, can
estimated treatment effect
propensity score methods accurately
differs from the population (or
recover the true treatment effect?
specified) treatment effect.
RQ1b: Does the magnitude and
 Magnitude of effect - Cohen's
direction of the estimated treatment
d effect size
effect differ across propensity score  Direction of effect - sign of the
methods depending on group coding?
regression coefficient for
grouping variable
RQ2: When the treatment group is
 Standardized mean difference
larger than the comparison group, can
(SMD) on each covariate and
propensity score methods achieve
propensity score
adequate group balance on the
 Percentage in bias reduction
covariates?
for each covariate and
propensity score
 Propensity score variance ratio
RQ3: When the treatment group is
 Percent of unmatched
larger than the comparison group, does treatment group members
the loss of treatment group members  Average group propensity
differ across conditions?
score

















Conditions Examined
Treatment sample size (3)
T:C ratio (3)
True treatment effect size (4)
Propensity score methods (3)
Coding methods (2)
Treatment sample size (3)
T:C ratio (3)
True treatment effect size (4)
Propensity score methods (3)
Coding methods (2)
Treatment sample size (3)
T:C ratio (3)
Propensity score methods (3)
Coding methods (2)
Initial covariate balance (5)






Treatment sample size (3)
T:C ratio (3)
Propensity score methods (2)
Coding methods (2)

Values Saved from Simulated Data
 Intercept (mean outcome for group coded
"0")
 Regression coefficient for grouping
variable (estimated treatment effect)
 t-value for regression coefficient (to
compute Cohen's d effect size)
 Regression coefficient for grouping
variable (estimated treatment effect)
 Matched & unmatched sample sizes
 SMD for covariates and propensity score
(before and after matching/weighting)
 Percentage in bias reduction (after
matching/weighting)
 Propensity score variance ratio (after
matching/weighting)
 Matched & unmatched sample sizes
 Propensity score variance ratio (after
matching/weighting)
 Group propensity score averages (for
matched and unmatched simulees)

Note. RQ3 was evaluated over 2 of the 3 propensity score methods (nearest neighbor matching and nearest neighbor
matching with a 0.20 SD caliper). RQ3 was not evaluated for generalized boosted modeling because there would be no loss
of treatment group members.
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Table 5
Standardized Group Mean Differences and Correlations between Covariates
and Latent Propensity Scores by Validation Sample

Variable
Sample A
X1
X2
X3
X4
X5
Sample B
X1
X2
X3
X4
X5
Sample C
X1
X2
X3
X4
X5
Sample D
X1
X2
X3
X4
X5
Sample E
X1
X2
X3
X4
X5
Sample F
X1
X2
X3
X4
X5

SMD

Latent
Propensity

X1

X2

X3

X4

X5

-0.01
0.17
0.62
0.80
1.14

-0.01
0.13
0.48
0.64
0.83

1.00
0.28
0.23
0.33
0.37

1.00
0.30
0.30
0.41

1.00
0.36
0.42

1.00
0.65

1.00

0.07
0.23
0.54
0.76
1.18

0.06
0.19
0.43
0.62
0.89

1.00
0.12
0.22
0.32
0.36

1.00
0.31
0.28
0.37

1.00
0.30
0.42

1.00
0.63

1.00

0.06
0.22
0.48
0.89
1.22

0.05
0.18
0.39
0.68
0.88

1.00
0.14
0.20
0.33
0.33

1.00
0.30
0.31
0.36

1.00
0.29
0.43

1.00
0.64

1.00

-0.21
0.17
0.46
0.75
1.13

-0.18
0.13
0.36
0.55
0.79

1.00
0.23
0.26
0.36
0.38

1.00
0.31
0.28
0.37

1.00
0.37
0.43

1.00
0.64

1.00

0.02
0.21
0.46
0.81
1.20

0.01
0.18
0.38
0.65
0.89

1.00
0.13
0.20
0.32
0.35

1.00
0.31
0.30
0.37

1.00
0.30
0.43

1.00
0.64

1.00

0.00
0.26
0.46
0.91
1.26

0.00
0.21
0.37
0.68
0.89

1.00
0.14
0.21
0.33
0.33

1.00
0.30
0.31
0.37

1.00
0.31
0.44

1.00
0.64

1.00
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Table 5 Cont.

Variable
Sample G
X1
X2
X3
X4
X5
Sample H
X1
X2
X3
X4
X5
Sample I
X1
X2
X3
X4
X5

SMD

Latent
Propensity

X1

X2

X3

X4

X5

-0.02
0.21
0.52
0.88
1.19

-0.01
0.16
0.37
0.62
0.80

1.00
0.13
0.21
0.33
0.36

1.00
0.32
0.30
0.38

1.00
0.29
0.43

1.00
0.64

1.00

-0.05
0.21
0.59
0.99
1.29

-0.03
0.15
0.40
0.64
0.80

1.00
0.10
0.20
0.31
0.31

1.00
0.29
0.31
0.35

1.00
0.31
0.46

1.00
0.64

1.00

-0.01
0.17
0.47
1.00
1.36

0.00
0.12
0.34
0.64
0.82

1.00
0.10
0.21
0.29
0.30

1.00
0.28
0.30
0.35

1.00
0.31
0.44

1.00
0.65

1.00
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Table 6
Treatment and Comparison Group Size, Treatment to Comparison Ratio, and True
Treatment Effect by Validation Sample
True Treatment Effect
Treatment Comparison T:C
Sample
N
N
Ratio
Y1
Y2
Y3
Y4
Sample A
212
88
0.707 -0.01
0.18
0.48
0.78
Sample B
609
291
0.677
0.00
0.19
0.49
0.79
Sample C
1004
496
0.669
0.10
0.28
0.56
0.84
Sample D
203
147
0.580 -0.02
0.16
0.44
0.73
Sample E
600
450
0.571
0.02
0.20
0.49
0.77
Sample F
995
755
0.569 -0.04
0.14
0.41
0.69
Sample G
187
813
0.187
0.15
0.34
0.63
0.91
Sample H
597
2403
0.199
0.02
0.21
0.50
0.79
Sample I
1009
3991
0.202
0.02
0.21
0.50
0.79
Note. T:C Ratio was set as follows: samples A-C, .667 (ratio of 2:1); samples D-F,
.571 (ratio of 4:3); samples G-I, .200 (ratio of 1:4). For all samples, true treatment
effect was set as follows: Y1, 0; Y2, 0.20; Y3, 0.50; Y4, 0.80.
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Note. Covariate means and standard deviations are averaged across 1,000 replications for each scenario. Standard errors indicate the
variability in each parameter across the 1,000 replications. Each scenario represents a unique combination of treatment sample size
and treatment to comparison group ratio as follows: scenario A (NTreatment = 200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1),
scenario C (NTreatment = 1,000, T:C = 2:1), scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F
(NTreatment = 1,000, T:C = 4:3), scenario G (NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment
= 1,000, T:C = 1:4).
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Table 8
Average Simulated Correlations between Covariates and True Propensity Scores
by Scenario
Scenario
Scenario A
X1
X2
X3
X4
X5
Scenario B
X1
X2
X3
X4
X5
Scenario C
X1
X2
X3
X4
X5
Scenario D
X1
X2
X3
X4
X5
Scenario E
X1
X2
X3
X4
X5
Scenario F
X1
X2
X3
X4
X5

True Propensity Scores

X1

X2

X3

X4

X5

-0.02
0.14
0.38
0.66
0.85

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00

-0.02
0.14
0.38
0.67
0.86

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00

-0.02
0.14
0.38
0.67
0.86

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00

-0.02
0.15
0.39
0.68
0.87

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00

-0.02
0.14
0.39
0.68
0.88

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00

-0.02
0.15
0.39
0.68
0.88

1.00
0.10
0.20
0.30
0.30

1.00
0.30
0.30
0.35

1.00
0.30
0.45

1.00
0.65

1.00
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Table 8 Cont.
Scenario
True Propensity Scores X1
X2
X3
X4
X5
Scenario G
X1
-0.02
1.00
X2
0.14
0.10
1.00
X3
0.36
0.20
0.30
1.00
X4
0.63
0.30
0.30
0.30
1.00
X5
0.81
0.30
0.35
0.45
0.65
1.00
Scenario H
X1
-0.02
1.00
X2
0.13
0.10
1.00
X3
0.36
0.20
0.30
1.00
X4
0.63
0.30
0.30
0.30
1.00
X5
0.82
0.30
0.35
0.45
0.65
1.00
Scenario I
X1
-0.02
1.00
X2
0.14
0.10
1.00
X3
0.36
0.20
0.30
1.00
X4
0.64
0.30
0.30
0.30
1.00
X5
0.82
0.30
0.35
0.45
0.65
1.00
Note. Correlations are averaged across 1,000 replications for each scenario. Each
scenario represents a unique combination of treatment sample size and treatment
to comparison group ratio as follows: scenario A (NTreatment = 200, T:C = 2:1),
scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C = 2:1),
scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3),
scenario F (NTreatment = 1,000, T:C = 4:3), scenario G (NTreatment = 200, T:C = 1:4),
scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C =
1:4).

119

Note. Outcome variable (Y1 through Y4) means and standard deviations are averaged across 1,000 replications for
each scenario. Standard errors indicate the variability in each parameter across the 1,000 replications. Each scenario
represents a unique combination of treatment sample size and treatment to comparison group ratio as follows: scenario
A (NTreatment = 200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C = 2:1),
scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F (NTreatment = 1,000, T:C =
4:3), scenario G (NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000,
T:C = 1:4).
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Table 10
Average Simulated True Treatment Effect for Each Outcome Variable by Scenario and
Coding Method
Y1

Y2

Y3

Y4

Scenario
M
SE
M
SE
M
SE
M
SE
Scenario A
ATT
0.00
0.12
0.18
0.12
0.46
0.13
0.75
0.13
ATC
0.00
0.12
-0.18
0.12
-0.46
0.13
-0.75
0.13
Scenario B
ATT
0.00
0.07
0.19
0.07
0.47
0.07
0.76
0.07
ATC
0.00
0.07
-0.19
0.07
-0.47
0.07
-0.76
0.07
Scenario C
ATT
0.00
0.06
0.18
0.06
0.47
0.06
0.75
0.06
ATC
0.00
0.06
-0.18
0.06
-0.47
0.06
-0.75
0.06
Scenario D
ATT
0.00
0.11
0.18
0.11
0.46
0.11
0.74
0.11
ATC
0.00
0.11
-0.18
0.11
-0.46
0.11
-0.74
0.11
Scenario E
ATT
0.00
0.06
0.18
0.06
0.47
0.06
0.75
0.06
ATC
0.00
0.06
-0.18
0.06
-0.47
0.06
-0.75
0.06
Scenario F
ATT
0.00
0.05
0.18
0.05
0.46
0.05
0.75
0.05
ATC
0.00
0.05
-0.18
0.05
-0.46
0.05
-0.75
0.05
Scenario G
ATT
0.00
0.08
0.19
0.08
0.49
0.08
0.78
0.08
ATC
0.00
0.08
-0.19
0.08
-0.49
0.08
-0.78
0.08
Scenario H
ATT
0.00
0.05
0.19
0.05
0.49
0.05
0.79
0.05
ATC
0.00
0.05
-0.19
0.05
-0.49
0.05
-0.79
0.05
Scenario I
ATT
0.00
0.04
0.19
0.04
0.49
0.04
0.78
0.04
ATC
0.00
0.04
-0.19
0.04
-0.49
0.04
-0.78
0.04
Note. The presented means for each Y outcome variable are averaged across 1,000
replications for each scenario. Standard errors indicate the variability in each parameter
across the 1,000 replications. Each scenario represents a unique combination of treatment
sample size and treatment to comparison group ratio as follows: scenario A (NTreatment =
200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000,
T:C = 2:1), scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C =
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4:3), scenario F (NTreatment = 1,000, T:C = 4:3), scenario G (NTreatment = 200, T:C = 1:4),
scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C = 1:4).
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Table 11
Mean, Median, Minimum, and Maximum Optimal Iterations for Generalized Boosted
Models by Scenario and Coding Method
Scenario
Mean
Median
Min
Max
Scenario A
ATT Coding
683.59
586.00
219.00
2675.00
ATC Coding
709.93
641.00
265.00
2342.00
Scenario B
ATT Coding
1217.34
1040.00
382.00
7595.00
ATC Coding
998.90
933.00
435.00
2757.00
Scenario C
ATT Coding
1617.80
1360.00
476.00
6575.00
ATC Coding
1180.18
1137.50
488.00
3434.00
Scenario D
ATT Coding
762.44
660.50
251.00
3019.00
ATC Coding
745.76
689.00
244.00
2572.00
Scenario E
ATT Coding
1212.78
1088.00
470.00
4443.00
ATC Coding
1102.21
1037.50
449.00
5925.00
Scenario F
ATT Coding
1500.39
1349.50
537.00
9904.00
ATC Coding
1338.18
1235.00
545.00
8261.00
Scenario G
ATT Coding
956.14
925.00
423.00
2599.00
ATC Coding
1423.77
1154.00
310.00
6737.00
Scenario H
ATT Coding
1347.55
1315.00
712.00
2650.00
ATC Coding
2986.81
2540.50
622.00
9997.00
Scenario I
ATT Coding
1544.35
1508.50
851.00
2827.00
ATC Coding
4128.92
3452.00
954.00
9992.00
Note. Each summary statistic is averaged across 1,000 replications for each scenario.
Each scenario represents a unique combination of treatment sample size and
treatment to comparison group ratio as follows: scenario A (NTreatment = 200, T:C =
2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C =
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2:1), scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3),
scenario F (NTreatment = 1,000, T:C = 4:3), scenario G (NTreatment = 200, T:C = 1:4),
scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C = 1:4).
For all scenarios, the maximum number of iterations allowed for generalized boosted
modeling was 10,000.

Table 12
Average Cohen’s D Estimated Treatment Effect, Average Bias in Estimated Treatment Effect, and Standard Errors by
Propensity Score Method and Coding Method
Method

M

Cohen's D Y1
SE M Bias

ATT Coding
Baseline
0.234 0.122 0.234
NN
0.232 0.142 0.232
NN Cal
0.000 0.176 0.000
GBM
0.045 0.133 0.045
ATC Coding
Baseline
-0.234 0.122 -0.234
NN
-0.106 0.141 -0.106
NN Cal
0.008 0.174 0.008
GBM
-0.044 0.124 -0.044
ATT Coding
Baseline
0.238 0.071 0.238
NN
0.240 0.082 0.240
NN Cal
0.002 0.098 0.002
GBM
0.033 0.072 0.033
ATC Coding
Baseline
-0.238 0.071 -0.238
NN
-0.106 0.082 -0.106
NN Cal
0.001 0.097 0.001
GBM
-0.037 0.070 -0.037

Cohen's D Y2
SE M Bias SE
Scenario A

M

Cohen's D Y3
SE M Bias

SE

M

Cohen's D Y4
SE M Bias

SE

0.123
0.143
0.176
0.142

0.768
0.769
0.540
0.434

0.126 0.268
0.147 0.269
0.179 0.040
0.167 -0.066

0.126
0.147
0.179
0.167

1.093
1.095
0.868
0.671

0.130 0.293
0.152 0.295
0.183 0.068
0.200 -0.129

0.130
0.152
0.183
0.200

-0.244 0.123
-0.117 0.142
-0.005 0.174
-0.010 0.130
Scenario B

-0.768
-0.644
-0.534
-0.467

0.126 -0.268 0.126
0.145 -0.144 0.145
0.177 -0.034 0.177
0.143 0.033 0.143

-1.093
-0.971
-0.862
-0.724

0.130 -0.293 0.130
0.151 -0.171 0.151
0.182 -0.062 0.182
0.162 0.076 0.162

0.072
0.083
0.098
0.081

0.772
0.776
0.540
0.384

0.074 0.272
0.085 0.276
0.100 0.040
0.103 -0.116

0.074
0.085
0.100
0.103

1.097
1.101
0.866
0.597

0.077 0.297
0.088 0.301
0.102 0.066
0.131 -0.203

0.072 -0.248 0.072
0.083 -0.117 0.083
0.097 -0.010 0.097
0.073 0.002 0.073

-0.772
-0.643
-0.537
-0.447

0.074 -0.272 0.074
0.085 -0.143 0.085
0.099 -0.037 0.099
0.082 0.053 0.082

-1.097
-0.970
-0.863
-0.695

0.077 -0.297 0.077
0.088 -0.170 0.088
0.101 -0.063 0.101
0.096 0.105 0.096

SE

M

0.122
0.142
0.176
0.133

0.444
0.443
0.212
0.198

0.123 0.244
0.143 0.243
0.176 0.012
0.142 -0.002

0.122
0.141
0.174
0.124

-0.444
-0.317
-0.205
-0.210

0.123
0.142
0.174
0.130

0.071
0.082
0.098
0.072

0.448
0.451
0.213
0.171

0.072 0.248
0.083 0.251
0.098 0.013
0.081 -0.029

0.071
0.082
0.097
0.070

-0.448
-0.317
-0.210
-0.198

0.077
0.088
0.102
0.131
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Table 12 Cont.
Method
ATT Coding
Baseline
NN
NN Cal
GBM
ATC Coding
Baseline
NN
NN Cal
GBM
ATT Coding
Baseline
NN
NN Cal
GBM
ATC Coding
Baseline
NN
NN Cal
GBM

Cohen's D Y1
SE M Bias

SE

M

Cohen's D Y2
SE M Bias SE
Scenario C

M

Cohen's D Y3
SE M Bias

SE

M

Cohen's D Y4
SE M Bias

SE

0.061
0.072
0.078
0.108

0.235
0.235
0.007
0.031

0.058
0.068
0.076
0.055

0.235
0.235
0.007
0.031

0.058
0.068
0.076
0.055

0.445
0.445
0.218
0.164

0.058 0.245
0.068 0.245
0.076 0.018
0.063 -0.036

0.058
0.068
0.076
0.063

0.769
0.769
0.544
0.370

0.059 0.269
0.070 0.269
0.077 0.044
0.083 -0.130

0.059
0.070
0.077
0.083

1.092
1.093
0.871
0.575

0.061 0.292
0.072 0.293
0.078 0.071
0.108 -0.225

-0.235
-0.102
-0.005
-0.030

0.058
0.066
0.075
0.055

-0.235
-0.102
-0.005
-0.030

0.058
0.066
0.075
0.055

-0.445
-0.313
-0.216
-0.187

0.058 -0.245 0.058
0.066 -0.113 0.066
0.075 -0.016 0.075
0.058 0.013 0.058
Scenario D

-0.769
-0.639
-0.543
-0.430

0.059 -0.269 0.059
0.067 -0.139 0.067
0.076 -0.043 0.076
0.067 0.070 0.067

-1.092
-0.964
-0.869
-0.673

0.061 -0.292 0.061
0.069 -0.164 0.069
0.078 -0.069 0.078
0.079 0.127 0.079

0.227
0.226
0.008
0.040

0.108
0.117
0.149
0.111

0.227
0.226
0.008
0.040

0.108
0.117
0.149
0.111

0.438
0.436
0.221
0.194

0.109 0.238
0.118 0.236
0.149 0.021
0.118 -0.006

0.109
0.118
0.149
0.118

0.762
0.761
0.549
0.433

0.111 0.262
0.121 0.261
0.152 0.049
0.137 -0.067

0.111
0.121
0.152
0.137

1.087
1.086
0.877
0.672

0.115 0.287
0.125 0.286
0.156 0.077
0.163 -0.128

-0.227
-0.157
-0.010
-0.041

0.108
0.115
0.149
0.109

-0.227
-0.157
-0.010
-0.041

0.108
0.115
0.149
0.109

-0.438
-0.368
-0.222
-0.203

0.109
0.116
0.149
0.114

-0.238 0.109
-0.168 0.116
-0.022 0.149
-0.003 0.114
Scenario E

-0.762
-0.695
-0.550
-0.453

0.111 -0.262 0.111
0.118 -0.195 0.118
0.150 -0.050 0.150
0.129 0.047 0.129

-1.087
-1.021
-0.878
-0.703

0.115 -0.287 0.115
0.121 -0.221 0.121
0.154 -0.078 0.154
0.150 0.097 0.150

0.232
0.233
0.003
0.034

0.061
0.065
0.089
0.063

0.232
0.233
0.003
0.034

0.061
0.065
0.089
0.063

0.442
0.443
0.214
0.178

0.061 0.242
0.065 0.243
0.089 0.014
0.069 -0.022

0.061
0.065
0.089
0.069

0.766
0.767
0.540
0.399

0.063 0.266
0.067 0.267
0.090 0.040
0.085 -0.101

0.063
0.067
0.090
0.085

1.090
1.092
0.867
0.621

0.065 0.290
0.069 0.292
0.093 0.067
0.106 -0.179

-0.232
-0.160
-0.002
-0.031

0.061
0.065
0.089
0.061

-0.232
-0.160
-0.002
-0.031

0.061
0.065
0.089
0.061

-0.442
-0.371
-0.213
-0.183

0.061 -0.242 0.061
0.066 -0.171 0.066
0.089 -0.013 0.089
0.066 0.017 0.066

-0.766
-0.697
-0.540
-0.418

0.063 -0.266 0.063
0.067 -0.197 0.067
0.091 -0.040 0.091
0.079 0.082 0.079

-1.090
-1.023
-0.866
-0.653

0.065 -0.290 0.065
0.069 -0.223 0.069
0.093 -0.066 0.093
0.097 0.147 0.097

0.115
0.125
0.156
0.163

0.065
0.069
0.093
0.106
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Method
ATT Coding
Baseline
NN
NN Cal
GBM
ATC Coding
Baseline
NN
NN Cal
GBM
ATT Coding
Baseline
NN
NN Cal
GBM
ATC Coding
Baseline
NN
NN Cal
GBM

Cohen's D Y1
SE M Bias

SE

M

Cohen's D Y2
SE M Bias SE
Scenario F

M

Cohen's D Y3
SE M Bias

SE

M

Cohen's D Y4
SE M Bias

SE

0.051
0.055
0.069
0.088

0.232
0.233
0.007
0.029

0.048
0.051
0.066
0.049

0.232
0.233
0.007
0.029

0.048
0.051
0.066
0.049

0.442
0.443
0.218
0.168

0.048 0.242
0.052 0.243
0.066 0.018
0.054 -0.032

0.048
0.052
0.066
0.054

0.767
0.767
0.544
0.383

0.050 0.267
0.053 0.267
0.067 0.044
0.069 -0.117

0.050
0.053
0.067
0.069

1.091
1.092
0.870
0.599

0.051 0.291
0.055 0.292
0.069 0.070
0.088 -0.201

-0.232
-0.162
-0.005
-0.030

0.048
0.050
0.067
0.047

-0.232
-0.162
-0.005
-0.030

0.048
0.050
0.067
0.047

-0.442
-0.372
-0.216
-0.179

0.048 -0.242 0.048
0.051 -0.172 0.051
0.067 -0.016 0.067
0.052 0.021 0.052
Scenario G

-0.767
-0.698
-0.543
-0.410

0.050 -0.267 0.050
0.052 -0.198 0.052
0.068 -0.043 0.068
0.064 0.090 0.064

-1.091
-1.024
-0.869
-0.641

0.051 -0.291 0.051
0.054 -0.224 0.054
0.070 -0.069 0.070
0.080 0.159 0.080

0.252
0.051
-0.002
0.039

0.077 0.252 0.077
0.100 0.051 0.100
0.113 -0.002 0.113
0.080 0.039 0.080

0.462
0.262
0.209
0.209

0.077
0.100
0.113
0.083

0.077
0.100
0.113
0.083

0.785
0.589
0.536
0.471

0.078 0.285
0.102 0.089
0.115 0.036
0.093 -0.029

0.078
0.102
0.115
0.093

1.109
0.915
0.863
0.734

0.080 0.309
0.104 0.115
0.118 0.063
0.106 -0.066

-0.252
-0.256
-0.004
-0.036

0.077
0.096
0.110
0.084

-0.252
-0.256
-0.004
-0.036

0.077
0.096
0.110
0.084

-0.462
-0.466
-0.215
-0.161

0.077 -0.262 0.077
0.097 -0.266 0.097
0.110 -0.015 0.110
0.095 0.039 0.095
Scenario H

-0.785
-0.790
-0.541
-0.355

0.078 -0.285 0.078
0.100 -0.290 0.100
0.111 -0.041 0.111
0.124 0.145 0.124

-1.109
-1.115
-0.867
-0.549

0.080 -0.309 0.080
0.105 -0.315 0.105
0.114 -0.067 0.114
0.159 0.251 0.159

0.253
0.051
0.005
0.027

0.044
0.056
0.063
0.045

0.253
0.051
0.005
0.027

0.044
0.056
0.063
0.045

0.462
0.262
0.216
0.192

0.044 0.262
0.056 0.062
0.063 0.016
0.047 -0.008

0.044
0.056
0.063
0.047

0.786
0.588
0.543
0.447

0.045 0.286
0.057 0.088
0.064 0.043
0.054 -0.053

0.045
0.057
0.064
0.054

1.110
0.914
0.869
0.702

0.046 0.310
0.059 0.114
0.066 0.069
0.063 -0.098

-0.253
-0.253
-0.012
-0.030

0.044
0.056
0.062
0.047

-0.253
-0.253
-0.012
-0.030

0.044
0.056
0.062
0.047

-0.462
-0.463
-0.223
-0.144

0.044 -0.262 0.044
0.056 -0.263 0.056
0.063 -0.023 0.063
0.057 0.056 0.057

-0.786
-0.787
-0.549
-0.321

0.045 -0.286 0.045
0.058 -0.287 0.058
0.064 -0.049 0.064
0.080 0.179 0.080

-1.110
-1.112
-0.876
-0.497

0.046 -0.310 0.046
0.060 -0.312 0.060
0.066 -0.076 0.066
0.108 0.303 0.108

0.262
0.062
0.009
0.009

0.080
0.104
0.118
0.106

0.046
0.059
0.066
0.063
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Table 12 Cont.
Method
ATT Coding
Baseline
NN
NN Cal
GBM
ATC Coding
Baseline
NN
NN Cal
GBM

M

Cohen's D Y1
SE M Bias

SE

M

Cohen's D Y2
SE M Bias SE
Scenario I

M

Cohen's D Y3
SE M Bias

SE

M

Cohen's D Y4
SE M Bias

SE

0.037
0.048
0.050
0.052

0.253
0.049
0.001
0.021

0.036
0.046
0.048
0.036

0.253
0.049
0.001
0.021

0.036
0.046
0.048
0.036

0.462
0.260
0.212
0.183

0.036 0.262
0.046 0.060
0.048 0.012
0.038 -0.017

0.036
0.046
0.048
0.038

0.786
0.586
0.538
0.434

0.037 0.286
0.047 0.086
0.049 0.038
0.044 -0.066

0.037
0.047
0.049
0.044

1.110
0.912
0.864
0.684

0.037 0.310
0.048 0.112
0.050 0.064
0.052 -0.116

-0.253
-0.253
-0.007
-0.025

0.036
0.046
0.048
0.037

-0.253
-0.253
-0.007
-0.025

0.036
0.046
0.048
0.037

-0.462
-0.463
-0.218
-0.134

0.036 -0.262 0.036
0.046 -0.263 0.046
0.048 -0.018 0.048
0.046 0.066 0.046

-0.786
-0.787
-0.544
-0.302

0.037 -0.286 0.037
0.047 -0.287 0.047
0.049 -0.044 0.049
0.067 0.198 0.067

-1.110
-1.112
-0.870
-0.470

0.037 -0.310 0.037
0.048 -0.312 0.048
0.050 -0.070 0.050
0.093 0.330 0.093

Note. Each scenario represents a unique combination of treatment sample size and treatment to comparison group ratio as
follows: scenario A (NTreatment = 200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C =
2:1), scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F (NTreatment = 1,000, T:C =
4:3), scenario G (NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C =
1:4). Mean bias values ≤ |0.10| are bolded.
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Table 13
ANOVA Results for Bias in the Estimated Treatment Effect
Source
Method
Coding
Ratio
Size
EffSize
Method*Coding
Method*Ratio
Method*Size
Method*EffSize
Coding*Ratio
Coding*Size
Coding*EffSize
Ratio*Size
Ratio*EffSize
Size*EffSize
Method*Coding*Ratio
Method*Coding*Size
Method*Coding*EffSize
Method*Ratio*Size
Method*Ratio*EffSize
Method*Size*EffSize
Coding*Ratio*Size
Coding*Ratio*EffSize
Coding*Size*EffSize
Ratio*Size*EffSize
Method*Coding*Ratio*Size
Method*Coding*Ratio*EffSize
Method*Coding*Size*EffSize
Method*Ratio*Size*EffSize
Coding*Ratio*Size*EffSize
Method*Coding*Ratio*Size*EffSize
Method*Coding*Ratio*Size*EffSize

df
SS
MS
F Value
2 2491.966 1245.983 132231.000
1
0.742
0.742
78.770
2
18.461
9.230
979.580
2
5.796
2.898
307.560
3
16.278
5.426
575.830
2
2.144
1.072
113.770
4
13.860
3.465
367.720
4
13.355
3.339
354.320
6 466.586
77.764
8252.800
2
48.995
24.497
2599.800
2
0.010
0.005
0.530
3
0.641
0.214
22.680
4
0.174
0.043
4.610
6
1.392
0.232
24.620
6
2.259
0.377
39.960
4 384.535
96.134 10202.300
4
0.164
0.041
4.360
6
1.412
0.235
24.980
8
0.864
0.108
11.460
12
2.359
0.197
20.860
12
3.377
0.281
29.860
4
0.247
0.062
6.550
6
14.391
2.399
254.550
6
0.011
0.002
0.190
12
0.034
0.003
0.300
8
0.542
0.068
7.190
12 25.852
2.154
228.630
12
0.014
0.001
0.130
24
0.013
0.001
0.060
12
0.160
0.013
1.410
24
0.369
0.015
1.630
24
0.981
0.041
7.400

p
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
0.589
<.001
0.001
<.001
<.001
<.001
0.002
<.001
<.001
<.001
<.001
<.001
<.001
0.981
0.990
<.001
<.001
1.000
1.000
0.152
0.027
<.001

Partial
η2
0.551
0.000
0.009
0.003
0.008
0.001
0.007
0.007
0.187
0.024
0.000
0.000
0.000
0.001
0.001
0.159
0.000
0.001
0.000
0.001
0.002
0.000
0.007
0.000
0.000
0.000
0.013
0.000
0.000
0.000
0.000
0.001

Note. Method refers to propensity score method, coding refers to ATT or ATC coding,
size refers to treatment sample size, and effSize refers to true treatment effect size.
Effects that were statistically significant and meaningful (partial η2 ≥ 0.02) are bolded.
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Table 14
Bias Means, Standard deviations, and Differences for ATC Coding and ATT Coding by
Treatment to Comparison Ratio for Each Propensity Score Method
ATC Coding
M
SD

ATT Coding
M
SD

Ratio
Difference
p
Cohen's d
NN
1:4
0.280
0.075
0.078
0.076
0.201
<.001
1.878
2:1
0.133
0.107
0.263
0.108
-0.130
<.001
-0.855
4:3
0.187
0.087
0.257
0.088
-0.069
<.001
-0.560
GBM
1:4
-0.123
0.153
-0.030
0.081
-0.093
<.001
-0.537
2:1
-0.030
0.115
-0.069
0.148
0.039
<.001
0.209
4:3
-0.046
0.114
-0.062
0.126
0.016
<.001
0.095
NN Cal
1:4
0.036
0.083
0.029
0.085
0.006
<.001
0.053
2:1
0.028
0.127
0.032
0.129
-0.004
0.007
-0.021
4:3
0.035
0.112
0.035
0.112
0.000
0.919
-0.001
Note. Because the direction of bias differed consistently across ATT and ATC coding,
the sign was reversed for all bias values for ATC coding prior to conducting the
ANOVA.

Table 15
Bias Means, Standard deviations, and Differences for Nearest Neighbor Matching, Nearest Neighbor Matching with a
Caliper, and Generalized Boosted Modeling by True Treatment Effect Size
True Treatment
Effect Size
None (0)
Small (0.20)
Medium (0.50)
Large (0.80)

NN
M
SD
0.173 0.114
0.183 0.114
0.208 0.115
0.234 0.117

NN Cal
M
SD
0.004 0.105
0.015 0.105
0.042 0.107
0.069 0.109

GBM
NN with NN Cal
NN with GBM
NN Cal with GBM
M
SD Difference p Cohen's d Difference p Cohen's d Difference p Cohen's d
0.033 0.077
0.169 <.001 1.090
0.139 <.001 1.012
-0.030 <.001 -0.229
-0.019 0.085
0.168 <.001 1.083
0.202 <.001 1.420
0.034 <.001 0.253
-0.091 0.109
0.167 <.001 1.062
0.300 <.001 1.890
0.133 <.001 0.873
-0.163 0.140
0.165 <.001 1.031
0.397 <.001 2.173
0.232 <.001 1.303

Note. Due to the negative average bias values for generalized boosted modeling (for small, medium, and large true treatment
effect sizes), the magnitude of the differences (absolute value) in bias between generalized boosted modeling and nearest
neighbor matching or nearest neighbor matching with a caliper are slightly inflated. Comparison of the magnitude (absolute
value) of differences between nearest neighbor matching and generalized boosted modeling resulted in Difference Small =
0.164, Cohen’s dSmall = 1.153, DifferenceMedium = 0.117, Cohen’s dMedium = 0.741, and DifferenceLarge = 0.071, Cohen’s dLarge =
0.388. Comparison of the magnitude (absolute value) of differences between nearest neighbor matching with a caliper and
generalized boosted modeling resulted in Difference Small = -0.004, Cohen’s dSmall = -0.029, DifferenceMedium = -0.049, Cohen’s
dMedium = -0.322, and DifferenceLarge = -0.094, Cohen’s dLarge = -0.530.
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Table 16
Standardized Mean Differences and Percentage in Bias Reduction for Covariates and Estimated Propensity Scores

Method

X1
Median
SMD
PBR

ATT Coding
Baseline
-0.03
NN
-0.03
NN Cal
0.00
GBM
-0.09
ATC Coding
Baseline
0.03
NN
0.01
NN Cal
0.01
GBM
0.06
ATT Coding
Baseline
-0.02
NN
-0.03
NN Cal
0.00
GBM
-0.06
ATC Coding
Baseline
0.02
NN
0.01
NN Cal
0.00
GBM
0.04

X2
Median
SMD
PBR

X3
X4
Median
Median
SMD
PBR
SMD
PBR
Scenario A

-12.61
25.60
0.00

0.18
0.18
0.01
-0.01

-6.27
64.12
65.31

0.48
0.48
0.01
0.13

32.93
22.20
25.00

-0.18
-0.08
0.00
0.00

48.29
64.78
73.75

-0.49
-0.22
0.00
-0.12

-13.15
33.86
-1.74

0.17
0.17
0.01
-0.01

0.07
79.05
82.87

39.66
28.57
28.57

-0.17
-0.08
0.00
0.00

54.94
79.38
88.06

0.89
87.06
72.05

X5
Median
SMD
PBR

Propensity Score
Median Variance
SMD
PBR
Ratio

0.88
0.88
0.02
0.28

-0.23
94.34
67.81

1.19
1.19
0.03
0.40

0.03
96.92
66.25

1.66
1.66
0.03
-

-0.07
98.39
-

0.64
0.64
1.04
-

-0.91
55.02
-0.41
87.89
0.00
74.41
-0.25
Scenario B

55.01
94.48
72.22

-1.26
-0.56
-0.01
-0.37

55.29
97.53
70.53

1.32
0.74
0.01
-

44.40
99.18
-

0.64
0.57
0.98
-

0.47
0.47
0.01
0.11

0.54
92.84
76.69

0.87
0.87
0.02
0.22

0.10
96.67
74.07

1.18
1.18
0.03
0.31

-0.07
97.64
73.08

1.60
1.60
0.03
-

-0.01
98.33
-

0.64
0.64
1.04
-

-0.48
-0.21
0.00
-0.10

55.68
92.85
79.12

-0.90
-0.39
-0.01
-0.20

56.21
96.88
77.92

-1.25
-0.55
-0.01
-0.28

56.24
98.50
77.95

1.28
0.69
0.01
-

45.72
99.21
-

0.64
0.55
0.98
-
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Method

X1
Median
SMD
PBR

ATT Coding
Baseline
-0.03
NN
-0.03
NN Cal
0.00
GBM
-0.05
ATC Coding
Baseline
0.03
NN
0.01
NN Cal
0.00
GBM
0.03
ATT Coding
Baseline
-0.02
NN
-0.02
NN Cal
0.00
GBM
-0.07
ATC Coding
Baseline
0.02
NN
0.01
NN Cal
0.00
GBM
0.06

X2
Median
SMD
PBR

X3
X4
Median
Median
SMD
PBR
SMD
PBR
Scenario C

-8.42
30.14
-15.52

0.17
0.18
0.00
0.00

-1.37
84.92
87.76

0.47
0.47
0.01
0.10

38.64
36.45
31.37

-0.17
-0.08
0.00
0.00

55.81
83.92
91.52

-0.48
-0.21
0.00
-0.09

-3.87
29.75
7.67

0.17
0.17
0.00
-0.01

0.38
66.04
74.20

19.16
26.49
21.57

-0.17
-0.12
0.00
0.00

26.73
66.93
74.11

-0.34
94.72
78.44

X5
Median
SMD
PBR

Propensity Score
Median Variance
SMD
PBR
Ratio

0.87
0.87
0.02
0.20

0.10
97.28
76.23

1.18
1.18
0.03
0.28

-0.22
97.67
76.03

1.59
1.59
0.03
-

-0.16
98.32
-

0.64
0.64
1.04
-

-0.90
56.79
-0.39
94.58
-0.01
-0.17
81.84
Scenario D

56.68
97.74
81.28

-1.25
-0.54
-0.01
-0.23

56.68
98.77
81.44

1.27
0.68
0.01
-

46.35
99.21
-

0.64
0.55
0.97
-

0.47
0.46
0.01
0.12

0.61
89.53
74.35

0.87
0.87
0.01
0.25

0.41
95.00
70.83

1.18
1.18
0.02
0.36

0.29
97.27
69.36

1.51
1.50
0.02
-

0.31
98.52
-

0.84
0.84
1.04
-

-0.47
-0.33
0.00
-0.12

29.74
89.78
75.31

-0.88
-0.61
-0.01
-0.25

30.36
95.08
71.52

-1.21
-0.84
-0.01
-0.35

30.71
97.64
70.69

1.37
1.07
0.02
-

22.45
98.95
-

0.84
0.73
0.97
-
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Method

X1
Median
SMD
PBR

ATT Coding
Baseline
-0.02
NN
-0.02
NN Cal
0.00
GBM
-0.05
ATC Coding
Baseline
0.02
NN
0.01
NN Cal
0.00
GBM
0.04
ATT Coding
Baseline
-0.02
NN
-0.02
NN Cal
0.00
GBM
-0.04
ATC Coding
Baseline
0.02
NN
0.01
NN Cal
0.00
GBM
0.03

X2
Median
SMD
PBR

X3
X4
Median
Median
SMD
PBR
SMD
PBR
Scenario E

-4.72
32.58
2.67

0.17
0.17
0.00
0.00

-0.14
80.73
85.77

0.47
0.47
0.01
0.10

21.29
30.32
27.27

-0.17
-0.12
0.00
0.00

30.33
80.39
89.05

-0.47
-0.32
-0.01
-0.09

-6.14
36.76
0.00

0.17
0.17
0.00
0.00

-0.17
85.68
91.20

22.57
40.11
26.56

-0.17
-0.12
0.00
0.00

29.93
86.36
92.31

-0.01
93.74
77.92

X5
Median
SMD
PBR

Propensity Score
Median Variance
SMD
PBR
Ratio

0.86
0.86
0.02
0.20

0.18
96.90
76.32

1.18
1.18
0.02
0.29

0.12
98.13
75.77

1.49
1.49
0.02
-

0.16
98.50
-

0.83
0.83
1.04
-

-0.87
30.89
-0.60
93.91
-0.01
-0.19
80.19
Scenario F

31.14
97.23
78.01

-1.20
-0.83
-0.01
-0.26

31.25
98.47
77.83

1.36
1.04
0.01
-

23.18
98.90
-

0.83
0.72
0.97
-

0.47
0.47
0.01
0.09

0.05
95.13
80.40

0.87
0.86
0.01
0.18

0.09
97.61
79.06

1.18
1.18
0.02
0.25

0.04
98.22
78.65

1.48
1.48
0.02
-

-0.01
98.50
-

0.83
0.83
1.04
-

-0.47
-0.32
0.00
-0.08

30.77
95.64
81.80

-0.87
-0.60
-0.01
-0.17

30.88
97.84
80.63

-1.20
-0.83
-0.01
-0.23

30.96
98.73
80.82

1.35
1.04
0.01
-

22.96
98.90
-

0.83
0.71
0.97
-
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Method

X1
Median
SMD
PBR

ATT Coding
Baseline
-0.02
NN
-0.01
NN Cal
0.00
GBM
-0.04
ATC Coding
Baseline
0.02
NN
0.02
NN Cal
0.00
GBM
0.08
ATT Coding
Baseline
-0.02
NN
0.00
NN Cal
0.00
GBM
-0.02
ATC Coding
Baseline
0.02
NN
0.03
NN Cal
0.00
GBM
0.07

X2
Median
SMD
PBR

X3
X4
Median
Median
SMD
PBR
SMD
PBR
Scenario G

34.88
25.55
35.00

0.19
0.04
0.00
0.00

72.56
75.96
89.40

0.51
0.10
0.00
0.10

-25.74
21.98
-25.90

-0.19
-0.19
0.00
0.02

-2.19
76.58
77.22

-0.50
-0.51
-0.02
-0.11

42.31
28.38
49.18

0.18
0.03
0.00
0.00

79.61
86.87
95.79

-22.11
31.82
-75.00

-0.18
-0.18
-0.01
0.01

0.19
86.47
86.89

79.66
92.09
80.07

X5
Median
SMD
PBR

Propensity Score
Median Variance
SMD
PBR
Ratio

0.98
0.19
0.00
0.20

80.17
96.49
78.94

1.36
0.27
0.00
0.29

80.24
98.41
79.13

1.17
0.36
0.00
-

69.67
99.63
-

2.52
1.90
1.01
-

-0.92
0.06
-0.93
91.61
-0.03
77.67
-0.25
Scenario H

-0.19
95.74
71.70

-1.23
-1.23
-0.04
-0.36

0.00
96.82
70.26

1.86
1.86
0.03
-

-0.10
98.28
-

2.52
2.59
0.97
-

0.51
0.10
0.00
0.08

80.84
95.42
84.94

0.97
0.18
0.00
0.14

80.84
98.06
85.46

1.35
0.26
0.00
0.19

80.84
99.06
85.89

1.16
0.34
0.00
-

70.50
99.64
-

2.48
1.88
1.01
-

-0.50
-0.50
-0.02
-0.10

0.06
94.83
79.48

-0.92
-0.92
-0.03
-0.21

0.02
96.73
76.33

-1.22
-1.23
-0.04
-0.30

-0.02
96.93
75.03

1.83
1.83
0.03
-

0.02
98.24
-

2.48
2.49
0.96
-
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Method

X1
Median
SMD
PBR

ATT Coding
Baseline
-0.02
NN
0.00
NN Cal
0.00
GBM
-0.01
ATC Coding
Baseline
0.02
NN
0.02
NN Cal
0.00
GBM
0.06

X2
Median
SMD
PBR

X3
X4
Median
Median
SMD
PBR
SMD
PBR
Scenario I

X5
Median
SMD
PBR

Propensity Score
Median Variance
SMD
PBR
Ratio

44.95
41.28
57.66

0.19
0.04
0.00
0.01

80.79
89.58
96.61

0.52
0.10
0.00
0.07

81.22
96.78
87.17

0.97
0.19
0.00
0.12

80.80
98.49
88.01

1.36
0.26
0.00
0.16

80.77
99.29
88.28

1.16
0.34
0.00
-

70.40
99.64
-

2.49
1.89
1.01
-

-23.11
37.60
-82.66

-0.19
-0.19
-0.01
0.00

0.90
90.28
90.30

-0.51
-0.51
-0.02
-0.09

0.03
95.95
81.03

-0.92
-0.92
-0.03
-0.20

-0.05
96.93
77.73

-1.23
-1.23
-0.04
-0.28

-0.08
96.97
76.93

1.83
1.83
0.03
-

-0.01
98.24
-

2.49
2.51
0.96
-

Note. Each scenario represents a unique combination of treatment sample size and treatment to comparison group ratio as follows:
scenario A (NTreatment = 200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C = 2:1), scenario
D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F (NTreatment = 1,000, T:C = 4:3), scenario G
(NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C = 1:4). Each covariate
(X1 through X5) represented a different magnitude of standardized mean difference at baseline (i.e., baseline imbalance) as
follows: X1 = 0, X2 = 0.20, X3 = 0.50, X4 = 0.80, X5 = 1.20. Standardized mean differences, percentages in bias reduction, and
propensity score variance ratios are not provided for generalized boosted modeling (for all scenarios) because outcome variables
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are weighted by the propensity score based on group membership (i.e., treatment or comparison group). Thus, there was no change

to the sample that was used in the outcome analysis, and no change in the group balance on the propensity score or propensity score
variance ratio over that at baseline. SMD values ≤ |0.10| and PBR values ≥ 80.00 are bolded.
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Table 17
Baseline, Matched, and Unmatched Treatment and Comparison Group Sizes and Average Propensity Scores by Matching
Method and Coding Method

Method
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal

Baseline
Treatment
Mean
N
PS

Baseline
Comparison
Mean
N
PS

Matched
Treatment
Mean
N
PS

Unmatched
Treatment
Mean
N
PS
Scenario A

Matched
Comparison
Mean
N
PS

Unmatched
Comparison
Mean
N
PS
Treatment Loss

200.378 0.781
200.378 0.781

99.622
99.622

0.441
0.441

99.622
64.290

0.781
0.582

100.756 0.781
136.088 0.873

99.622
64.290

0.441
0.576

0.000
35.332

0.203

50.28%
67.92%

200.378 0.219
200.378 0.219

99.622
99.622

0.559
0.559

99.622
64.316

0.368
0.423

100.756 0.070
136.062 0.125
Scenario B

99.622
64.316

0.559
0.425

0.000
35.306

0.794

50.28%
67.90%

600.219 0.776
600.219 0.776

299.781 0.449
299.781 0.449

299.781 0.776
199.505 0.580

300.438 0.776
400.714 0.873

299.781 0.449
199.505 0.575

0.000
100.276 0.201

50.05%
66.76%

600.219 0.224
600.219 0.224

299.781 0.551
299.781 0.551

299.781 0.373
199.445 0.425

300.438 0.075
400.774 0.125
Scenario C

299.781 0.551
199.445 0.427

0.000
100.336 0.796

50.05%
66.77%

1000.800 0.775
1000.800 0.775

499.196 0.452
499.196 0.452

499.196 0.775
333.474 0.581

501.604 0.775
667.326 0.873

499.196 0.452
333.474 0.575

0.000
165.722 0.198

50.12%
66.68%

1000.800 0.225
1000.800 0.225

499.196 0.548
499.196 0.548

499.196 0.375
333.382 0.424

501.604 0.076
667.418 0.125

499.196 0.548
333.382 0.426

0.000
165.814 0.798

50.12%
66.69%
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Table 17 Cont.

Method
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal

Baseline
Treatment
Mean
N
PS

Baseline
Comparison
Mean
N
PS

Matched
Treatment
Mean
N
PS

Unmatched
Treatment
Mean
N
PS
Scenario D

Matched
Comparison
Mean
N
PS

Unmatched
Comparison
Mean
N
PS
Treatment Loss

199.827 0.717
199.827 0.717

150.173 0.377
150.173 0.377

150.163 0.716
83.825 0.536

49.664 0.719
116.002 0.848

150.163 0.377
83.825 0.531

0.010
66.348 0.018

24.85%
58.05%

199.827 0.283
199.827 0.283

150.173 0.623
150.173 0.623

150.163 0.358
83.824 0.468

49.664 0.052
116.003 0.149
Scenario E

150.163 0.623
83.824 0.471

0.010
66.349 0.560

24.85%
58.05%

600.046 0.715
600.046 0.715

449.954 0.381
449.954 0.381

449.954 0.714
258.109 0.536

150.092 0.715
341.937 0.848

449.954 0.381
258.109 0.531

0.000
191.845 0.180

25.01%
56.99%

600.046 0.285
600.046 0.285

449.954 0.619
449.954 0.619

449.954 0.362
257.973 0.468

150.092 0.054
342.073 0.149
Scenario F

449.954 0.619
257.973 0.472

0.000
191.981 0.817

25.01%
57.01%

999.427 0.714
999.427 0.714

750.573 0.381
750.573 0.381

750.573 0.714
431.941 0.536

248.854 0.714
567.486 0.849

750.573 0.381
431.941 0.531

0.000
318.632 0.179

24.90%
56.78%

999.427 0.286
999.427 0.286

750.573 0.619
750.573 0.619

750.573 0.363
431.833 0.468

248.854 0.054
567.594 0.148
Scenario G

750.573 0.619
431.833 0.472

0.000
318.740 0.817

24.90%
56.79%

200.040 0.441
200.040 0.441

799.960 0.140
799.960 0.140

200.040 0.441
157.791 0.352

0.000
42.249 0.767

200.040 0.348
157.791 0.351

599.920 0.070
642.169 0.088

0.00%
21.12%

200.040 0.559
200.040 0.559

799.960 0.860
799.960 0.860

200.040 0.559
157.868 0.649

0.000
42.172 0.230

200.040 0.861
157.868 0.654

599.920 0.860
642.092 0.911

0.00%
21.08%
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Table 17 Cont.

Method
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal
ATT Coding
NN
NN Cal
ATC Coding
NN
NN Cal

Baseline
Treatment
Mean
N
PS

Baseline
Comparison
Mean
N
PS

Matched
Treatment
Mean
N
PS

Unmatched
Treatment
Mean
N
PS
Scenario H

Matched
Comparison
Mean
N
PS

Unmatched
Comparison
Mean
N
PS
Treatment Loss

599.374 0.436
599.374 0.436

2400.630 0.141
2400.630 0.141

599.374 0.436
481.147 0.354

0.000
118.227 0.775

599.374 0.349
481.147 0.353

1801.256 0.071
1919.483 0.088

0.00%
19.73%

599.374 0.564
599.374 0.564

2400.630 0.859
2400.630 0.859

599.374 0.564
481.205 0.647

0.000
118.169 0.222
Scenario I

599.374 0.859
481.205 0.652

1801.256 0.859
1919.425 0.911

0.00%
19.72%

997.619 0.437
997.619 0.437

4002.380 0.140
4002.380 0.140

997.619 0.437
803.472 0.354

0.000
194.147 0.775

997.619 0.349
803.472 0.353

3004.761 0.071
3198.908 0.087

0.00%
19.46%

997.619 0.563
997.619 0.563

4002.380 0.860
4002.380 0.860

997.619 0.563
803.735 0.647

0.000
193.884 0.221

997.619 0.860
803.735 0.652

3004.761 0.860
3198.645 0.911

0.00%
19.43%

Note. Each scenario represents a unique combination of treatment sample size and treatment to comparison group ratio as
follows: scenario A (NTreatment = 200, T:C = 2:1), scenario B (NTreatment = 600, T:C = 2:1), scenario C (NTreatment = 1,000, T:C =
2:1), scenario D (NTreatment = 200, T:C = 4:3), scenario E (NTreatment = 600, T:C = 4:3), scenario F (NTreatment = 1,000, T:C =
4:3), scenario G (NTreatment = 200, T:C = 1:4), scenario H (NTreatment = 600, T:C = 1:4), and scenario I (NTreatment = 1,000, T:C =
1:4). Scenario D shows a fraction of an unmatched comparison group member after nearest neighbor matching, for both
ATT and ATC coding. One replication (out of 1,000) in scenario D had a comparison group that was larger than the
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treatment group. Thus, for the one replication, there were a few unmatched comparison group members.
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Figure 1
Example Jitter Plot after Matching on the Propensity Score

Note. Example jitter plot produced after matching treatment and comparison
group members on the propensity score (Perkins & Horst, 2020). Jitter plots
allow for the examination of the propensity score distributions of each group.

Figure 2
Jitter Plots Demonstrating Group Propensity Score Distributions Prior to Matching or Weighting
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Note. Jitter plots demonstrating group propensity score distributions prior to matching or weighting. Samples A through C have a
treatment to comparison ratio of 2:1 (treatment N = 200, 600, and 1,000 from left to right). Samples D through F have a treatment
to comparison ration of 4:3 (treatment N = 200, 600, and 1,000 from left to right). Samples G through I have a treatment to
comparison ratio of 1:4 (treatment N = 200, 600, and 1,000 from left to right). All validation samples have adequate common
support between treatment and comparison group propensity score distributions.
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Figure 3
Average Bias for the Interaction between Coding Method and Treatment to Comparison Ratio for Each Propensity Score Method

Note. Line graph of the interaction between coding method and treatment to comparison ratio for each propensity score method. A 1:4
treatment to comparison ratio is indicated by orange, circles, and a solid line. A 2:1 treatment to comparison ratio is indicated by
green, triangles, and a short, dashed line. A 4:3 treatment to comparison ratio is indicated by purple, squares, and a long, dashed line.
The solid black line indicates bias of zero (the ideal average bias over a large number of replications).
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Figure 4
Average Bias for the Interaction between Propensity Score Method and True
Treatment Effect Size

Note. Line graph of the average magnitude of bias (absolute value) in the estimated
treatment effect for the two-way interaction between propensity score method and true
treatment effect size. True treatment effect sizes were Y1 = 0, Y2 = 0.20, Y3 = 0.40,
and Y4 = 0.80. Nearest neighbor matching is indicated by orange, circles, and a solid
line. Nearest neighbor matching with a caliper is indicated by green, triangles, and a
dash-dot line. Generalized boosted modeling is indicated by purple, squares, and a
long, dashed line. Bias in the estimated treatment effect at baseline (prior to matching
or weighting) is indicated by black, crosses, and a short, dashed line.

Figure 5
Average Standardized Mean Difference for Covariates and Propensity Score across Propensity Score Method, Coding Method, and
Treatment to Comparison Ratio
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Note. The standardized mean difference before matching or weighting is noted by the horizontal line for each covariate (X1 = 0, X2 =
0.20, X3 = 0.50, X4 = 0.80, and X5 = 1.20). Standardized mean difference for the propensity score is not presented for GBM because
the full sample is retained, and there is no change to the distribution of the propensity score. PS stands for propensity score. ATC
coding is indicated in orange and ATT coding is indicated in green. For each coding method, each treatment to comparison ratio is
indicated by a lighter shading (ratio of 1:4), medium shading (ratio of 2:1), and darker shading (ratio of 4:3) of each respective color.
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Figure 6
Average Propensity Score for Baseline and Matched Treatment and Comparison Groups across Matching Method,
Coding Method, and Treatment to Comparison Ratio
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Note. For each coding method, the baseline treatment and comparison group means did not differ across matching
method (as shown by the overlapping symbols for both methods at baseline). Comparison group means are indicated by
circles and treatment group means are indicated by triangle. Orange, solid lines and shapes indicate means associated
with nearest neighbor matching and green, dashed lines and shapes indicate means associated with nearest neighbor
matching with a caliper. Results were not included for generalized boosted modeling because there is no matched
treatment or comparison group. That is, the original sample is retained and average propensity scores for each group do
not differ from baseline.
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Appendix
Simulation code for Configuration A (adapted from simulation code used by
Harris, 2018). The following code was adapted for each configuration by changing the
proportion of the sample receiving treatment (TreatP) and the total sample size
(Nexaminee). For each configuration, the following values were substituted:
Configuration
A
B
C
D
E
F
G
H
I

TreatP
.667
.667
.667
.571
.571
.571
.200
.200
.200

Nexaminee
300
900
1500
350
1050
1750
1000
3000
5000

#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
# ~~~~~~~~~~~~~~~~
Dissertation Code
~~~~~~~~~~~~~~~
# ~~~~~~~~~~~~~~~~
Beth Perkins
~~~~~~~~~~~~~~~
# ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#Set working directory for saving simulated data
setwd("C:/Users/perkinba/Desktop/Dissertation/Chapter 4 - Results")
getwd()
install.packages("permute")
install.packages("mvtnorm")
install.packages("MatchIt")
install.packages("reshape2")
install.packages("twang")
install.packages("psych")
install.packages("writexl")
# ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#
CREATING THE SAVE-OUT VALUES.
# ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
# A denotes elements of Scenario A (2:1 ratio, T=200,C=100) before
matching/weighting
AvgX1TreatA
AvgX2TreatA
AvgX3TreatA
AvgX4TreatA
AvgX5TreatA
AvgYA1TreatA
AvgYA2TreatA
AvgYA3TreatA
AvgYA4TreatA
AvgPSTreatA
AvgX1CompA
AvgX2CompA

<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)

151
AvgX3CompA
AvgX4CompA
AvgX5CompA
AvgYA1CompA
AvgYA2CompA
AvgYA3CompA
AvgYA4CompA
AvgPSCompA
SDX1TreatA
SDX2TreatA
SDX3TreatA
SDX4TreatA
SDX5TreatA
SDYA1TreatA
SDYA2TreatA
SDYA3TreatA
SDYA4TreatA
SDPSTreatA
SDX1CompA
SDX2CompA
SDX3CompA
SDX4CompA
SDX5CompA
SDYA1CompA
SDYA2CompA
SDYA3CompA
SDYA4CompA
SDPSCompA
SMD_X1_All
SMD_X2_All
SMD_X3_All
SMD_X4_All
SMD_X5_All
SMD_PS_All
SMD_X1_AllATC
SMD_X2_AllATC
SMD_X3_AllATC
SMD_X4_AllATC
SMD_X5_AllATC
SMD_PS_AllATC
Cor_X1.X2_A
Cor_X1.X3_A
Cor_X1.X4_A
Cor_X1.X5_A
Cor_X2.X3_A
Cor_X2.X4_A
Cor_X2.X5_A
Cor_X3.X4_A
Cor_X3.X5_A
Cor_X4.X5_A
Cor_X1.PS_A
Cor_X2.PS_A
Cor_X3.PS_A
Cor_X4.PS_A
Cor_X5.PS_A
Cor_X1.Y1_A
Cor_X2.Y1_A

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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Cor_X3.Y1_A
Cor_X4.Y1_A
Cor_X5.Y1_A
Cor_X1.Y2_A
Cor_X2.Y2_A
Cor_X3.Y2_A
Cor_X4.Y2_A
Cor_X5.Y2_A
Cor_X1.Y3_A
Cor_X2.Y3_A
Cor_X3.Y3_A
Cor_X4.Y3_A
Cor_X5.Y3_A
Cor_X1.Y4_A
Cor_X2.Y4_A
Cor_X3.Y4_A
Cor_X4.Y4_A
Cor_X5.Y4_A
Cor_G.Y1_A
Cor_G.Y2_A
Cor_G.Y3_A
Cor_G.Y4_A
PopY1A
PopY2A
PopY3A
PopY4A
tPopY1A
tPopY2A
tPopY3A
tPopY4A
treatPopNA
compPopNA
PopCohenY1A
PopCohenY2A
PopCohenY3A
PopCohenY4A
BaseY1A
BaseY2A
BaseY3A
BaseY4A
tBaseY1A
tBaseY2A
tBaseY3A
tBaseY4A
treatBaseNA
compBaseNA
BaseCohenY1A
BaseCohenY2A
BaseCohenY3A
BaseCohenY4A
PopATCY1A
PopATCY2A
PopATCY3A
PopATCY4A
tPopATCY1A
tPopATCY2A
tPopATCY3A

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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tPopATCY4A
treatPopNAATC
compPopNAATC
PopCohenATCY1A
PopCohenATCY2A
PopCohenATCY3A
PopCohenATCY4A
BaseATCY1A
BaseATCY2A
BaseATCY3A
BaseATCY4A
tBaseATCY1A
tBaseATCY2A
tBaseATCY3A
tBaseATCY4A
treatBaseNAATC
compBaseNAATC
BaseCohenATCY1A
BaseCohenATCY2A
BaseCohenATCY3A
BaseCohenATCY4A
VRB
VRBATC
AvgX1TreatANN
AvgX2TreatANN
AvgX3TreatANN
AvgX4TreatANN
AvgX5TreatANN
AvgYA1TreatANN
AvgYA2TreatANN
AvgYA3TreatANN
AvgYA4TreatANN
AvgPSTreatANN
AvgX1CompANN
AvgX2CompANN
AvgX3CompANN
AvgX4CompANN
AvgX5CompANN
AvgYA1CompANN
AvgYA2CompANN
AvgYA3CompANN
AvgYA4CompANN
AvgPSCompANN
SDX1TreatANN
SDX2TreatANN
SDX3TreatANN
SDX4TreatANN
SDX5TreatANN
SDYA1TreatANN
SDYA2TreatANN
SDYA3TreatANN
SDYA4TreatANN
SDPSTreatANN
SDX1CompANN
SDX2CompANN
SDX3CompANN
SDX4CompANN

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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SDX5CompANN
<- rep(NA, 1000)
SDYA1CompANN
<- rep(NA, 1000)
SDYA2CompANN
<- rep(NA, 1000)
SDYA3CompANN
<- rep(NA, 1000)
SDYA4CompANN
<- rep(NA, 1000)
SDPSCompANN
<- rep(NA, 1000)
SMD_X1_ANN
<- rep(NA, 1000)
SMD_X2_ANN
<- rep(NA, 1000)
SMD_X3_ANN
<- rep(NA, 1000)
SMD_X4_ANN
<- rep(NA, 1000)
SMD_X5_ANN
<- rep(NA, 1000)
SMD_PS_ANN
<- rep(NA, 1000)
PBR_X1_ANN
<- rep(NA, 1000)
PBR_X2_ANN
<- rep(NA, 1000)
PBR_X3_ANN
<- rep(NA, 1000)
PBR_X4_ANN
<- rep(NA, 1000)
PBR_X5_ANN
<- rep(NA, 1000)
PBR_PS_ANN
<- rep(NA, 1000)
Y1ANN
<- rep(NA, 1000)
Y2ANN
<- rep(NA, 1000)
Y3ANN
<- rep(NA, 1000)
Y4ANN
<- rep(NA, 1000)
tNNY1A
<- rep(NA, 1000)
tNNY2A
<- rep(NA, 1000)
tNNY3A
<- rep(NA, 1000)
tNNY4A
<- rep(NA, 1000)
NNtreatNA
<- rep(NA, 1000)
NNcompNA
<- rep(NA, 1000)
NNCohenY1A
<- rep(NA, 1000)
NNCohenY2A
<- rep(NA, 1000)
NNCohenY3A
<- rep(NA, 1000)
NNCohenY4A
<- rep(NA, 1000)
PSMeanMatchedTreatANN
<- rep(NA,
PSMeanMatchedCompANN
<- rep(NA,
PSMeanUnMatchedTreatANN
<- rep(NA,
PSMeanUnMatchedCompANN
<- rep(NA,
PSMedMatchedTreatANN
<- rep(NA,
PSMedMatchedCompANN
<- rep(NA,
PSMedUnMatchedTreatANN
<- rep(NA,
PSMedUnMatchedCompANN
<- rep(NA,
PSsdMatchedTreatANN
<- rep(NA,
PSsdMatchedCompANN
<- rep(NA,
PSsdUnMatchedTreatANN
<- rep(NA,
PSsdUnMatchedCompANN
<- rep(NA,
VRANN
<- rep(NA, 1000)
AvgX1TreatANNATC
<- rep(NA, 1000)
AvgX2TreatANNATC
<- rep(NA, 1000)
AvgX3TreatANNATC
<- rep(NA, 1000)
AvgX4TreatANNATC
<- rep(NA, 1000)
AvgX5TreatANNATC
<- rep(NA, 1000)
AvgYA1TreatANNATC
<- rep(NA, 1000)
AvgYA2TreatANNATC
<- rep(NA, 1000)
AvgYA3TreatANNATC
<- rep(NA, 1000)
AvgYA4TreatANNATC
<- rep(NA, 1000)
AvgPSTreatANNATC
<- rep(NA, 1000)
AvgX1CompANNATC
<- rep(NA, 1000)
AvgX2CompANNATC
<- rep(NA, 1000)

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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AvgX3CompANNATC
<- rep(NA, 1000)
AvgX4CompANNATC
<- rep(NA, 1000)
AvgX5CompANNATC
<- rep(NA, 1000)
AvgYA1CompANNATC
<- rep(NA, 1000)
AvgYA2CompANNATC
<- rep(NA, 1000)
AvgYA3CompANNATC
<- rep(NA, 1000)
AvgYA4CompANNATC
<- rep(NA, 1000)
AvgPSCompANNATC
<- rep(NA, 1000)
SDX1TreatANNATC
<- rep(NA, 1000)
SDX2TreatANNATC
<- rep(NA, 1000)
SDX3TreatANNATC
<- rep(NA, 1000)
SDX4TreatANNATC
<- rep(NA, 1000)
SDX5TreatANNATC
<- rep(NA, 1000)
SDYA1TreatANNATC
<- rep(NA, 1000)
SDYA2TreatANNATC
<- rep(NA, 1000)
SDYA3TreatANNATC
<- rep(NA, 1000)
SDYA4TreatANNATC
<- rep(NA, 1000)
SDPSTreatANNATC
<- rep(NA, 1000)
SDX1CompANNATC
<- rep(NA, 1000)
SDX2CompANNATC
<- rep(NA, 1000)
SDX3CompANNATC
<- rep(NA, 1000)
SDX4CompANNATC
<- rep(NA, 1000)
SDX5CompANNATC
<- rep(NA, 1000)
SDYA1CompANNATC
<- rep(NA, 1000)
SDYA2CompANNATC
<- rep(NA, 1000)
SDYA3CompANNATC
<- rep(NA, 1000)
SDYA4CompANNATC
<- rep(NA, 1000)
SDPSCompANNATC
<- rep(NA, 1000)
SMD_X1_ANNATC
<- rep(NA, 1000)
SMD_X2_ANNATC
<- rep(NA, 1000)
SMD_X3_ANNATC
<- rep(NA, 1000)
SMD_X4_ANNATC
<- rep(NA, 1000)
SMD_X5_ANNATC
<- rep(NA, 1000)
SMD_PS_ANNATC
<- rep(NA, 1000)
PBR_X1_ANNATC
<- rep(NA, 1000)
PBR_X2_ANNATC
<- rep(NA, 1000)
PBR_X3_ANNATC
<- rep(NA, 1000)
PBR_X4_ANNATC
<- rep(NA, 1000)
PBR_X5_ANNATC
<- rep(NA, 1000)
PBR_PS_ANNATC
<- rep(NA, 1000)
Y1ANNATC
<- rep(NA, 1000)
Y2ANNATC
<- rep(NA, 1000)
Y3ANNATC
<- rep(NA, 1000)
Y4ANNATC
<- rep(NA, 1000)
tNNATCY1A
<- rep(NA, 1000)
tNNATCY2A
<- rep(NA, 1000)
tNNATCY3A
<- rep(NA, 1000)
tNNATCY4A
<- rep(NA, 1000)
NNATCtreatNA
<- rep(NA, 1000)
NNATCcompNA
<- rep(NA, 1000)
NNATCCohenY1A
<- rep(NA, 1000)
NNATCCohenY2A
<- rep(NA, 1000)
NNATCCohenY3A
<- rep(NA, 1000)
NNATCCohenY4A
<- rep(NA, 1000)
PSMeanMatchedTreatANNATC
<- rep(NA, 1000)
PSMeanMatchedCompANNATC
<- rep(NA, 1000)
PSMeanUnMatchedTreatANNATC
<- rep(NA, 1000)
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PSMeanUnMatchedCompANNATC
<- rep(NA,
PSMedMatchedTreatANNATC
<- rep(NA,
PSMedMatchedCompANNATC
<- rep(NA,
PSMedUnMatchedTreatANNATC
<- rep(NA,
PSMedUnMatchedCompANNATC
<- rep(NA,
PSsdMatchedTreatANNATC
<- rep(NA,
PSsdMatchedCompANNATC
<- rep(NA,
PSsdUnMatchedTreatANNATC
<- rep(NA,
PSsdUnMatchedCompANNATC
<- rep(NA,
VRANNATC
<- rep(NA, 1000)
AvgX1TreatANNCal
<- rep(NA, 1000)
AvgX2TreatANNCal
<- rep(NA, 1000)
AvgX3TreatANNCal
<- rep(NA, 1000)
AvgX4TreatANNCal
<- rep(NA, 1000)
AvgX5TreatANNCal
<- rep(NA, 1000)
AvgYA1TreatANNCal
<- rep(NA, 1000)
AvgYA2TreatANNCal
<- rep(NA, 1000)
AvgYA3TreatANNCal
<- rep(NA, 1000)
AvgYA4TreatANNCal
<- rep(NA, 1000)
AvgPSTreatANNCal
<- rep(NA, 1000)
AvgX1CompANNCal
<- rep(NA, 1000)
AvgX2CompANNCal
<- rep(NA, 1000)
AvgX3CompANNCal
<- rep(NA, 1000)
AvgX4CompANNCal
<- rep(NA, 1000)
AvgX5CompANNCal
<- rep(NA, 1000)
AvgYA1CompANNCal
<- rep(NA, 1000)
AvgYA2CompANNCal
<- rep(NA, 1000)
AvgYA3CompANNCal
<- rep(NA, 1000)
AvgYA4CompANNCal
<- rep(NA, 1000)
AvgPSCompANNCal
<- rep(NA, 1000)
SDX1TreatANNCal
<- rep(NA, 1000)
SDX2TreatANNCal
<- rep(NA, 1000)
SDX3TreatANNCal
<- rep(NA, 1000)
SDX4TreatANNCal
<- rep(NA, 1000)
SDX5TreatANNCal
<- rep(NA, 1000)
SDYA1TreatANNCal
<- rep(NA, 1000)
SDYA2TreatANNCal
<- rep(NA, 1000)
SDYA3TreatANNCal
<- rep(NA, 1000)
SDYA4TreatANNCal
<- rep(NA, 1000)
SDPSTreatANNCal
<- rep(NA, 1000)
SDX1CompANNCal
<- rep(NA, 1000)
SDX2CompANNCal
<- rep(NA, 1000)
SDX3CompANNCal
<- rep(NA, 1000)
SDX4CompANNCal
<- rep(NA, 1000)
SDX5CompANNCal
<- rep(NA, 1000)
SDYA1CompANNCal
<- rep(NA, 1000)
SDYA2CompANNCal
<- rep(NA, 1000)
SDYA3CompANNCal
<- rep(NA, 1000)
SDYA4CompANNCal
<- rep(NA, 1000)
SDPSCompANNCal
<- rep(NA, 1000)
SMD_X1_ANNCal
<- rep(NA, 1000)
SMD_X2_ANNCal
<- rep(NA, 1000)
SMD_X3_ANNCal
<- rep(NA, 1000)
SMD_X4_ANNCal
<- rep(NA, 1000)
SMD_X5_ANNCal
<- rep(NA, 1000)
SMD_PS_ANNCal
<- rep(NA, 1000)
PBR_X1_ANNCal
<- rep(NA, 1000)

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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PBR_X2_ANNCal
<- rep(NA, 1000)
PBR_X3_ANNCal
<- rep(NA, 1000)
PBR_X4_ANNCal
<- rep(NA, 1000)
PBR_X5_ANNCal
<- rep(NA, 1000)
PBR_PS_ANNCal
<- rep(NA, 1000)
Y1ANNCal
<- rep(NA, 1000)
Y2ANNCal
<- rep(NA, 1000)
Y3ANNCal
<- rep(NA, 1000)
Y4ANNCal
<- rep(NA, 1000)
tNNCalY1A
<- rep(NA, 1000)
tNNCalY2A
<- rep(NA, 1000)
tNNCalY3A
<- rep(NA, 1000)
tNNCalY4A
<- rep(NA, 1000)
NNCaltreatNA
<- rep(NA, 1000)
NNCalcompNA
<- rep(NA, 1000)
NNCalCohenY1A
<- rep(NA, 1000)
NNCalCohenY2A
<- rep(NA, 1000)
NNCalCohenY3A
<- rep(NA, 1000)
NNCalCohenY4A
<- rep(NA, 1000)
PSMeanMatchedTreatANNCal
<- rep(NA,
PSMeanMatchedCompANNCal
<- rep(NA,
PSMeanUnMatchedTreatANNCal
<- rep(NA,
PSMeanUnMatchedCompANNCal
<- rep(NA,
PSMedMatchedTreatANNCal
<- rep(NA,
PSMedMatchedCompANNCal
<- rep(NA,
PSMedUnMatchedTreatANNCal
<- rep(NA,
PSMedUnMatchedCompANNCal
<- rep(NA,
PSsdMatchedTreatANNCal
<- rep(NA,
PSsdMatchedCompANNCal
<- rep(NA,
PSsdUnMatchedTreatANNCal
<- rep(NA,
PSsdUnMatchedCompANNCal
<- rep(NA,
VRANNCal
<- rep(NA, 1000)
AvgX1TreatANNCalATC
<- rep(NA, 1000)
AvgX2TreatANNCalATC
<- rep(NA, 1000)
AvgX3TreatANNCalATC
<- rep(NA, 1000)
AvgX4TreatANNCalATC
<- rep(NA, 1000)
AvgX5TreatANNCalATC
<- rep(NA, 1000)
AvgYA1TreatANNCalATC
<- rep(NA, 1000)
AvgYA2TreatANNCalATC
<- rep(NA, 1000)
AvgYA3TreatANNCalATC
<- rep(NA, 1000)
AvgYA4TreatANNCalATC
<- rep(NA, 1000)
AvgPSTreatANNCalATC
<- rep(NA, 1000)
AvgX1CompANNCalATC
<- rep(NA, 1000)
AvgX2CompANNCalATC
<- rep(NA, 1000)
AvgX3CompANNCalATC
<- rep(NA, 1000)
AvgX4CompANNCalATC
<- rep(NA, 1000)
AvgX5CompANNCalATC
<- rep(NA, 1000)
AvgYA1CompANNCalATC
<- rep(NA, 1000)
AvgYA2CompANNCalATC
<- rep(NA, 1000)
AvgYA3CompANNCalATC
<- rep(NA, 1000)
AvgYA4CompANNCalATC
<- rep(NA, 1000)
AvgPSCompANNCalATC
<- rep(NA, 1000)
SDX1TreatANNCalATC
<- rep(NA, 1000)
SDX2TreatANNCalATC
<- rep(NA, 1000)
SDX3TreatANNCalATC
<- rep(NA, 1000)
SDX4TreatANNCalATC
<- rep(NA, 1000)
SDX5TreatANNCalATC
<- rep(NA, 1000)

1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
1000)
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1000)
1000)
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SDYA1TreatANNCalATC
<- rep(NA, 1000)
SDYA2TreatANNCalATC
<- rep(NA, 1000)
SDYA3TreatANNCalATC
<- rep(NA, 1000)
SDYA4TreatANNCalATC
<- rep(NA, 1000)
SDPSTreatANNCalATC
<- rep(NA, 1000)
SDX1CompANNCalATC
<- rep(NA, 1000)
SDX2CompANNCalATC
<- rep(NA, 1000)
SDX3CompANNCalATC
<- rep(NA, 1000)
SDX4CompANNCalATC
<- rep(NA, 1000)
SDX5CompANNCalATC
<- rep(NA, 1000)
SDYA1CompANNCalATC
<- rep(NA, 1000)
SDYA2CompANNCalATC
<- rep(NA, 1000)
SDYA3CompANNCalATC
<- rep(NA, 1000)
SDYA4CompANNCalATC
<- rep(NA, 1000)
SDPSCompANNCalATC
<- rep(NA, 1000)
SMD_X1_ANNCalATC
<- rep(NA, 1000)
SMD_X2_ANNCalATC
<- rep(NA, 1000)
SMD_X3_ANNCalATC
<- rep(NA, 1000)
SMD_X4_ANNCalATC
<- rep(NA, 1000)
SMD_X5_ANNCalATC
<- rep(NA, 1000)
SMD_PS_ANNCalATC
<- rep(NA, 1000)
PBR_X1_ANNCalATC
<- rep(NA, 1000)
PBR_X2_ANNCalATC
<- rep(NA, 1000)
PBR_X3_ANNCalATC
<- rep(NA, 1000)
PBR_X4_ANNCalATC
<- rep(NA, 1000)
PBR_X5_ANNCalATC
<- rep(NA, 1000)
PBR_PS_ANNCalATC
<- rep(NA, 1000)
Y1ANNCalATC
<- rep(NA, 1000)
Y2ANNCalATC
<- rep(NA, 1000)
Y3ANNCalATC
<- rep(NA, 1000)
Y4ANNCalATC
<- rep(NA, 1000)
tNNCalATCY1A
<- rep(NA, 1000)
tNNCalATCY2A
<- rep(NA, 1000)
tNNCalATCY3A
<- rep(NA, 1000)
tNNCalATCY4A
<- rep(NA, 1000)
NNCalATCtreatNA
<- rep(NA, 1000)
NNCalATCcompNA
<- rep(NA, 1000)
NNCalATCCohenY1A
<- rep(NA, 1000)
NNCalATCCohenY2A
<- rep(NA, 1000)
NNCalATCCohenY3A
<- rep(NA, 1000)
NNCalATCCohenY4A
<- rep(NA, 1000)
PSMeanMatchedTreatANNCalATC
<- rep(NA,
PSMeanMatchedCompANNCalATC
<- rep(NA,
PSMeanUnMatchedTreatANNCalATC
<- rep(NA,
PSMeanUnMatchedCompANNCalATC
<- rep(NA,
PSMedMatchedTreatANNCalATC
<- rep(NA,
PSMedMatchedCompANNCalATC
<- rep(NA,
PSMedUnMatchedTreatANNCalATC
<- rep(NA,
PSMedUnMatchedCompANNCalATC
<- rep(NA,
PSsdMatchedTreatANNCalATC
<- rep(NA,
PSsdMatchedCompANNCalATC
<- rep(NA,
PSsdUnMatchedTreatANNCalATC
<- rep(NA,
PSsdUnMatchedCompANNCalATC
<- rep(NA,
VRANNCalATC
<- rep(NA, 1000)
AvgX1TreatAGBM
<- rep(NA, 1000)
AvgX2TreatAGBM
<- rep(NA, 1000)
AvgX3TreatAGBM
<- rep(NA, 1000)
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AvgX4TreatAGBM
AvgX5TreatAGBM
AvgX1CompAGBM
AvgX2CompAGBM
AvgX3CompAGBM
AvgX4CompAGBM
AvgX5CompAGBM
SDX1TreatAGBM
SDX2TreatAGBM
SDX3TreatAGBM
SDX4TreatAGBM
SDX5TreatAGBM
SDX1CompAGBM
SDX2CompAGBM
SDX3CompAGBM
SDX4CompAGBM
SDX5CompAGBM
SMD_X1_AGBM
SMD_X2_AGBM
SMD_X3_AGBM
SMD_X4_AGBM
SMD_X5_AGBM
PBR_X1_AGBM
PBR_X2_AGBM
PBR_X3_AGBM
PBR_X4_AGBM
PBR_X5_AGBM
Y1AGBM
Y2AGBM
Y3AGBM
Y4AGBM
tGBMY1A
tGBMY2A
tGBMY3A
tGBMY4A
GBMtreatNA
GBMcompNA
GBMCohenY1A
GBMCohenY2A
GBMCohenY3A
GBMCohenY4A
AvgX1TreatAGBMATC
AvgX2TreatAGBMATC
AvgX3TreatAGBMATC
AvgX4TreatAGBMATC
AvgX5TreatAGBMATC
AvgX1CompAGBMATC
AvgX2CompAGBMATC
AvgX3CompAGBMATC
AvgX4CompAGBMATC
AvgX5CompAGBMATC
SDX1TreatAGBMATC
SDX2TreatAGBMATC
SDX3TreatAGBMATC
SDX4TreatAGBMATC
SDX5TreatAGBMATC
SDX1CompAGBMATC

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
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rep(NA,
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rep(NA,
rep(NA,
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rep(NA,
rep(NA,
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rep(NA,
rep(NA,
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rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
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1000)
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SDX2CompAGBMATC
SDX3CompAGBMATC
SDX4CompAGBMATC
SDX5CompAGBMATC
SMD_X1_AGBMATC
SMD_X2_AGBMATC
SMD_X3_AGBMATC
SMD_X4_AGBMATC
SMD_X5_AGBMATC
PBR_X1_AGBMATC
PBR_X2_AGBMATC
PBR_X3_AGBMATC
PBR_X4_AGBMATC
PBR_X5_AGBMATC
Y1AGBMATC
Y2AGBMATC
Y3AGBMATC
Y4AGBMATC
tGBMATCY1A
tGBMATCY2A
tGBMATCY3A
tGBMATCY4A
GBMATCtreatNA
GBMATCcompNA
GBMATCCohenY1A
GBMATCCohenY2A
GBMATCCohenY3A
GBMATCCohenY4A
ESS_CompGBM
mean.esGBM
iterGBM
ESS_CompGBMATC
mean.esGBMATC
iterGBMATC

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-

rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
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rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
rep(NA,
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rep(NA,
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# ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#
BEGIN LOOP
# ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
set.seed(27)
for(i in 1:1000){
##Set treatment/comparison group ratio
#******SET RATIO
TreatP=.667
mycut=qnorm(1-TreatP) # threshold
#mycut
##initial correlation matrix
corrX=matrix(c(1,.1,.2,.3,.3,
.1,1,.3,.3,.35,
.2,.3,1,.3,.45,
.3,.3,.3,1,.65,
.3,.35,.45,.65,1),5,5)
##call these programs for simulating data (mvtnorm) & screening (psych)
library(mvtnorm)
library(psych)
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library(permute)
##Set number of examinees
Nexaminee=300
#*******TOTAL SAMPLE SIZE
Nrep=1000
##used for grouping using the PS
##Simulating the five original covariates
X=rmvnorm(Nexaminee, rep(0,5), corrX, method="chol")
##Coerce into a data frame, so can use it more easily
X <-as.data.frame(X)
#Correlation between covariates and latent propensity
#Note - we may want to fiddle with the strength of these
relationships.
#Will specify group balance on covariates. Tried transforming cohens d
to correlation, but did not result in large
#enough baseline SMD for X4 and X5. Played with values till SMD were
consistently what I wanted them to be.
corrXp = c(-.02,.15,.40,.70,.90)
##calculate regression coefficients
#install.packages("reshape2")
library(reshape2)
##Use the above correlation matrix to calculate the regression
coefficients
##These are coefficients for the PS model (not the outcome model)
PcoefA=solve(corrX) %*% corrXp
##Variance explained for model
##Creating a temporary matrix of squared values (jh)
##This will be used to create overall R-squared for model
##this is the variance in the latent propensity explained by covariates
tempA=PcoefA %*% t(PcoefA)*corrX
varExpPA=sum(tempA) #Summing everyting in temp
#varExpPA
xnew=as.matrix.data.frame(X)
###############################Propensity
scores########################
##This is like the sum of bx for each person
scores)
noErrA=as.vector(xnew %*% PcoefA)
#describe(noErrA)

(i.e., their y' predicted

#plot(noErrA)
##Variance explained in propensity score by X1-X5
RsqA=varExpPA/(1+varExpPA) #because the error variance of a probit is 1
##Rescale around the threshold to ensure the correct treatment to
comparison group ratio
distA=noErrA-(mycut/sqrt(1-RsqA))
##Finding the probability density
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##(help page says 'vector of probabilities')
##Assumes a normal distribution
truepropA=pnorm(distA)
##Randomly assign a random draw to each person Nrep times
randraw=matrix(runif(Nexaminee*Nrep),nrow=Nexaminee,ncol=Nrep)
options(scipen=999)
str(randraw)
##If propensity score is greater than the random draw,then assign to
treatment
##Otherwise, assign to comparison group
groupA=ifelse(truepropA>randraw,1,0)
##Creating a data frame with X1-X5, grouping variable, and true
propensity score
dataA=data.frame(X,groupA[,1])
##Assign variable names
library(reshape2)
names(dataA) <- c("x1","x2","x3","x4","x5","group")
##Calculate true propensity scores from logistic regression to obtain
logistic regression coefficients
dataA <- as.data.frame(dataA)
PbA=glm(formula= group ~ x1+x2+x3+x4+x5, data=dataA, family=binomial)
#PbA
##True propensity scores
dataA$TRUEprop<-predict(PbA, type="response")
#plot(dataA$TRUEprop)
#plot(dataA$TRUEprop, dataA$group)
##Outcome model
##Random error in the model
v <- rnorm(Nexaminee, mean=0, sd=0.5)
v <- as.data.frame(v) #coerce to data frame
##Each person's Y for the outcome model - would I create 4 different
models, one for each treatment effect size?
YA1 = 0 + 0*dataA$group + .05*dataA$x1 +
.05*dataA$x4 + .05*dataA$x5 + v
YA2 = 0 + .11*dataA$group + .05*dataA$x1
+ .05*dataA$x4 + .05*dataA$x5 + v
YA3 = 0 + .28*dataA$group + .05*dataA$x1
+ .05*dataA$x4 + .05*dataA$x5 + v
YA4 = 0 + .45*dataA$group + .05*dataA$x1
+ .05*dataA$x4 + .05*dataA$x5 + v

.05*dataA$x2 + .05*dataA$x3 +
+ .05*dataA$x2 + .05*dataA$x3
+ .05*dataA$x2 + .05*dataA$x3
+ .05*dataA$x2 + .05*dataA$x3

#describe(YA1)
#describe(YA2)
#describe(YA3)
#describe(YA4)
describe(dataA$group)
ATCgroup<-ifelse(dataA$group==0, 1, ifelse(dataA$group==1, 0, -1 ))
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ATCgroup
finalDataA<-cbind(dataA,YA1,YA2,YA3,YA4,ATCgroup)
finalDataA<-as.data.frame(finalDataA)
#head(finalDataA)
describe(finalDataA)
#describeBy(finalDataA, finalDataA$group)
#cor(finalDataA)
library(reshape2)
names(finalDataA) <- c("x1","x2","x3","x4","x5","group", "PS",
"YA1","YA2","YA3","YA4", "ATCgroup")
#What should the coefficient be - if treatment and comparison group
members differ on the outcome by the specified size of treatment effect
#We want to recover these values after matching/weighting
require(MatchIt)
PopY1=lm(YA1~group+x1+x2+x3+x4+x5,
#PopY1
PopY2=lm(YA2~group+x1+x2+x3+x4+x5,
#PopY2
PopY3=lm(YA3~group+x1+x2+x3+x4+x5,
#PopY3
PopY4=lm(YA4~group+x1+x2+x3+x4+x5,
#PopY4

data=finalDataA)
data=finalDataA)
data=finalDataA)
data=finalDataA)

ATCPopY1=lm(YA1~ATCgroup+x1+x2+x3+x4+x5,
#ATCPopY1
ATCPopY2=lm(YA2~ATCgroup+x1+x2+x3+x4+x5,
#ATCPopY2
ATCPopY3=lm(YA3~ATCgroup+x1+x2+x3+x4+x5,
#ATCPopY3
ATCPopY4=lm(YA4~ATCgroup+x1+x2+x3+x4+x5,
#ATCPopY4

data=finalDataA)
data=finalDataA)
data=finalDataA)
data=finalDataA)

#Use these values to transform t to d to make sure the treatment effect
is what we want it to be
#summary(PopY1)
#summary(PopY2)
#summary(PopY3)
#summary(PopY4)
#summary(ATCPopY1)
#summary(ATCPopY2)
#summary(ATCPopY3)
#summary(ATCPopY4)
#Computing Cohen's D for Population Treatment effect
tPopY1<-summary(PopY1)$coef[2, 3]
tPopY2<-summary(PopY2)$coef[2, 3]
tPopY3<-summary(PopY3)$coef[2, 3]
tPopY4<-summary(PopY4)$coef[2, 3]
treatn<-nobs(finalDataA$group[finalDataA$group==1])
compn<-nobs(finalDataA$group[finalDataA$group==0])
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cohenPopY1
cohenPopY2
cohenPopY3
cohenPopY4

<-(tPopY1)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tPopY2)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tPopY3)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tPopY4)*(((1/(treatn))+(1/(compn)))^0.5)

tPopATCY1<-summary(ATCPopY1)$coef[2, 3]
tPopATCY2<-summary(ATCPopY2)$coef[2, 3]
tPopATCY3<-summary(ATCPopY3)$coef[2, 3]
tPopATCY4<-summary(ATCPopY4)$coef[2, 3]
treatnATC<-nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==0])
compnATC<-nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==1])
cohenPopATCY1
cohenPopATCY2
cohenPopATCY3
cohenPopATCY4

<-(tPopATCY1)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tPopATCY2)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tPopATCY3)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tPopATCY4)*(((1/(treatnATC))+(1/(compnATC)))^0.5)

#Baseline group differences on outcome - deviation from PopY1-PopY4
indicate bias in the estimated treatment effect
baseout1=lm(YA1~group, data=finalDataA)
baseout2=lm(YA2~group, data=finalDataA)
baseout3=lm(YA3~group, data=finalDataA)
baseout4=lm(YA4~group, data=finalDataA)
ATCbaseout1=lm(YA1~ATCgroup,
ATCbaseout2=lm(YA2~ATCgroup,
ATCbaseout3=lm(YA3~ATCgroup,
ATCbaseout4=lm(YA4~ATCgroup,

data=finalDataA)
data=finalDataA)
data=finalDataA)
data=finalDataA)

#Computing Cohen's D for Baseline Treatment effect
tBaseY1<-summary(baseout1)$coef[2, 3]
tBaseY2<-summary(baseout2)$coef[2, 3]
tBaseY3<-summary(baseout3)$coef[2, 3]
tBaseY4<-summary(baseout4)$coef[2, 3]
cohenBaseY1
cohenBaseY2
cohenBaseY3
cohenBaseY4

<-(tBaseY1)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tBaseY2)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tBaseY3)*(((1/(treatn))+(1/(compn)))^0.5)
<-(tBaseY4)*(((1/(treatn))+(1/(compn)))^0.5)

#Computing Cohen's D for Baseline Treatment effect, ATC
tBaseATCY1<-summary(ATCbaseout1)$coef[2, 3]
tBaseATCY2<-summary(ATCbaseout2)$coef[2, 3]
tBaseATCY3<-summary(ATCbaseout3)$coef[2, 3]
tBaseATCY4<-summary(ATCbaseout4)$coef[2, 3]
cohenBaseATCY1
cohenBaseATCY2
cohenBaseATCY3
cohenBaseATCY4

<-(tBaseATCY1)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tBaseATCY2)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tBaseATCY3)*(((1/(treatnATC))+(1/(compnATC)))^0.5)
<-(tBaseATCY4)*(((1/(treatnATC))+(1/(compnATC)))^0.5)

#Baseline group differences on outcome - deviation from PopY1-PopY4
indicate bias in the estimated treatment effect
#baseout1
#baseout2
#baseout3
#baseout4
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#summary(baseout1)
#summary(baseout2)
#summary(baseout3)
#summary(baseout4)
#summary(ATCbaseout1)
#summary(ATCbaseout2)
#summary(ATCbaseout3)
#summary(ATCbaseout4)
#describeBy(finalDataA, finalDataA$group)
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~
Matching/Weighting:
~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~
Nearest Neighbor
~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#NN - ATT Coding
require(MatchIt)
m.outANN =
matchit(finalDataA$group~finalDataA$x1+finalDataA$x2+finalDataA$x3+fina
lDataA$x4+finalDataA$x5,data=finalDataA, method="nearest",
m.order="random", ratio=1)
m.outANN
MANN <- summary(m.outANN, standardize = TRUE)
ANN <- match.data(m.outANN, group="all")
FullANN<-match.data(m.outANN, group="all", drop.unmatched = FALSE)
#NN - ATC Coding
require(MatchIt)
m.outANNATC =
matchit(finalDataA$ATCgroup~finalDataA$x1+finalDataA$x2+finalDataA$x3+f
inalDataA$x4+finalDataA$x5, data=finalDataA, method="nearest",
m.order="random", ratio=1)
m.outANNATC
MANNATC <- summary(m.outANNATC, standardize = TRUE)
ANNATC <- match.data(m.outANNATC, group="all")
FullANNATC<-match.data(m.outANNATC, group="all", drop.unmatched =
FALSE)
#~~~~~~~~~~~ESTIMATED TREATMENT EFFECT~~~~~~~~~~~~~~~~~~
OutcomeA.1NN <- lm(YA1 ~ group, data = ANN)
OutcomeA.2NN <- lm(YA2 ~ group, data = ANN)
OutcomeA.3NN <- lm(YA3 ~ group, data = ANN)
OutcomeA.4NN <- lm(YA4 ~ group, data = ANN)
OutcomeA.1NNATC <- lm(YA1 ~ ATCgroup, data = ANNATC)
OutcomeA.2NNATC <- lm(YA2 ~ ATCgroup, data = ANNATC)
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OutcomeA.3NNATC <- lm(YA3 ~ ATCgroup, data = ANNATC)
OutcomeA.4NNATC <- lm(YA4 ~ ATCgroup, data = ANNATC)
#Cohen's D for estimated treatment effect
tANNY1<-summary(OutcomeA.1NN)$coef[2, 3]
tANNY2<-summary(OutcomeA.2NN)$coef[2, 3]
tANNY3<-summary(OutcomeA.3NN)$coef[2, 3]
tANNY4<-summary(OutcomeA.4NN)$coef[2, 3]
treatnANN<-nobs(ANN$group[ANN$group==1])
compnANN<-nobs(ANN$group[ANN$group==0])
cohenANNY1
cohenANNY2
cohenANNY3
cohenANNY4

<-(tANNY1)*(((1/(treatnANN))+(1/(compnANN)))^0.5)
<-(tANNY2)*(((1/(treatnANN))+(1/(compnANN)))^0.5)
<-(tANNY3)*(((1/(treatnANN))+(1/(compnANN)))^0.5)
<-(tANNY4)*(((1/(treatnANN))+(1/(compnANN)))^0.5)

#Cohen's D for estimated treatment effect, ATC coding
tANNATCY1<-summary(OutcomeA.1NNATC)$coef[2, 3]
tANNATCY2<-summary(OutcomeA.2NNATC)$coef[2, 3]
tANNATCY3<-summary(OutcomeA.3NNATC)$coef[2, 3]
tANNATCY4<-summary(OutcomeA.4NNATC)$coef[2, 3]
treatnANNATC<-nobs(ANN$ATCgroup[ANN$ATCgroup==0])
compnANNATC<-nobs(ANN$ATCgroup[ANN$ATCgroup==1])
cohenANNATCY1 <(tANNATCY1)*(((1/(treatnANNATC))+(1/(compnANNATC)))^0.5)
cohenANNATCY2 <(tANNATCY2)*(((1/(treatnANNATC))+(1/(compnANNATC)))^0.5)
cohenANNATCY3 <(tANNATCY3)*(((1/(treatnANNATC))+(1/(compnANNATC)))^0.5)
cohenANNATCY4 <(tANNATCY4)*(((1/(treatnANNATC))+(1/(compnANNATC)))^0.5)
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~
NN, 0.20 SD Caliper
~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#NN with 0.20 Caliper - ATT Coding
require(MatchIt)
m.outANNCal =
matchit(finalDataA$group~finalDataA$x1+finalDataA$x2+finalDataA$x3+fina
lDataA$x4+finalDataA$x5, data=finalDataA, method="nearest",
caliper=0.20, m.order="random", ratio=1)
m.outANNCal
MANNCal <- summary(m.outANNCal, standardize = TRUE)
ANNCal <- match.data(m.outANNCal, group="all")
FullANNCal<-match.data(m.outANNCal, group="all", drop.unmatched =
FALSE)
#NN with 0.20 Caliper - ATC Coding
require(MatchIt)
m.outANNCalATC =
matchit(finalDataA$ATCgroup~finalDataA$x1+finalDataA$x2+finalDataA$x3+f
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inalDataA$x4+finalDataA$x5, data=finalDataA, method="nearest",
caliper=0.20, m.order="random", ratio=1)
m.outANNCalATC
MANNCalATC <- summary(m.outANNCalATC, standardize = TRUE)
ANNCalATC <- match.data(m.outANNCalATC, group="all")
FullANNCalATC<-match.data(m.outANNCalATC, group="all", drop.unmatched =
FALSE)
#~~~~~~~~~~~ESTIMATED TREATMENT EFFECT~~~~~~~~~~~~~~~~~~
OutcomeA.1NNCal <- lm(YA1 ~ group, data = ANNCal)
OutcomeA.2NNCal <- lm(YA2 ~ group, data = ANNCal)
OutcomeA.3NNCal <- lm(YA3 ~ group, data = ANNCal)
OutcomeA.4NNCal <- lm(YA4 ~ group, data = ANNCal)
OutcomeA.1NNCalATC <- lm(YA1 ~ ATCgroup, data = ANNCalATC)
OutcomeA.2NNCalATC <- lm(YA2 ~ ATCgroup, data = ANNCalATC)
OutcomeA.3NNCalATC <- lm(YA3 ~ ATCgroup, data = ANNCalATC)
OutcomeA.4NNCalATC <- lm(YA4 ~ ATCgroup, data = ANNCalATC)
#Cohen's D for estimated treatment effect
tANNCalY1<-summary(OutcomeA.1NNCal)$coef[2, 3]
tANNCalY2<-summary(OutcomeA.2NNCal)$coef[2, 3]
tANNCalY3<-summary(OutcomeA.3NNCal)$coef[2, 3]
tANNCalY4<-summary(OutcomeA.4NNCal)$coef[2, 3]
treatnANNCal<-nobs(ANNCal$group[ANNCal$group==1])
compnANNCal<-nobs(ANNCal$group[ANNCal$group==0])
cohenANNCalY1 <(tANNCalY1)*(((1/(treatnANNCal))+(1/(compnANNCal)))^0.5)
cohenANNCalY2 <(tANNCalY2)*(((1/(treatnANNCal))+(1/(compnANNCal)))^0.5)
cohenANNCalY3 <(tANNCalY3)*(((1/(treatnANNCal))+(1/(compnANNCal)))^0.5)
cohenANNCalY4 <(tANNCalY4)*(((1/(treatnANNCal))+(1/(compnANNCal)))^0.5)
#Cohen's D for estimated treatment effect, ATC coding
tANNCalATCY1<-summary(OutcomeA.1NNCalATC)$coef[2, 3]
tANNCalATCY2<-summary(OutcomeA.2NNCalATC)$coef[2, 3]
tANNCalATCY3<-summary(OutcomeA.3NNCalATC)$coef[2, 3]
tANNCalATCY4<-summary(OutcomeA.4NNCalATC)$coef[2, 3]
treatnANNCalATC<-nobs(ANNCalATC$ATCgroup[ANNCalATC$ATCgroup==0])
compnANNCalATC<-nobs(ANNCalATC$ATCgroup[ANNCalATC$ATCgroup==1])
cohenANNCalATCY1 <(tANNCalATCY1)*(((1/(treatnANNCalATC))+(1/(compnANNCalATC)))^0.5)
cohenANNCalATCY2 <(tANNCalATCY2)*(((1/(treatnANNCalATC))+(1/(compnANNCalATC)))^0.5)
cohenANNCalATCY3 <(tANNCalATCY3)*(((1/(treatnANNCalATC))+(1/(compnANNCalATC)))^0.5)
cohenANNCalATCY4 <(tANNCalATCY4)*(((1/(treatnANNCalATC))+(1/(compnANNCalATC)))^0.5)
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
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#~~~~~~
Genearlized Boosted Modeling
~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#GBM - ATT Coding
require(twang)
ps.AGBM <- ps (group~x1+x2+x3+x4+x5,
data = finalDataA,
n.trees=10000,
## Max #iterations (from 1 to n)
interaction.depth=3,
## Level of interactions (default
= 3)
shrinkage=0.01,
## Allowable level of shrinkage
stop.method=c("es.mean"),
## Other options are es.max
or ks.mean
estimand="ATT",
## Other option is ATE
verbose=FALSE)
## Do you want a ton of information?
(TRUE)
MAGBM <- summary(ps.AGBM)
MAGBM
BalAGBM <- bal.table(ps.AGBM)
BalAGBM
finalDataA$w <- get.weights(ps.AGBM, stop.method="es.mean")
options(scipen=999)
designA.ps <- svydesign (ids = ~1, weights = ~w, data = finalDataA)
#GBM - ATC Coding
require(twang)
ps.AGBMATC <- ps (ATCgroup~x1+x2+x3+x4+x5,
data = finalDataA,
n.trees=10000,
## Max #iterations (from 1 to n)
interaction.depth=3,
## Level of interactions (default
= 3)
shrinkage=0.01,
## Allowable level of shrinkage
stop.method=c("es.mean"), ## Other options are es.max
or ks.mean
estimand="ATT",
##Technically ATC b/c of the
grouping variable that is being used
verbose=FALSE)
## Do you want a ton of information?
(TRUE)
MAGBMATC <- summary(ps.AGBMATC)
BalAGBMATC <- bal.table(ps.AGBMATC)
finalDataA$wATC <- get.weights(ps.AGBMATC, stop.method="es.mean")
options(scipen=999)
designAATC.ps <- svydesign (ids = ~1, weights = ~wATC, data =
finalDataA)
#~~~~~~~~~~~ESTIMATED TREATMENT EFFECT~~~~~~~~~~~~~~~~~~
OutcomeA.1GBM <- svyglm(YA1 ~ group, design = designA.ps)
OutcomeA.2GBM <- svyglm(YA2 ~ group, design = designA.ps)
OutcomeA.3GBM <- svyglm(YA3 ~ group, design = designA.ps)
OutcomeA.4GBM <- svyglm(YA4 ~ group, design = designA.ps)
OutcomeA.1GBMATC <- svyglm(YA1 ~ ATCgroup, design = designAATC.ps)
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OutcomeA.2GBMATC <- svyglm(YA2 ~ ATCgroup, design = designAATC.ps)
OutcomeA.3GBMATC <- svyglm(YA3 ~ ATCgroup, design = designAATC.ps)
OutcomeA.4GBMATC <- svyglm(YA4 ~ ATCgroup, design = designAATC.ps)
#Cohen's D for estimated treatment effect
tAGBMY1<-summary(OutcomeA.1GBM)$coef[2, 3]
tAGBMY2<-summary(OutcomeA.2GBM)$coef[2, 3]
tAGBMY3<-summary(OutcomeA.3GBM)$coef[2, 3]
tAGBMY4<-summary(OutcomeA.4GBM)$coef[2, 3]
treatnAGBM<-nobs(finalDataA$group[finalDataA$group==1])
compnAGBM<-nobs(finalDataA$group[finalDataA$group==0])
cohenAGBMY1
cohenAGBMY2
cohenAGBMY3
cohenAGBMY4

<-(tAGBMY1)*(((1/(treatnAGBM))+(1/(compnAGBM)))^0.5)
<-(tAGBMY2)*(((1/(treatnAGBM))+(1/(compnAGBM)))^0.5)
<-(tAGBMY3)*(((1/(treatnAGBM))+(1/(compnAGBM)))^0.5)
<-(tAGBMY4)*(((1/(treatnAGBM))+(1/(compnAGBM)))^0.5)

#Cohen's D for estimated treatment effect, ATC coding
tAGBMATCY1<-summary(OutcomeA.1GBMATC)$coef[2, 3]
tAGBMATCY2<-summary(OutcomeA.2GBMATC)$coef[2, 3]
tAGBMATCY3<-summary(OutcomeA.3GBMATC)$coef[2, 3]
tAGBMATCY4<-summary(OutcomeA.4GBMATC)$coef[2, 3]
treatnAGBMATC<-nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==0])
compnAGBMATC<-nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==1])
cohenAGBMATCY1 <(tAGBMATCY1)*(((1/(treatnAGBMATC))+(1/(compnAGBMATC)))^0.5)
cohenAGBMATCY2 <(tAGBMATCY2)*(((1/(treatnAGBMATC))+(1/(compnAGBMATC)))^0.5)
cohenAGBMATCY3 <(tAGBMATCY3)*(((1/(treatnAGBMATC))+(1/(compnAGBMATC)))^0.5)
cohenAGBMATCY4 <(tAGBMATCY4)*(((1/(treatnAGBMATC))+(1/(compnAGBMATC)))^0.5)
#~~~~~~~~~~~~~~~~~COMPUTING PBR FOR GBM~~~~~~~~~~~~~~~~~~~
X1TreatABef
<-BalAGBM$unw$`tx.mn`[1]
X2TreatABef
<-BalAGBM$unw$`tx.mn`[2]
X3TreatABef
<-BalAGBM$unw$`tx.mn`[3]
X4TreatABef
<-BalAGBM$unw$`tx.mn`[4]
X5TreatABef
<-BalAGBM$unw$`tx.mn`[5]
X1CompABef
X2CompABef
X3CompABef
X4CompABef
X5CompABef
X1TreatAAft
X2TreatAAft
X3TreatAAft
X4TreatAAft
X5TreatAAft
X1CompAAft
X2CompAAft
X3CompAAft
X4CompAAft

<-BalAGBM$unw$`ct.mn`[1]
<-BalAGBM$unw$`ct.mn`[2]
<-BalAGBM$unw$`ct.mn`[3]
<-BalAGBM$unw$`ct.mn`[4]
<-BalAGBM$unw$`ct.mn`[5]
<-BalAGBM$es.mean.ATT$`tx.mn`[1]
<-BalAGBM$es.mean.ATT$`tx.mn`[2]
<-BalAGBM$es.mean.ATT$`tx.mn`[3]
<-BalAGBM$es.mean.ATT$`tx.mn`[4]
<-BalAGBM$es.mean.ATT$`tx.mn`[5]
<-BalAGBM$es.mean.ATT$`ct.mn`[1]
<-BalAGBM$es.mean.ATT$`ct.mn`[2]
<-BalAGBM$es.mean.ATT$`ct.mn`[3]
<-BalAGBM$es.mean.ATT$`ct.mn`[4]
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X5CompAAft

<-BalAGBM$es.mean.ATT$`ct.mn`[5]

PBRX1GBM
<-100*((abs(X1TreatABef-X1CompABef)-abs(X1TreatAAftX1CompAAft))/abs(X1TreatABef-X1CompABef))
PBRX2GBM
<-100*((abs(X2TreatABef-X2CompABef)-abs(X2TreatAAftX2CompAAft))/abs(X2TreatABef-X2CompABef))
PBRX3GBM
<-100*((abs(X3TreatABef-X3CompABef)-abs(X3TreatAAftX3CompAAft))/abs(X3TreatABef-X3CompABef))
PBRX4GBM
<-100*((abs(X4TreatABef-X4CompABef)-abs(X4TreatAAftX4CompAAft))/abs(X4TreatABef-X4CompABef))
PBRX5GBM
<-100*((abs(X5TreatABef-X5CompABef)-abs(X5TreatAAftX5CompAAft))/abs(X5TreatABef-X5CompABef))
#ATC Coding
X1TreatABefATC
X2TreatABefATC
X3TreatABefATC
X4TreatABefATC
X5TreatABefATC
X1CompABefATC
X2CompABefATC
X3CompABefATC
X4CompABefATC
X5CompABefATC
X1TreatAAftATC
X2TreatAAftATC
X3TreatAAftATC
X4TreatAAftATC
X5TreatAAftATC
X1CompAAftATC
X2CompAAftATC
X3CompAAftATC
X4CompAAftATC
X5CompAAftATC

<-BalAGBMATC$unw$`tx.mn`[1]
<-BalAGBMATC$unw$`tx.mn`[2]
<-BalAGBMATC$unw$`tx.mn`[3]
<-BalAGBMATC$unw$`tx.mn`[4]
<-BalAGBMATC$unw$`tx.mn`[5]
<-BalAGBMATC$unw$`ct.mn`[1]
<-BalAGBMATC$unw$`ct.mn`[2]
<-BalAGBMATC$unw$`ct.mn`[3]
<-BalAGBMATC$unw$`ct.mn`[4]
<-BalAGBMATC$unw$`ct.mn`[5]
<-BalAGBMATC$es.mean.ATT$`tx.mn`[1]
<-BalAGBMATC$es.mean.ATT$`tx.mn`[2]
<-BalAGBMATC$es.mean.ATT$`tx.mn`[3]
<-BalAGBMATC$es.mean.ATT$`tx.mn`[4]
<-BalAGBMATC$es.mean.ATT$`tx.mn`[5]
<-BalAGBMATC$es.mean.ATT$`ct.mn`[1]
<-BalAGBMATC$es.mean.ATT$`ct.mn`[2]
<-BalAGBMATC$es.mean.ATT$`ct.mn`[3]
<-BalAGBMATC$es.mean.ATT$`ct.mn`[4]
<-BalAGBMATC$es.mean.ATT$`ct.mn`[5]

PBRX1GBMATC
<-100*((abs(X1TreatABefATC-X1CompABefATC)abs(X1TreatAAftATC-X1CompAAftATC))/abs(X1TreatABefATC-X1CompABefATC))
PBRX2GBMATC
<-100*((abs(X2TreatABefATC-X2CompABefATC)abs(X2TreatAAftATC-X2CompAAftATC))/abs(X2TreatABefATC-X2CompABefATC))
PBRX3GBMATC
<-100*((abs(X3TreatABefATC-X3CompABefATC)abs(X3TreatAAftATC-X3CompAAftATC))/abs(X3TreatABefATC-X3CompABefATC))
PBRX4GBMATC
<-100*((abs(X4TreatABefATC-X4CompABefATC)abs(X4TreatAAftATC-X4CompAAftATC))/abs(X4TreatABefATC-X4CompABefATC))
PBRX5GBMATC
<-100*((abs(X5TreatABefATC-X5CompABefATC)abs(X5TreatAAftATC-X5CompAAftATC))/abs(X5TreatABefATC-X5CompABefATC))
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~
Saving Out Diagnostics
~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#All variables BEFORE matching/weighting
AvgX1TreatA[i]
<- mean(finalDataA$x1[finalDataA$group==1])
AvgX2TreatA[i]
<- mean(finalDataA$x2[finalDataA$group==1])
AvgX3TreatA[i]
<- mean(finalDataA$x3[finalDataA$group==1])
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AvgX4TreatA[i]
AvgX5TreatA[i]
AvgYA1TreatA[i]
AvgYA2TreatA[i]
AvgYA3TreatA[i]
AvgYA4TreatA[i]
AvgPSTreatA[i]

<- mean(finalDataA$x4[finalDataA$group==1])
<- mean(finalDataA$x5[finalDataA$group==1])
<- mean(finalDataA$YA1[finalDataA$group==1])
<- mean(finalDataA$YA2[finalDataA$group==1])
<- mean(finalDataA$YA3[finalDataA$group==1])
<- mean(finalDataA$YA4[finalDataA$group==1])
<- mean(finalDataA$PS[finalDataA$group==1])

AvgX1CompA[i]
AvgX2CompA[i]
AvgX3CompA[i]
AvgX4CompA[i]
AvgX5CompA[i]
AvgYA1CompA[i]
AvgYA2CompA[i]
AvgYA3CompA[i]
AvgYA4CompA[i]
AvgPSCompA[i]

<- mean(finalDataA$x1[finalDataA$group==0])
<- mean(finalDataA$x2[finalDataA$group==0])
<- mean(finalDataA$x3[finalDataA$group==0])
<- mean(finalDataA$x4[finalDataA$group==0])
<- mean(finalDataA$x5[finalDataA$group==0])
<- mean(finalDataA$YA1[finalDataA$group==0])
<- mean(finalDataA$YA2[finalDataA$group==0])
<- mean(finalDataA$YA3[finalDataA$group==0])
<- mean(finalDataA$YA4[finalDataA$group==0])
<- mean(finalDataA$PS[finalDataA$group==0])

SDX1TreatA[i]
SDX2TreatA[i]
SDX3TreatA[i]
SDX4TreatA[i]
SDX5TreatA[i]
SDYA1TreatA[i]
SDYA2TreatA[i]
SDYA3TreatA[i]
SDYA4TreatA[i]
SDPSTreatA[i]

<- sd(finalDataA$x1[finalDataA$group==1])
<- sd(finalDataA$x2[finalDataA$group==1])
<- sd(finalDataA$x3[finalDataA$group==1])
<- sd(finalDataA$x4[finalDataA$group==1])
<- sd(finalDataA$x5[finalDataA$group==1])
<- sd(finalDataA$YA1[finalDataA$group==1])
<- sd(finalDataA$YA2[finalDataA$group==1])
<- sd(finalDataA$YA3[finalDataA$group==1])
<- sd(finalDataA$YA4[finalDataA$group==1])
<- sd(finalDataA$PS[finalDataA$group==1])

SDX1CompA[i]
SDX2CompA[i]
SDX3CompA[i]
SDX4CompA[i]
SDX5CompA[i]
SDYA1CompA[i]
SDYA2CompA[i]
SDYA3CompA[i]
SDYA4CompA[i]
SDPSCompA[i]
#Standardized
SMD_X1_All[i]
SMD_X2_All[i]
SMD_X3_All[i]
SMD_X4_All[i]
SMD_X5_All[i]
SMD_PS_All[i]

<- sd(finalDataA$x1[finalDataA$group==0])
<- sd(finalDataA$x2[finalDataA$group==0])
<- sd(finalDataA$x3[finalDataA$group==0])
<- sd(finalDataA$x4[finalDataA$group==0])
<- sd(finalDataA$x5[finalDataA$group==0])
<- sd(finalDataA$YA1[finalDataA$group==0])
<- sd(finalDataA$YA2[finalDataA$group==0])
<- sd(finalDataA$YA3[finalDataA$group==0])
<- sd(finalDataA$YA4[finalDataA$group==0])
<- sd(finalDataA$PS[finalDataA$group==0])
mean differences before matching, ATT Coding
<- MANN$sum.all[c(14)]
<- MANN$sum.all[c(15)]
<- MANN$sum.all[c(16)]
<- MANN$sum.all[c(17)]
<- MANN$sum.all[c(18)]
<- MANN$sum.all[c(13)]

#Standardized mean differences before matching, ATC Coding
SMD_X1_AllATC[i] <- MANNATC$sum.all[c(14)]
SMD_X2_AllATC[i] <- MANNATC$sum.all[c(15)]
SMD_X3_AllATC[i] <- MANNATC$sum.all[c(16)]
SMD_X4_AllATC[i] <- MANNATC$sum.all[c(17)]
SMD_X5_AllATC[i] <- MANNATC$sum.all[c(18)]
SMD_PS_AllATC[i] <- MANNATC$sum.all[c(13)]
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#Correlations
Cor_X1.X2_A[i]
<- cor(finalDataA$x1, finalDataA$x2)
Cor_X1.X3_A[i]
<- cor(finalDataA$x1, finalDataA$x3)
Cor_X1.X4_A[i]
<- cor(finalDataA$x1, finalDataA$x4)
Cor_X1.X5_A[i]
<- cor(finalDataA$x1, finalDataA$x5)
Cor_X2.X3_A[i]
<- cor(finalDataA$x2, finalDataA$x3)
Cor_X2.X4_A[i]
<- cor(finalDataA$x2, finalDataA$x4)
Cor_X2.X5_A[i]
<- cor(finalDataA$x2, finalDataA$x5)
Cor_X3.X4_A[i]
<- cor(finalDataA$x3, finalDataA$x4)
Cor_X3.X5_A[i]
<- cor(finalDataA$x3, finalDataA$x5)
Cor_X4.X5_A[i]
<- cor(finalDataA$x4, finalDataA$x5)
Cor_X1.PS_A[i]
<- cor(finalDataA$x1, finalDataA$PS)
Cor_X2.PS_A[i]
<- cor(finalDataA$x2, finalDataA$PS)
Cor_X3.PS_A[i]
<- cor(finalDataA$x3, finalDataA$PS)
Cor_X4.PS_A[i]
<- cor(finalDataA$x4, finalDataA$PS)
Cor_X5.PS_A[i]
<- cor(finalDataA$x5, finalDataA$PS)
Cor_X1.Y1_A[i]
<- cor(finalDataA$x1, finalDataA$YA1)
Cor_X2.Y1_A[i]
<- cor(finalDataA$x2, finalDataA$YA1)
Cor_X3.Y1_A[i]
<- cor(finalDataA$x3, finalDataA$YA1)
Cor_X4.Y1_A[i]
<- cor(finalDataA$x4, finalDataA$YA1)
Cor_X5.Y1_A[i]
<- cor(finalDataA$x5, finalDataA$YA1)
Cor_X1.Y2_A[i]
<- cor(finalDataA$x1, finalDataA$YA2)
Cor_X2.Y2_A[i]
<- cor(finalDataA$x2, finalDataA$YA2)
Cor_X3.Y2_A[i]
<- cor(finalDataA$x3, finalDataA$YA2)
Cor_X4.Y2_A[i]
<- cor(finalDataA$x4, finalDataA$YA2)
Cor_X5.Y2_A[i]
<- cor(finalDataA$x5, finalDataA$YA2)
Cor_X1.Y3_A[i]
<- cor(finalDataA$x1, finalDataA$YA3)
Cor_X2.Y3_A[i]
<- cor(finalDataA$x2, finalDataA$YA3)
Cor_X3.Y3_A[i]
<- cor(finalDataA$x3, finalDataA$YA3)
Cor_X4.Y3_A[i]
<- cor(finalDataA$x4, finalDataA$YA3)
Cor_X5.Y3_A[i]
<- cor(finalDataA$x5, finalDataA$YA3)
Cor_X1.Y4_A[i]
<- cor(finalDataA$x1, finalDataA$YA4)
Cor_X2.Y4_A[i]
<- cor(finalDataA$x2, finalDataA$YA4)
Cor_X3.Y4_A[i]
<- cor(finalDataA$x3, finalDataA$YA4)
Cor_X4.Y4_A[i]
<- cor(finalDataA$x4, finalDataA$YA4)
Cor_X5.Y4_A[i]
<- cor(finalDataA$x5, finalDataA$YA4)
Cor_G.Y1_A[i]
<- cor(finalDataA$group, finalDataA$YA1)
Cor_G.Y2_A[i]
<- cor(finalDataA$group, finalDataA$YA2)
Cor_G.Y3_A[i]
<- cor(finalDataA$group, finalDataA$YA3)
Cor_G.Y4_A[i]
<- cor(finalDataA$group, finalDataA$YA4)
#Population Group Regression Coefficient
PopY1A[i]
<- as.numeric(PopY1$coef[2])
PopY2A[i]
<- as.numeric(PopY2$coef[2])
PopY3A[i]
<- as.numeric(PopY3$coef[2])
PopY4A[i]
<- as.numeric(PopY4$coef[2])
#Population Group t-value for each regression coefficient
tPopY1A[i]
<-summary(PopY1)$coef[2, 3]
tPopY2A[i]
<-summary(PopY2)$coef[2, 3]
tPopY3A[i]
<-summary(PopY3)$coef[2, 3]
tPopY4A[i]
<-summary(PopY4)$coef[2, 3]
#Treatment Group N (before matching)
treatPopNA[i]
<-nobs(finalDataA$group[finalDataA$group==1])
#Comparison Group N (before matching)
compPopNA[i]
<-nobs(finalDataA$group[finalDataA$group==0])
#Population Cohen's D for Treatment Effect
PopCohenY1A[i]
<-cohenPopY1
PopCohenY2A[i]
<-cohenPopY2
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PopCohenY3A[i]
<-cohenPopY3
PopCohenY4A[i]
<-cohenPopY4
#Baseline Group Regression Coefficient
BaseY1A[i]
<- as.numeric(baseout1$coef[2])
BaseY2A[i]
<- as.numeric(baseout2$coef[2])
BaseY3A[i]
<- as.numeric(baseout3$coef[2])
BaseY4A[i]
<- as.numeric(baseout4$coef[2])
#Baseline Group t-value for each regression coefficient
tBaseY1A[i]
<-summary(baseout1)$coef[2, 3]
tBaseY2A[i]
<-summary(baseout2)$coef[2, 3]
tBaseY3A[i]
<-summary(baseout3)$coef[2, 3]
tBaseY4A[i]
<-summary(baseout4)$coef[2, 3]
#Treatment Group N (before matching)
treatBaseNA[i]
<-nobs(finalDataA$group[finalDataA$group==1])
#Comparison Group N (before matching)
compBaseNA[i]
<-nobs(finalDataA$group[finalDataA$group==0])
#Baseline Cohen's D for Treatment Effect
BaseCohenY1A[i]
<-cohenBaseY1
BaseCohenY2A[i]
<-cohenBaseY2
BaseCohenY3A[i]
<-cohenBaseY3
BaseCohenY4A[i]
<-cohenBaseY4
#Population Group Regression Coefficient, ATC coding
PopATCY1A[i]
<- as.numeric(ATCPopY1$coef[2])
PopATCY2A[i]
<- as.numeric(ATCPopY2$coef[2])
PopATCY3A[i]
<- as.numeric(ATCPopY3$coef[2])
PopATCY4A[i]
<- as.numeric(ATCPopY4$coef[2])
#Population Group t-value for each regression coefficient, ATC coding
tPopATCY1A[i]
<-summary(ATCPopY1)$coef[2, 3]
tPopATCY2A[i]
<-summary(ATCPopY2)$coef[2, 3]
tPopATCY3A[i]
<-summary(ATCPopY3)$coef[2, 3]
tPopATCY4A[i]
<-summary(ATCPopY4)$coef[2, 3]
#Treatment Group N (before matching), ATC coding
treatPopNAATC[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==0])
#Comparison Group N (before matching), ATC coding
compPopNAATC[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==1])
#Population Cohen's D for Treatment Effect, ATC coding
PopCohenATCY1A[i]
<-cohenPopATCY1
PopCohenATCY2A[i]
<-cohenPopATCY2
PopCohenATCY3A[i]
<-cohenPopATCY3
PopCohenATCY4A[i]
<-cohenPopATCY4
#Baseline Group Regression Coefficient, ATC coding
BaseATCY1A[i]
<- as.numeric(ATCbaseout1$coef[2])
BaseATCY2A[i]
<- as.numeric(ATCbaseout2$coef[2])
BaseATCY3A[i]
<- as.numeric(ATCbaseout3$coef[2])
BaseATCY4A[i]
<- as.numeric(ATCbaseout4$coef[2])
#Baseline Group t-value for each regression coefficient, ATC coding
tBaseATCY1A[i]
<-summary(ATCbaseout1)$coef[2, 3]
tBaseATCY2A[i]
<-summary(ATCbaseout2)$coef[2, 3]
tBaseATCY3A[i]
<-summary(ATCbaseout3)$coef[2, 3]
tBaseATCY4A[i]
<-summary(ATCbaseout4)$coef[2, 3]
#Treatment Group N (before matching), ATC coding
treatBaseNAATC[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==0])
#Comparison Group N (before matching), ATC coding
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compBaseNAATC[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==1])
#Baseline Cohen's D for Treatment Effect, ATC coding
BaseCohenATCY1A[i]
<-cohenBaseATCY1
BaseCohenATCY2A[i]
<-cohenBaseATCY2
BaseCohenATCY3A[i]
<-cohenBaseATCY3
BaseCohenATCY4A[i]
<-cohenBaseATCY4
#Variance Ratio for unmatched groups (baseline data
VRB[i] <var(finalDataA$PS[finalDataA$group==1])/var(finalDataA$PS[finalDataA$gr
oup==0])
VRBATC[i] <var(finalDataA$PS[finalDataA$ATCgroup==0])/var(finalDataA$PS[finalDataA
$ATCgroup==1])
#All variables AFTER Nearest Neighbor Matching, ATT Coding
AvgX1TreatANN[i]
<- mean(ANN$x1[ANN$group==1])
AvgX2TreatANN[i]
<- mean(ANN$x2[ANN$group==1])
AvgX3TreatANN[i]
<- mean(ANN$x3[ANN$group==1])
AvgX4TreatANN[i]
<- mean(ANN$x4[ANN$group==1])
AvgX5TreatANN[i]
<- mean(ANN$x5[ANN$group==1])
AvgYA1TreatANN[i]
<- mean(ANN$YA1[ANN$group==1])
AvgYA2TreatANN[i]
<- mean(ANN$YA2[ANN$group==1])
AvgYA3TreatANN[i]
<- mean(ANN$YA3[ANN$group==1])
AvgYA4TreatANN[i]
<- mean(ANN$YA4[ANN$group==1])
AvgPSTreatANN[i]
<- mean(ANN$PS[ANN$group==1])
AvgX1CompANN[i]
AvgX2CompANN[i]
AvgX3CompANN[i]
AvgX4CompANN[i]
AvgX5CompANN[i]
AvgYA1CompANN[i]
AvgYA2CompANN[i]
AvgYA3CompANN[i]
AvgYA4CompANN[i]
AvgPSCompANN[i]

<<<<<<<<<<-

mean(ANN$x1[ANN$group==0])
mean(ANN$x2[ANN$group==0])
mean(ANN$x3[ANN$group==0])
mean(ANN$x4[ANN$group==0])
mean(ANN$x5[ANN$group==0])
mean(ANN$YA1[ANN$group==0])
mean(ANN$YA2[ANN$group==0])
mean(ANN$YA3[ANN$group==0])
mean(ANN$YA4[ANN$group==0])
mean(ANN$PS[ANN$group==0])

SDX1TreatANN[i]
SDX2TreatANN[i]
SDX3TreatANN[i]
SDX4TreatANN[i]
SDX5TreatANN[i]
SDYA1TreatANN[i]
SDYA2TreatANN[i]
SDYA3TreatANN[i]
SDYA4TreatANN[i]
SDPSTreatANN[i]

<<<<<<<<<<-

sd(ANN$x1[ANN$group==1])
sd(ANN$x2[ANN$group==1])
sd(ANN$x3[ANN$group==1])
sd(ANN$x4[ANN$group==1])
sd(ANN$x5[ANN$group==1])
sd(ANN$YA1[ANN$group==1])
sd(ANN$YA2[ANN$group==1])
sd(ANN$YA3[ANN$group==1])
sd(ANN$YA4[ANN$group==1])
sd(ANN$PS[ANN$group==1])

SDX1CompANN[i]
SDX2CompANN[i]
SDX3CompANN[i]
SDX4CompANN[i]
SDX5CompANN[i]
SDYA1CompANN[i]
SDYA2CompANN[i]
SDYA3CompANN[i]

<<<<<<<<-

sd(ANN$x1[ANN$group==0])
sd(ANN$x2[ANN$group==0])
sd(ANN$x3[ANN$group==0])
sd(ANN$x4[ANN$group==0])
sd(ANN$x5[ANN$group==0])
sd(ANN$YA1[ANN$group==0])
sd(ANN$YA2[ANN$group==0])
sd(ANN$YA3[ANN$group==0])
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SDYA4CompANN[i]
SDPSCompANN[i]
#Standardized
SMD_X1_ANN[i]
SMD_X2_ANN[i]
SMD_X3_ANN[i]
SMD_X4_ANN[i]
SMD_X5_ANN[i]
SMD_PS_ANN[i]

<<-

sd(ANN$YA4[ANN$group==0])
sd(ANN$PS[ANN$group==0])

Mean Difference after NN matching
<- MANN$sum.matched[c(14)]
<- MANN$sum.matched[c(15)]
<- MANN$sum.matched[c(16)]
<- MANN$sum.matched[c(17)]
<- MANN$sum.matched[c(18)]
<- MANN$sum.matched[c(13)]

#Percent Bias Reduction after NN matching
PBR_X1_ANN[i] <- MANN$reduction[c(2)]
PBR_X2_ANN[i] <- MANN$reduction[c(3)]
PBR_X3_ANN[i] <- MANN$reduction[c(4)]
PBR_X4_ANN[i] <- MANN$reduction[c(5)]
PBR_X5_ANN[i] <- MANN$reduction[c(6)]
PBR_PS_ANN[i] <- MANN$reduction[c(1)]
#Group Regression Coefficient after NN matching
Y1ANN[i]
<- as.numeric(OutcomeA.1NN$coef[2])
Y2ANN[i]
<- as.numeric(OutcomeA.2NN$coef[2])
Y3ANN[i]
<- as.numeric(OutcomeA.3NN$coef[2])
Y4ANN[i]
<- as.numeric(OutcomeA.4NN$coef[2])
#Group t-value for each regression coefficient after NN matching
tNNY1A[i]
<-summary(OutcomeA.1NN)$coef[2, 3]
tNNY2A[i]
<-summary(OutcomeA.2NN)$coef[2, 3]
tNNY3A[i]
<-summary(OutcomeA.3NN)$coef[2, 3]
tNNY4A[i]
<-summary(OutcomeA.4NN)$coef[2, 3]
#Treatment Group N (after NN matching)
NNtreatNA[i]
<-nobs(ANN$group[ANN$group==1])
#Comparison Group N (after NN matching)
NNcompNA[i]
<-nobs(ANN$group[ANN$group==0])
#Cohen's D for Treatment Effect after NN matching
NNCohenY1A[i]
<-cohenANNY1
NNCohenY2A[i]
<-cohenANNY2
NNCohenY3A[i]
<-cohenANNY3
NNCohenY4A[i]
<-cohenANNY4
#Matched & Unmatched PS mean, median, and sd after NN matching
PSMeanMatchedTreatANN[i]
<- mean(FullANN$distance[FullANN$group==1 &
FullANN$weights==1])
PSMeanMatchedCompANN[i]
<- mean(FullANN$distance[FullANN$group==0 &
FullANN$weights==1])
PSMeanUnMatchedTreatANN[i]
<- mean(FullANN$distance[FullANN$group==1
& FullANN$weights==0])
PSMeanUnMatchedCompANN[i]
<- mean(FullANN$distance[FullANN$group==0
& FullANN$weights==0])
PSMedMatchedTreatANN[i]
<- median(FullANN$distance[FullANN$group==1
& FullANN$weights==1])
PSMedMatchedCompANN[i]
<- median(FullANN$distance[FullANN$group==0 &
FullANN$weights==1])
PSMedUnMatchedTreatANN[i]
<median(FullANN$distance[FullANN$group==1 & FullANN$weights==0])
PSMedUnMatchedCompANN[i]
<- median(FullANN$distance[FullANN$group==0
& FullANN$weights==0])
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PSsdMatchedTreatANN[i]
<- sd(FullANN$distance[FullANN$group==1 &
FullANN$weights==1])
PSsdMatchedCompANN[i]
<- sd(FullANN$distance[FullANN$group==0 &
FullANN$weights==1])
PSsdUnMatchedTreatANN[i]
<- sd(FullANN$distance[FullANN$group==1 &
FullANN$weights==0])
PSsdUnMatchedCompANN[i]
<- sd(FullANN$distance[FullANN$group==0 &
FullANN$weights==0])
#Variance Ratio for matched groups, after NN Matching
VRANN[i] <var(ANN$distance[ANN$group==1])/var(ANN$distance[ANN$group==0])
#All variables AFTER Nearest Neighbor Matching, ATC Coding
AvgX1TreatANNATC[i]
<- mean(ANNATC$x1[ANNATC$ATCgroup==0])
AvgX2TreatANNATC[i]
<- mean(ANNATC$x2[ANNATC$ATCgroup==0])
AvgX3TreatANNATC[i]
<- mean(ANNATC$x3[ANNATC$ATCgroup==0])
AvgX4TreatANNATC[i]
<- mean(ANNATC$x4[ANNATC$ATCgroup==0])
AvgX5TreatANNATC[i]
<- mean(ANNATC$x5[ANNATC$ATCgroup==0])
AvgYA1TreatANNATC[i]
<- mean(ANNATC$YA1[ANNATC$ATCgroup==0])
AvgYA2TreatANNATC[i]
<- mean(ANNATC$YA2[ANNATC$ATCgroup==0])
AvgYA3TreatANNATC[i]
<- mean(ANNATC$YA3[ANNATC$ATCgroup==0])
AvgYA4TreatANNATC[i]
<- mean(ANNATC$YA4[ANNATC$ATCgroup==0])
AvgPSTreatANNATC[i]
<- mean(ANNATC$PS[ANNATC$ATCgroup==0])
AvgX1CompANNATC[i]
AvgX2CompANNATC[i]
AvgX3CompANNATC[i]
AvgX4CompANNATC[i]
AvgX5CompANNATC[i]
AvgYA1CompANNATC[i]
AvgYA2CompANNATC[i]
AvgYA3CompANNATC[i]
AvgYA4CompANNATC[i]
AvgPSCompANNATC[i]

<<<<<<<<<<-

mean(ANNATC$x1[ANNATC$ATCgroup==1])
mean(ANNATC$x2[ANNATC$ATCgroup==1])
mean(ANNATC$x3[ANNATC$ATCgroup==1])
mean(ANNATC$x4[ANNATC$ATCgroup==1])
mean(ANNATC$x5[ANNATC$ATCgroup==1])
mean(ANNATC$YA1[ANNATC$ATCgroup==1])
mean(ANNATC$YA2[ANNATC$ATCgroup==1])
mean(ANNATC$YA3[ANNATC$ATCgroup==1])
mean(ANNATC$YA4[ANNATC$ATCgroup==1])
mean(ANNATC$PS[ANNATC$ATCgroup==1])

SDX1TreatANNATC[i]
SDX2TreatANNATC[i]
SDX3TreatANNATC[i]
SDX4TreatANNATC[i]
SDX5TreatANNATC[i]
SDYA1TreatANNATC[i]
SDYA2TreatANNATC[i]
SDYA3TreatANNATC[i]
SDYA4TreatANNATC[i]
SDPSTreatANNATC[i]

<<<<<<<<<<-

sd(ANNATC$x1[ANNATC$ATCgroup==0])
sd(ANNATC$x2[ANNATC$ATCgroup==0])
sd(ANNATC$x3[ANNATC$ATCgroup==0])
sd(ANNATC$x4[ANNATC$ATCgroup==0])
sd(ANNATC$x5[ANNATC$ATCgroup==0])
sd(ANNATC$YA1[ANNATC$ATCgroup==0])
sd(ANNATC$YA2[ANNATC$ATCgroup==0])
sd(ANNATC$YA3[ANNATC$ATCgroup==0])
sd(ANNATC$YA4[ANNATC$ATCgroup==0])
sd(ANNATC$PS[ANNATC$ATCgroup==0])

SDX1CompANNATC[i]
SDX2CompANNATC[i]
SDX3CompANNATC[i]
SDX4CompANNATC[i]
SDX5CompANNATC[i]
SDYA1CompANNATC[i]
SDYA2CompANNATC[i]
SDYA3CompANNATC[i]
SDYA4CompANNATC[i]

<<<<<<<<<-

sd(ANNATC$x1[ANNATC$ATCgroup==1])
sd(ANNATC$x2[ANNATC$ATCgroup==1])
sd(ANNATC$x3[ANNATC$ATCgroup==1])
sd(ANNATC$x4[ANNATC$ATCgroup==1])
sd(ANNATC$x5[ANNATC$ATCgroup==1])
sd(ANNATC$YA1[ANNATC$ATCgroup==1])
sd(ANNATC$YA2[ANNATC$ATCgroup==1])
sd(ANNATC$YA3[ANNATC$ATCgroup==1])
sd(ANNATC$YA4[ANNATC$ATCgroup==1])
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SDPSCompANNATC[i]

<-

sd(ANNATC$PS[ANNATC$ATCgroup==1])

#Standardized Mean Difference after NN matching, ATC coding
SMD_X1_ANNATC[i] <- MANNATC$sum.matched[c(14)]
SMD_X2_ANNATC[i] <- MANNATC$sum.matched[c(15)]
SMD_X3_ANNATC[i] <- MANNATC$sum.matched[c(16)]
SMD_X4_ANNATC[i] <- MANNATC$sum.matched[c(17)]
SMD_X5_ANNATC[i] <- MANNATC$sum.matched[c(18)]
SMD_PS_ANNATC[i] <- MANNATC$sum.matched[c(13)]
#Percent Bias Reduction after NN matching, ATC coding
PBR_X1_ANNATC[i] <- MANNATC$reduction[c(2)]
PBR_X2_ANNATC[i] <- MANNATC$reduction[c(3)]
PBR_X3_ANNATC[i] <- MANNATC$reduction[c(4)]
PBR_X4_ANNATC[i] <- MANNATC$reduction[c(5)]
PBR_X5_ANNATC[i] <- MANNATC$reduction[c(6)]
PBR_PS_ANNATC[i] <- MANNATC$reduction[c(1)]
#Group Regression Coefficient after NN matching, ATC coding
Y1ANNATC[i]
<- as.numeric(OutcomeA.1NNATC$coef[2])
Y2ANNATC[i]
<- as.numeric(OutcomeA.2NNATC$coef[2])
Y3ANNATC[i]
<- as.numeric(OutcomeA.3NNATC$coef[2])
Y4ANNATC[i]
<- as.numeric(OutcomeA.4NNATC$coef[2])
#Group t-value for each regression coefficient after NN matching, ATC
coding
tNNATCY1A[i]
<-summary(OutcomeA.1NNATC)$coef[2, 3]
tNNATCY2A[i]
<-summary(OutcomeA.2NNATC)$coef[2, 3]
tNNATCY3A[i]
<-summary(OutcomeA.3NNATC)$coef[2, 3]
tNNATCY4A[i]
<-summary(OutcomeA.4NNATC)$coef[2, 3]
#Treatment Group N (after NN matching), ATC coding
NNATCtreatNA[i]
<-nobs(ANNATC$group[ANNATC$group==0])
#Comparison Group N (after NN matching)
NNATCcompNA[i]
<-nobs(ANNATC$group[ANNATC$group==1])
#Cohen's D for Treatment Effect after NN matching, ATC coding
NNATCCohenY1A[i]
<-cohenANNATCY1
NNATCCohenY2A[i]
<-cohenANNATCY2
NNATCCohenY3A[i]
<-cohenANNATCY3
NNATCCohenY4A[i]
<-cohenANNATCY4
#Matched & Unmatched PS mean, median, and sd
Coding
PSMeanMatchedTreatANNATC[i]
<mean(FullANNATC$distance[FullANNATC$group==0
PSMeanMatchedCompANNATC[i]
<mean(FullANNATC$distance[FullANNATC$group==1
PSMeanUnMatchedTreatANNATC[i]
<mean(FullANNATC$distance[FullANNATC$group==0
PSMeanUnMatchedCompANNATC[i]
<mean(FullANNATC$distance[FullANNATC$group==1

after NN matching, ATC
& FullANNATC$weights==1])
& FullANNATC$weights==1])
& FullANNATC$weights==0])
& FullANNATC$weights==0])

PSMedMatchedTreatANNATC[i]
<median(FullANNATC$distance[FullANNATC$group==0 &
FullANNATC$weights==1])
PSMedMatchedCompANNATC[i]
<median(FullANNATC$distance[FullANNATC$group==1 &
FullANNATC$weights==1])
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PSMedUnMatchedTreatANNATC[i]
<median(FullANNATC$distance[FullANNATC$group==0 &
FullANNATC$weights==0])
PSMedUnMatchedCompANNATC[i]
<median(FullANNATC$distance[FullANNATC$group==1 &
FullANNATC$weights==0])
PSsdMatchedTreatANNATC[i]
<sd(FullANNATC$distance[FullANNATC$group==0
PSsdMatchedCompANNATC[i]
<sd(FullANNATC$distance[FullANNATC$group==1
PSsdUnMatchedTreatANNATC[i]
<sd(FullANNATC$distance[FullANNATC$group==0
PSsdUnMatchedCompANNATC[i]
<sd(FullANNATC$distance[FullANNATC$group==1

& FullANNATC$weights==1])
& FullANNATC$weights==1])
& FullANNATC$weights==0])
& FullANNATC$weights==0])

#Variance Ratio for matched groups, after NN Matching, ATC coding
VRANNATC[i] <var(ANNATC$distance[ANNATC$ATCgroup==0])/var(ANNATC$distance[ANNATC$ATC
group==1])
#All variables AFTER Nearest Neighbor Matching with 0.20 Caliper, ATT
Coding
AvgX1TreatANNCal[i]
<- mean(ANNCal$x1[ANNCal$group==1])
AvgX2TreatANNCal[i]
<- mean(ANNCal$x2[ANNCal$group==1])
AvgX3TreatANNCal[i]
<- mean(ANNCal$x3[ANNCal$group==1])
AvgX4TreatANNCal[i]
<- mean(ANNCal$x4[ANNCal$group==1])
AvgX5TreatANNCal[i]
<- mean(ANNCal$x5[ANNCal$group==1])
AvgYA1TreatANNCal[i]
<- mean(ANNCal$YA1[ANNCal$group==1])
AvgYA2TreatANNCal[i]
<- mean(ANNCal$YA2[ANNCal$group==1])
AvgYA3TreatANNCal[i]
<- mean(ANNCal$YA3[ANNCal$group==1])
AvgYA4TreatANNCal[i]
<- mean(ANNCal$YA4[ANNCal$group==1])
AvgPSTreatANNCal[i]
<- mean(ANNCal$PS[ANNCal$group==1])
AvgX1CompANNCal[i]
AvgX2CompANNCal[i]
AvgX3CompANNCal[i]
AvgX4CompANNCal[i]
AvgX5CompANNCal[i]
AvgYA1CompANNCal[i]
AvgYA2CompANNCal[i]
AvgYA3CompANNCal[i]
AvgYA4CompANNCal[i]
AvgPSCompANNCal[i]

<<<<<<<<<<-

mean(ANNCal$x1[ANNCal$group==0])
mean(ANNCal$x2[ANNCal$group==0])
mean(ANNCal$x3[ANNCal$group==0])
mean(ANNCal$x4[ANNCal$group==0])
mean(ANNCal$x5[ANNCal$group==0])
mean(ANNCal$YA1[ANNCal$group==0])
mean(ANNCal$YA2[ANNCal$group==0])
mean(ANNCal$YA3[ANNCal$group==0])
mean(ANNCal$YA4[ANNCal$group==0])
mean(ANNCal$PS[ANNCal$group==0])

SDX1TreatANNCal[i]
SDX2TreatANNCal[i]
SDX3TreatANNCal[i]
SDX4TreatANNCal[i]
SDX5TreatANNCal[i]
SDYA1TreatANNCal[i]
SDYA2TreatANNCal[i]
SDYA3TreatANNCal[i]
SDYA4TreatANNCal[i]
SDPSTreatANNCal[i]

<<<<<<<<<<-

sd(ANNCal$x1[ANNCal$group==1])
sd(ANNCal$x2[ANNCal$group==1])
sd(ANNCal$x3[ANNCal$group==1])
sd(ANNCal$x4[ANNCal$group==1])
sd(ANNCal$x5[ANNCal$group==1])
sd(ANNCal$YA1[ANNCal$group==1])
sd(ANNCal$YA2[ANNCal$group==1])
sd(ANNCal$YA3[ANNCal$group==1])
sd(ANNCal$YA4[ANNCal$group==1])
sd(ANNCal$PS[ANNCal$group==1])

SDX1CompANNCal[i]

<-

sd(ANNCal$x1[ANNCal$group==0])
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SDX2CompANNCal[i]
SDX3CompANNCal[i]
SDX4CompANNCal[i]
SDX5CompANNCal[i]
SDYA1CompANNCal[i]
SDYA2CompANNCal[i]
SDYA3CompANNCal[i]
SDYA4CompANNCal[i]
SDPSCompANNCal[i]

<<<<<<<<<-

sd(ANNCal$x2[ANNCal$group==0])
sd(ANNCal$x3[ANNCal$group==0])
sd(ANNCal$x4[ANNCal$group==0])
sd(ANNCal$x5[ANNCal$group==0])
sd(ANNCal$YA1[ANNCal$group==0])
sd(ANNCal$YA2[ANNCal$group==0])
sd(ANNCal$YA3[ANNCal$group==0])
sd(ANNCal$YA4[ANNCal$group==0])
sd(ANNCal$PS[ANNCal$group==0])

#Standardized Mean Difference after NN matching with caliper
SMD_X1_ANNCal[i] <- MANNCal$sum.matched[c(14)]
SMD_X2_ANNCal[i] <- MANNCal$sum.matched[c(15)]
SMD_X3_ANNCal[i] <- MANNCal$sum.matched[c(16)]
SMD_X4_ANNCal[i] <- MANNCal$sum.matched[c(17)]
SMD_X5_ANNCal[i] <- MANNCal$sum.matched[c(18)]
SMD_PS_ANNCal[i] <- MANNCal$sum.matched[c(13)]
#Percent Bias Reduction after NN matching with caliper
PBR_X1_ANNCal[i] <- MANNCal$reduction[c(2)]
PBR_X2_ANNCal[i] <- MANNCal$reduction[c(3)]
PBR_X3_ANNCal[i] <- MANNCal$reduction[c(4)]
PBR_X4_ANNCal[i] <- MANNCal$reduction[c(5)]
PBR_X5_ANNCal[i] <- MANNCal$reduction[c(6)]
PBR_PS_ANNCal[i] <- MANNCal$reduction[c(1)]
#Group Regression Coefficient after NN matching with caliper
Y1ANNCal[i]
<- as.numeric(OutcomeA.1NNCal$coef[2])
Y2ANNCal[i]
<- as.numeric(OutcomeA.2NNCal$coef[2])
Y3ANNCal[i]
<- as.numeric(OutcomeA.3NNCal$coef[2])
Y4ANNCal[i]
<- as.numeric(OutcomeA.4NNCal$coef[2])
#Group t-value for each regression coefficient after NN matching with
caliper
tNNCalY1A[i]
<-summary(OutcomeA.1NNCal)$coef[2, 3]
tNNCalY2A[i]
<-summary(OutcomeA.2NNCal)$coef[2, 3]
tNNCalY3A[i]
<-summary(OutcomeA.3NNCal)$coef[2, 3]
tNNCalY4A[i]
<-summary(OutcomeA.4NNCal)$coef[2, 3]
#Treatment Group N (after NN matching with caliper)
NNCaltreatNA[i]
<-nobs(ANNCal$group[ANNCal$group==1])
#Comparison Group N (after NN matching)
NNCalcompNA[i]
<-nobs(ANNCal$group[ANNCal$group==0])
#Cohen's D for Treatment Effect after NN matching with caliper
NNCalCohenY1A[i]
<-cohenANNCalY1
NNCalCohenY2A[i]
<-cohenANNCalY2
NNCalCohenY3A[i]
<-cohenANNCalY3
NNCalCohenY4A[i]
<-cohenANNCalY4
#Matched & Unmatched PS mean, median, and sd
Caliper
PSMeanMatchedTreatANNCal[i]
<mean(FullANNCal$distance[FullANNCal$group==1
PSMeanMatchedCompANNCal[i]
<mean(FullANNCal$distance[FullANNCal$group==0
PSMeanUnMatchedTreatANNCal[i]
<mean(FullANNCal$distance[FullANNCal$group==1
PSMeanUnMatchedCompANNCal[i]
<mean(FullANNCal$distance[FullANNCal$group==0

after NN matching with
& FullANNCal$weights==1])
& FullANNCal$weights==1])
& FullANNCal$weights==0])
& FullANNCal$weights==0])
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PSMedMatchedTreatANNCal[i]
<median(FullANNCal$distance[FullANNCal$group==1
FullANNCal$weights==1])
PSMedMatchedCompANNCal[i]
<median(FullANNCal$distance[FullANNCal$group==0
FullANNCal$weights==1])
PSMedUnMatchedTreatANNCal[i]
<median(FullANNCal$distance[FullANNCal$group==1
FullANNCal$weights==0])
PSMedUnMatchedCompANNCal[i]
<median(FullANNCal$distance[FullANNCal$group==0
FullANNCal$weights==0])
PSsdMatchedTreatANNCal[i]
<sd(FullANNCal$distance[FullANNCal$group==1
PSsdMatchedCompANNCal[i]
<sd(FullANNCal$distance[FullANNCal$group==0
PSsdUnMatchedTreatANNCal[i]
<sd(FullANNCal$distance[FullANNCal$group==1
PSsdUnMatchedCompANNCal[i]
<sd(FullANNCal$distance[FullANNCal$group==0

&
&
&
&

& FullANNCal$weights==1])
& FullANNCal$weights==1])
& FullANNCal$weights==0])
& FullANNCal$weights==0])

#Variance Ratio for matched groups, after NN Matching with Caliper
VRANNCal[i] <var(ANNCal$distance[ANNCal$group==1])/var(ANNCal$distance[ANNCal$group=
=0])
#All variables AFTER Nearest Neighbor Matching with 0.20 Caliper, ATC
Coding
AvgX1TreatANNCalATC[i]
<- mean(ANNCalATC$x1[ANNCalATC$ATCgroup==0])
AvgX2TreatANNCalATC[i]
<- mean(ANNCalATC$x2[ANNCalATC$ATCgroup==0])
AvgX3TreatANNCalATC[i]
<- mean(ANNCalATC$x3[ANNCalATC$ATCgroup==0])
AvgX4TreatANNCalATC[i]
<- mean(ANNCalATC$x4[ANNCalATC$ATCgroup==0])
AvgX5TreatANNCalATC[i]
<- mean(ANNCalATC$x5[ANNCalATC$ATCgroup==0])
AvgYA1TreatANNCalATC[i]
<mean(ANNCalATC$YA1[ANNCalATC$ATCgroup==0])
AvgYA2TreatANNCalATC[i]
<mean(ANNCalATC$YA2[ANNCalATC$ATCgroup==0])
AvgYA3TreatANNCalATC[i]
<mean(ANNCalATC$YA3[ANNCalATC$ATCgroup==0])
AvgYA4TreatANNCalATC[i]
<mean(ANNCalATC$YA4[ANNCalATC$ATCgroup==0])
AvgPSTreatANNCalATC[i]
<- mean(ANNCalATC$PS[ANNCalATC$ATCgroup==0])
AvgX1CompANNCalATC[i]
AvgX2CompANNCalATC[i]
AvgX3CompANNCalATC[i]
AvgX4CompANNCalATC[i]
AvgX5CompANNCalATC[i]
AvgYA1CompANNCalATC[i]
AvgYA2CompANNCalATC[i]
AvgYA3CompANNCalATC[i]
AvgYA4CompANNCalATC[i]
AvgPSCompANNCalATC[i]

<<<<<<<<<<-

mean(ANNCalATC$x1[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$x2[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$x3[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$x4[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$x5[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$YA1[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$YA2[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$YA3[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$YA4[ANNCalATC$ATCgroup==1])
mean(ANNCalATC$PS[ANNCalATC$ATCgroup==1])

SDX1TreatANNCalATC[i]

<-

sd(ANNCalATC$x1[ANNCalATC$ATCgroup==0])
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SDX2TreatANNCalATC[i]
SDX3TreatANNCalATC[i]
SDX4TreatANNCalATC[i]
SDX5TreatANNCalATC[i]
SDYA1TreatANNCalATC[i]
SDYA2TreatANNCalATC[i]
SDYA3TreatANNCalATC[i]
SDYA4TreatANNCalATC[i]
SDPSTreatANNCalATC[i]
SDX1CompANNCalATC[i]
SDX2CompANNCalATC[i]
SDX3CompANNCalATC[i]
SDX4CompANNCalATC[i]
SDX5CompANNCalATC[i]
SDYA1CompANNCalATC[i]
SDYA2CompANNCalATC[i]
SDYA3CompANNCalATC[i]
SDYA4CompANNCalATC[i]
SDPSCompANNCalATC[i]

<<<<<<<<<<<<<<<<<<<-

sd(ANNCalATC$x2[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$x3[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$x4[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$x5[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$YA1[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$YA2[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$YA3[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$YA4[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$PS[ANNCalATC$ATCgroup==0])
sd(ANNCalATC$x1[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$x2[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$x3[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$x4[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$x5[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$YA1[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$YA2[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$YA3[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$YA4[ANNCalATC$ATCgroup==1])
sd(ANNCalATC$PS[ANNCalATC$ATCgroup==1])

#Standardized Mean Difference after NN matching with caliper, ATC
coding
SMD_X1_ANNCalATC[i] <- MANNCalATC$sum.matched[c(14)]
SMD_X2_ANNCalATC[i] <- MANNCalATC$sum.matched[c(15)]
SMD_X3_ANNCalATC[i] <- MANNCalATC$sum.matched[c(16)]
SMD_X4_ANNCalATC[i] <- MANNCalATC$sum.matched[c(17)]
SMD_X5_ANNCalATC[i] <- MANNCalATC$sum.matched[c(18)]
SMD_PS_ANNCalATC[i] <- MANNCalATC$sum.matched[c(13)]
#Percent Bias Reduction
PBR_X1_ANNCalATC[i] <PBR_X2_ANNCalATC[i] <PBR_X3_ANNCalATC[i] <PBR_X4_ANNCalATC[i] <PBR_X5_ANNCalATC[i] <PBR_PS_ANNCalATC[i] <-

after NN matching with caliper, ATC coding
MANNCalATC$reduction[c(2)]
MANNCalATC$reduction[c(3)]
MANNCalATC$reduction[c(4)]
MANNCalATC$reduction[c(5)]
MANNCalATC$reduction[c(6)]
MANNCalATC$reduction[c(1)]

#Group Regression Coefficient after NN matching with caliper, ATC
coding
Y1ANNCalATC[i]
<- as.numeric(OutcomeA.1NNCalATC$coef[2])
Y2ANNCalATC[i]
<- as.numeric(OutcomeA.2NNCalATC$coef[2])
Y3ANNCalATC[i]
<- as.numeric(OutcomeA.3NNCalATC$coef[2])
Y4ANNCalATC[i]
<- as.numeric(OutcomeA.4NNCalATC$coef[2])
#Group t-value for each regression coefficient after NN matching with
caliper, ATC coding
tNNCalATCY1A[i]
<-summary(OutcomeA.1NNCalATC)$coef[2, 3]
tNNCalATCY2A[i]
<-summary(OutcomeA.2NNCalATC)$coef[2, 3]
tNNCalATCY3A[i]
<-summary(OutcomeA.3NNCalATC)$coef[2, 3]
tNNCalATCY4A[i]
<-summary(OutcomeA.4NNCalATC)$coef[2, 3]
#Treatment Group N (after NN matching with caliper), ATC coding
NNCalATCtreatNA[i]
<-nobs(ANNCalATC$group[ANNCalATC$group==0])
#Comparison Group N (after NN matching with caliper)
NNCalATCcompNA[i]
<-nobs(ANNCalATC$group[ANNCalATC$group==1])
#Cohen's D for Treatment Effect after NN matching with caliper, ATC
coding
NNCalATCCohenY1A[i]
<-cohenANNCalATCY1
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NNCalATCCohenY2A[i]
NNCalATCCohenY3A[i]
NNCalATCCohenY4A[i]

<-cohenANNCalATCY2
<-cohenANNCalATCY3
<-cohenANNCalATCY4

#Matched & Unmatched PS mean, median, and sd after
Caliper, ATC Coding
PSMeanMatchedTreatANNCalATC[i]
<mean(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==1])
PSMeanMatchedCompANNCalATC[i]
<mean(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==1])
PSMeanUnMatchedTreatANNCalATC[i]
<mean(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==0])
PSMeanUnMatchedCompANNCalATC[i]
<mean(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==0])

NN matching with
&
&
&
&

PSMedMatchedTreatANNCalATC[i]
<median(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==1])
PSMedMatchedCompANNCalATC[i]
<median(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==1])
PSMedUnMatchedTreatANNCalATC[i]
<median(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==0])
PSMedUnMatchedCompANNCalATC[i]
<median(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==0])
PSsdMatchedTreatANNCalATC[i]
<sd(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==1])
PSsdMatchedCompANNCalATC[i]
<sd(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==1])
PSsdUnMatchedTreatANNCalATC[i]
<sd(FullANNCalATC$distance[FullANNCalATC$group==0
FullANNCalATC$weights==0])
PSsdUnMatchedCompANNCalATC[i]
<sd(FullANNCalATC$distance[FullANNCalATC$group==1
FullANNCalATC$weights==0])

&
&
&
&

&
&
&
&

#Variance Ratio for matched groups, after NN Matching with Caliper, ATC
coding
VRANNCalATC[i] <var(ANNCalATC$distance[ANNCalATC$ATCgroup==0])/var(ANNCalATC$distance[A
NNCalATC$ATCgroup==1])
#All variables AFTER Generalized Boosted Modeling, ATT Coding
AvgX1TreatAGBM[i]
<- BalAGBM$es.mean.ATT$`tx.mn`[1]
AvgX2TreatAGBM[i]
<- BalAGBM$es.mean.ATT$`tx.mn`[2]
AvgX3TreatAGBM[i]
<- BalAGBM$es.mean.ATT$`tx.mn`[3]
AvgX4TreatAGBM[i]
<- BalAGBM$es.mean.ATT$`tx.mn`[4]
AvgX5TreatAGBM[i]
<- BalAGBM$es.mean.ATT$`tx.mn`[5]
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AvgX1CompAGBM[i]
AvgX2CompAGBM[i]
AvgX3CompAGBM[i]
AvgX4CompAGBM[i]
AvgX5CompAGBM[i]

<<<<<-

BalAGBM$es.mean.ATT$`ct.mn`[1]
BalAGBM$es.mean.ATT$`ct.mn`[2]
BalAGBM$es.mean.ATT$`ct.mn`[3]
BalAGBM$es.mean.ATT$`ct.mn`[4]
BalAGBM$es.mean.ATT$`ct.mn`[1]

SDX1TreatAGBM[i]
SDX2TreatAGBM[i]
SDX3TreatAGBM[i]
SDX4TreatAGBM[i]
SDX5TreatAGBM[i]

<<<<<-

BalAGBM$es.mean.ATT$`tx.sd`[1]
BalAGBM$es.mean.ATT$`tx.sd`[2]
BalAGBM$es.mean.ATT$`tx.sd`[3]
BalAGBM$es.mean.ATT$`tx.sd`[4]
BalAGBM$es.mean.ATT$`tx.sd`[5]

SDX1CompAGBM[i]
SDX2CompAGBM[i]
SDX3CompAGBM[i]
SDX4CompAGBM[i]
SDX5CompAGBM[i]
#Standardized Mean
SMD_X1_AGBM[i] <SMD_X2_AGBM[i] <SMD_X3_AGBM[i] <SMD_X4_AGBM[i] <SMD_X5_AGBM[i] <-

<<<<<-

BalAGBM$es.mean.ATT$`ct.sd`[1]
BalAGBM$es.mean.ATT$`ct.sd`[2]
BalAGBM$es.mean.ATT$`ct.sd`[3]
BalAGBM$es.mean.ATT$`ct.sd`[4]
BalAGBM$es.mean.ATT$`ct.sd`[5]

Difference after GBM
BalAGBM$es.mean.ATT$`std.eff.sz`[1]
BalAGBM$es.mean.ATT$`std.eff.sz`[2]
BalAGBM$es.mean.ATT$`std.eff.sz`[3]
BalAGBM$es.mean.ATT$`std.eff.sz`[4]
BalAGBM$es.mean.ATT$`std.eff.sz`[5]

#####Percent Bias Reduction after GBM
PBR_X1_AGBM[i] <- PBRX1GBM
PBR_X2_AGBM[i] <- PBRX2GBM
PBR_X3_AGBM[i] <- PBRX3GBM
PBR_X4_AGBM[i] <- PBRX4GBM
PBR_X5_AGBM[i] <- PBRX5GBM
#Group Regression Coefficient after GBM
Y1AGBM[i]
<- as.numeric(OutcomeA.1GBM$coef[2])
Y2AGBM[i]
<- as.numeric(OutcomeA.2GBM$coef[2])
Y3AGBM[i]
<- as.numeric(OutcomeA.3GBM$coef[2])
Y4AGBM[i]
<- as.numeric(OutcomeA.4GBM$coef[2])
#Group t-value for each regression coefficient after GBM
tGBMY1A[i]
<-summary(OutcomeA.1GBM)$coef[2, 3]
tGBMY2A[i]
<-summary(OutcomeA.2GBM)$coef[2, 3]
tGBMY3A[i]
<-summary(OutcomeA.3GBM)$coef[2, 3]
tGBMY4A[i]
<-summary(OutcomeA.4GBM)$coef[2, 3]
#Treatment Group N (after GBM)
GBMtreatNA[i]
<-nobs(finalDataA$group[finalDataA$group==1])
#Comparison Group N (after GBM)
GBMcompNA[i]
<-nobs(finalDataA$group[finalDataA$group==0])
#Cohen's D for Treatment Effect after GBM
GBMCohenY1A[i]
<-cohenAGBMY1
GBMCohenY2A[i]
<-cohenAGBMY2
GBMCohenY3A[i]
<-cohenAGBMY3
GBMCohenY4A[i]
<-cohenAGBMY4
#All variables AFTER Nearest Neighbor Matching with 0.20 Caliper, ATC
Coding
AvgX1TreatAGBMATC[i]
<- BalAGBMATC$es.mean.ATT$`tx.mn`[1]
AvgX2TreatAGBMATC[i]
<- BalAGBMATC$es.mean.ATT$`tx.mn`[2]
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AvgX3TreatAGBMATC[i]
AvgX4TreatAGBMATC[i]
AvgX5TreatAGBMATC[i]

<<<-

BalAGBMATC$es.mean.ATT$`tx.mn`[3]
BalAGBMATC$es.mean.ATT$`tx.mn`[4]
BalAGBMATC$es.mean.ATT$`tx.mn`[5]

AvgX1CompAGBMATC[i]
AvgX2CompAGBMATC[i]
AvgX3CompAGBMATC[i]
AvgX4CompAGBMATC[i]
AvgX5CompAGBMATC[i]

<<<<<-

BalAGBMATC$es.mean.ATT$`ct.mn`[1]
BalAGBMATC$es.mean.ATT$`ct.mn`[2]
BalAGBMATC$es.mean.ATT$`ct.mn`[3]
BalAGBMATC$es.mean.ATT$`ct.mn`[4]
BalAGBMATC$es.mean.ATT$`ct.mn`[1]

SDX1TreatAGBMATC[i]
SDX2TreatAGBMATC[i]
SDX3TreatAGBMATC[i]
SDX4TreatAGBMATC[i]
SDX5TreatAGBMATC[i]

<<<<<-

BalAGBMATC$es.mean.ATT$`tx.sd`[1]
BalAGBMATC$es.mean.ATT$`tx.sd`[2]
BalAGBMATC$es.mean.ATT$`tx.sd`[3]
BalAGBMATC$es.mean.ATT$`tx.sd`[4]
BalAGBMATC$es.mean.ATT$`tx.sd`[5]

SDX1CompAGBMATC[i]
SDX2CompAGBMATC[i]
SDX3CompAGBMATC[i]
SDX4CompAGBMATC[i]
SDX5CompAGBMATC[i]

<<<<<-

BalAGBMATC$es.mean.ATT$`ct.sd`[1]
BalAGBMATC$es.mean.ATT$`ct.sd`[2]
BalAGBMATC$es.mean.ATT$`ct.sd`[3]
BalAGBMATC$es.mean.ATT$`ct.sd`[4]
BalAGBMATC$es.mean.ATT$`ct.sd`[5]

#Standardized Mean Difference after GBM, ATC Coding
SMD_X1_AGBMATC[i] <- BalAGBMATC$es.mean.ATT$`std.eff.sz`[1]
SMD_X2_AGBMATC[i] <- BalAGBMATC$es.mean.ATT$`std.eff.sz`[2]
SMD_X3_AGBMATC[i] <- BalAGBMATC$es.mean.ATT$`std.eff.sz`[3]
SMD_X4_AGBMATC[i] <- BalAGBMATC$es.mean.ATT$`std.eff.sz`[4]
SMD_X5_AGBMATC[i] <- BalAGBMATC$es.mean.ATT$`std.eff.sz`[5]
#####Percent Bias Reduction after GBM, ATC Coding
PBR_X1_AGBMATC[i] <- PBRX1GBMATC
PBR_X2_AGBMATC[i] <- PBRX2GBMATC
PBR_X3_AGBMATC[i] <- PBRX3GBMATC
PBR_X4_AGBMATC[i] <- PBRX4GBMATC
PBR_X5_AGBMATC[i] <- PBRX5GBMATC
#Group Regression Coefficient after GBM, ATC Coding
Y1AGBMATC[i]
<- as.numeric(OutcomeA.1GBMATC$coef[2])
Y2AGBMATC[i]
<- as.numeric(OutcomeA.2GBMATC$coef[2])
Y3AGBMATC[i]
<- as.numeric(OutcomeA.3GBMATC$coef[2])
Y4AGBMATC[i]
<- as.numeric(OutcomeA.4GBMATC$coef[2])
#Group t-value for each regression coefficient after GBM, ATC
tGBMATCY1A[i]
<-summary(OutcomeA.1GBMATC)$coef[2,
tGBMATCY2A[i]
<-summary(OutcomeA.2GBMATC)$coef[2,
tGBMATCY3A[i]
<-summary(OutcomeA.3GBMATC)$coef[2,
tGBMATCY4A[i]
<-summary(OutcomeA.4GBMATC)$coef[2,
#Treatment Group N (after GBM), ATC Coding
GBMATCtreatNA[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==0])
#Comparison Group N (after GBM), ATC Coding
GBMATCcompNA[i]
<nobs(finalDataA$ATCgroup[finalDataA$ATCgroup==1])
#Cohen's D for Treatment Effect after GBM, ATC Coding
GBMATCCohenY1A[i]
<-cohenAGBMATCY1
GBMATCCohenY2A[i]
<-cohenAGBMATCY2
GBMATCCohenY3A[i]
<-cohenAGBMATCY3
GBMATCCohenY4A[i]
<-cohenAGBMATCY4

Coding
3]
3]
3]
3]
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#Other GBM Values
ESS_CompGBM[i]
mean.esGBM[i]
iterGBM[i]
ESS_CompGBMATC[i]
mean.esGBMATC[i]
iterGBMATC[i]

<-ps.AGBM$desc$es.mean.ATT$ess.ctrl
<-ps.AGBM$desc$es.mean.ATT$mean.es
<-ps.AGBM$desc$es.mean.ATT$n.trees
<-ps.AGBMATC$desc$es.mean.ATT$ess.ctrl
<-ps.AGBMATC$desc$es.mean.ATT$mean.es
<-ps.AGBMATC$desc$es.mean.ATT$n.trees}

#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~
Creating Excel File
~~~~~~~~~~~~~~~~~
#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Final.Sim.Data.A.BeforeMatching<-cbind(
#All,variables,BEFORE,matching/weighting
#Averages
AvgX1TreatA,AvgX2TreatA,AvgX3TreatA,AvgX4TreatA,AvgX5TreatA,AvgYA1Treat
A, AvgYA2TreatA,AvgYA3TreatA,
AvgYA4TreatA,AvgX1CompA,AvgX2CompA,AvgX3CompA,AvgX4CompA,AvgX5CompA,Avg
YA1CompA,AvgYA2CompA,AvgYA3CompA,AvgYA4CompA,
#Standard Deviations
SDX1TreatA,SDX2TreatA,SDX3TreatA,SDX4TreatA,SDX5TreatA,SDYA1TreatA,SDYA
2TreatA,SDYA3TreatA,SDYA4TreatA,
SDX1CompA,SDX2CompA,SDX3CompA,SDX4CompA,SDX5CompA,SDYA1CompA,SDYA2CompA
,SDYA3CompA,SDYA4CompA,
#Correlations
Cor_X1.X2_A,Cor_X1.X3_A,Cor_X1.X4_A,Cor_X1.X5_A,Cor_X2.X3_A,Cor_X2.X4_A
,Cor_X2.X5_A,Cor_X3.X4_A,
Cor_X3.X5_A,Cor_X4.X5_A,Cor_X1.PS_A,Cor_X2.PS_A,Cor_X3.PS_A,Cor_X4.PS_A
,Cor_X5.PS_A,Cor_X1.Y1_A,
Cor_X2.Y1_A,Cor_X3.Y1_A,Cor_X4.Y1_A,Cor_X5.Y1_A,Cor_X1.Y2_A,Cor_X2.Y2_A
,Cor_X3.Y2_A,Cor_X4.Y2_A,
Cor_X5.Y2_A,Cor_X1.Y3_A,Cor_X2.Y3_A,Cor_X3.Y3_A,Cor_X4.Y3_A,Cor_X5.Y3_A
,Cor_X1.Y4_A,Cor_X2.Y4_A,
Cor_X3.Y4_A,Cor_X4.Y4_A,Cor_X5.Y4_A,Cor_G.Y1_A,Cor_G.Y2_A,Cor_G.Y3_A,Co
r_G.Y4_A,
#Standardized Mean Differences
SMD_X1_All,SMD_X2_All,SMD_X3_All,SMD_X4_All,SMD_X5_All,SMD_PS_All,SMD_X
1_AllATC,SMD_X2_AllATC,SMD_X3_AllATC,SMD_X4_AllATC,SMD_X5_AllATC,SMD_PS
_AllATC,
#Outcome Variables
#Population Regression Coefficients
PopY1A,PopY2A,PopY3A,PopY4A,PopATCY1A,PopATCY2A,PopATCY3A,PopATCY4A,
#Population t values
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tPopY1A,tPopY2A,tPopY3A,tPopY4A,tPopATCY1A,tPopATCY2A,tPopATCY3A,tPopAT
CY4A,
#Population Cohen's d
PopCohenY1A,PopCohenY2A,PopCohenY3A,PopCohenY4A,PopCohenATCY1A,PopCohen
ATCY2A,PopCohenATCY3A,PopCohenATCY4A,
#Ns
treatPopNA,compPopNA,treatBaseNA,compBaseNA,treatPopNAATC,compPopNAATC,
treatBaseNAATC,compBaseNAATC,
#Baseline Regression Coefficients
BaseY1A,BaseY2A,BaseY3A,BaseY4A,BaseATCY1A,BaseATCY2A,BaseATCY3A,BaseAT
CY4A,
#Baseline t values
tBaseY1A,tBaseY2A,tBaseY3A,tBaseY4A,tBaseATCY1A,tBaseATCY2A,tBaseATCY3A
,tBaseATCY4A,
#Baseline Cohen's d
BaseCohenY1A,BaseCohenY2A,BaseCohenY3A,BaseCohenY4A,BaseCohenATCY1A,Bas
eCohenATCY2A,BaseCohenATCY3A,BaseCohenATCY4A,
#Propensity Score mean, sd by group (before matching)
AvgPSTreatA,AvgPSCompA,SDPSTreatA,SDPSCompA,
#VRs
VRB,VRBATC
)
Final.Sim.Data.A.AfterNNMatching<-cbind(
#All,variables,AFTER,NN matching
#Averages
AvgX1TreatANN,AvgX2TreatANN,AvgX3TreatANN,AvgX4TreatANN,AvgX5TreatANN,A
vgYA1TreatANN,AvgYA2TreatANN,
AvgYA3TreatANN,AvgYA4TreatANN,AvgPSTreatANN,AvgX1CompANN,AvgX2CompANN,A
vgX3CompANN,AvgX4CompANN,
AvgX5CompANN,AvgYA1CompANN,AvgYA2CompANN,AvgYA3CompANN,AvgYA4CompANN,Av
gPSCompANN,AvgX1TreatANNATC,
AvgX2TreatANNATC,AvgX3TreatANNATC,AvgX4TreatANNATC,AvgX5TreatANNATC,Avg
YA1TreatANNATC,AvgYA2TreatANNATC,
AvgYA3TreatANNATC,AvgYA4TreatANNATC,AvgPSTreatANNATC,AvgX1CompANNATC,Av
gX2CompANNATC,AvgX3CompANNATC,
AvgX4CompANNATC,AvgX5CompANNATC,AvgYA1CompANNATC,AvgYA2CompANNATC,AvgYA
3CompANNATC,AvgYA4CompANNATC,AvgPSCompANNATC,
#Standard Deviations
SDX1TreatANN,SDX2TreatANN,SDX3TreatANN,SDX4TreatANN,SDX5TreatANN,SDYA1T
reatANN,SDYA2TreatANN,
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SDYA3TreatANN,SDYA4TreatANN,SDPSTreatANN,SDX1CompANN,SDX2CompANN,SDX3Co
mpANN,SDX4CompANN,
SDX5CompANN,SDYA1CompANN,SDYA2CompANN,SDYA3CompANN,SDYA4CompANN,SDPSCom
pANN,SDX1TreatANNATC,
SDX2TreatANNATC,SDX3TreatANNATC,SDX4TreatANNATC,SDX5TreatANNATC,SDYA1Tr
eatANNATC,SDYA2TreatANNATC,
SDYA3TreatANNATC,SDYA4TreatANNATC,SDPSTreatANNATC,SDX1CompANNATC,SDX2Co
mpANNATC,SDX3CompANNATC,
SDX4CompANNATC,SDX5CompANNATC,SDYA1CompANNATC,SDYA2CompANNATC,SDYA3Comp
ANNATC,SDYA4CompANNATC,SDPSCompANNATC,
#Standardized Mean Differences
SMD_X1_ANN,SMD_X2_ANN,SMD_X3_ANN,SMD_X4_ANN,SMD_X5_ANN,SMD_PS_ANN,SMD_X
1_ANNATC,SMD_X2_ANNATC,SMD_X3_ANNATC,SMD_X4_ANNATC,SMD_X5_ANNATC,SMD_PS
_ANNATC,
#PBRs
PBR_X1_ANN,PBR_X2_ANN,PBR_X3_ANN,PBR_X4_ANN,PBR_X5_ANN,PBR_PS_ANN,PBR_X
1_ANNATC,PBR_X2_ANNATC,PBR_X3_ANNATC,PBR_X4_ANNATC,PBR_X5_ANNATC,PBR_PS
_ANNATC,
#Outcome Variables
#Regression Coefficients
Y1ANN,Y2ANN,Y3ANN,Y4ANN,Y1ANNATC,Y2ANNATC,Y3ANNATC,Y4ANNATC,
#t values
tNNY1A,tNNY2A,tNNY3A,tNNY4A,tNNATCY1A,tNNATCY2A,tNNATCY3A,tNNATCY4A,
#Cohen's d
NNCohenY1A,NNCohenY2A,NNCohenY3A,NNCohenY4A,NNATCCohenY1A,NNATCCohenY2A
,NNATCCohenY3A,NNATCCohenY4A,
#Ns
NNtreatNA,NNcompNA,NNATCtreatNA,NNATCcompNA,
#Propensity Score mean, median, sd by group/matching
PSMeanMatchedTreatANN,PSMeanMatchedCompANN,PSMeanUnMatchedTreatANN,PSMe
anUnMatchedCompANN,
PSMeanMatchedTreatANNATC,PSMeanMatchedCompANNATC,PSMeanUnMatchedTreatAN
NATC,PSMeanUnMatchedCompANNATC,
PSMedMatchedTreatANN,PSMedMatchedCompANN,PSMedUnMatchedTreatANN,PSMedUn
MatchedCompANN,
PSMedMatchedTreatANNATC,PSMedMatchedCompANNATC,PSMedUnMatchedTreatANNAT
C,PSMedUnMatchedCompANNATC,PSsdMatchedTreatANN,PSsdMatchedCompANN,PSsdU
nMatchedTreatANN,PSsdUnMatchedCompANN,
PSsdMatchedTreatANNATC,PSsdMatchedCompANNATC,PSsdUnMatchedTreatANNATC,P
SsdUnMatchedCompANNATC,
#VRs
VRANN,VRANNATC
)
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Final.Sim.Data.A.AfterNNCaliperMatching<-cbind(
#All,variables,AFTER,NN matching with caliper
#Averages
AvgX1TreatANNCal,AvgX2TreatANNCal,AvgX3TreatANNCal,AvgX4TreatANNCal,Avg
X5TreatANNCal,AvgYA1TreatANNCal,
AvgYA2TreatANNCal,AvgYA3TreatANNCal,AvgYA4TreatANNCal,AvgPSTreatANNCal,
AvgX1CompANNCal,AvgX2CompANNCal,
AvgX3CompANNCal,AvgX4CompANNCal,AvgX5CompANNCal,AvgYA1CompANNCal,AvgYA2
CompANNCal,AvgYA3CompANNCal,
AvgYA4CompANNCal,AvgPSCompANNCal,AvgX1TreatANNCalATC,AvgX2TreatANNCalAT
C,AvgX3TreatANNCalATC,
AvgX4TreatANNCalATC,AvgX5TreatANNCalATC,AvgYA1TreatANNCalATC,AvgYA2Trea
tANNCalATC,AvgYA3TreatANNCalATC,
AvgYA4TreatANNCalATC,AvgPSTreatANNCalATC,AvgX1CompANNCalATC,AvgX2CompAN
NCalATC,AvgX3CompANNCalATC,
AvgX4CompANNCalATC,AvgX5CompANNCalATC,AvgYA1CompANNCalATC,AvgYA2CompANN
CalATC,AvgYA3CompANNCalATC,AvgYA4CompANNCalATC,AvgPSCompANNCalATC,
#Standard Deviations
SDX1TreatANNCal,SDX2TreatANNCal,SDX3TreatANNCal,SDX4TreatANNCal,SDX5Tre
atANNCal,SDYA1TreatANNCal,
SDYA2TreatANNCal,SDYA3TreatANNCal,SDYA4TreatANNCal,SDPSTreatANNCal,SDX1
CompANNCal,SDX2CompANNCal,
SDX3CompANNCal,SDX4CompANNCal,SDX5CompANNCal,SDYA1CompANNCal,SDYA2CompA
NNCal,SDYA3CompANNCal,
SDYA4CompANNCal,SDPSCompANNCal,SDX1TreatANNCalATC,SDX2TreatANNCalATC,SD
X3TreatANNCalATC,
SDX4TreatANNCalATC,SDX5TreatANNCalATC,SDYA1TreatANNCalATC,SDYA2TreatANN
CalATC,SDYA3TreatANNCalATC,
SDYA4TreatANNCalATC,SDPSTreatANNCalATC,SDX1CompANNCalATC,SDX2CompANNCal
ATC,SDX3CompANNCalATC,
SDX4CompANNCalATC,SDX5CompANNCalATC,SDYA1CompANNCalATC,SDYA2CompANNCalA
TC,SDYA3CompANNCalATC,SDYA4CompANNCalATC,SDPSCompANNCalATC,
#Standardized Mean Differences
SMD_X1_ANNCal,SMD_X2_ANNCal,SMD_X3_ANNCal,SMD_X4_ANNCal,SMD_X5_ANNCal,S
MD_PS_ANNCal,SMD_X1_ANNCalATC,
SMD_X2_ANNCalATC,SMD_X3_ANNCalATC,SMD_X4_ANNCalATC,SMD_X5_ANNCalATC,SMD
_PS_ANNCalATC,
#PBRs
PBR_X1_ANNCal,PBR_X2_ANNCal,PBR_X3_ANNCal,PBR_X4_ANNCal,PBR_X5_ANNCal,P
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BR_PS_ANNCal,PBR_X1_ANNCalATC,PBR_X2_ANNCalATC,PBR_X3_ANNCalATC,PBR_X4_
ANNCalATC,PBR_X5_ANNCalATC,PBR_PS_ANNCalATC,
#Outcome Variables
#Regression Coefficients
Y1ANNCal,Y2ANNCal,Y3ANNCal,Y4ANNCal,Y1ANNCalATC,Y2ANNCalATC,Y3ANNCalATC
,Y4ANNCalATC,
#t values
tNNCalY1A,tNNCalY2A,tNNCalY3A,tNNCalY4A,tNNCalATCY1A,tNNCalATCY2A,tNNCa
lATCY3A,tNNCalATCY4A,
#Cohen's d
NNCalCohenY1A,NNCalCohenY2A,NNCalCohenY3A,NNCalCohenY4A,NNCalATCCohenY1
A,NNCalATCCohenY2A,NNCalATCCohenY3A,NNCalATCCohenY4A,
#Ns
NNCaltreatNA,NNCalcompNA,NNCalATCtreatNA,NNCalATCcompNA,
#Propensity Score mean, median, sd by group/matching
PSMeanMatchedTreatANNCal,PSMeanMatchedCompANNCal,PSMeanUnMatchedTreatAN
NCal,PSMeanUnMatchedCompANNCal,
PSMeanMatchedTreatANNCalATC,PSMeanMatchedCompANNCalATC,PSMeanUnMatchedT
reatANNCalATC,PSMeanUnMatchedCompANNCalATC,
PSMedMatchedTreatANNCal,PSMedMatchedCompANNCal,PSMedUnMatchedTreatANNCa
l,PSMedUnMatchedCompANNCal,
PSMedMatchedTreatANNCalATC,PSMedMatchedCompANNCalATC,PSMedUnMatchedTrea
tANNCalATC,PSMedUnMatchedCompANNCalATC,
PSsdMatchedTreatANNCal,PSsdMatchedCompANNCal,PSsdUnMatchedTreatANNCal,P
SsdUnMatchedCompANNCal,
PSsdMatchedTreatANNCalATC,PSsdMatchedCompANNCalATC,PSsdUnMatchedTreatAN
NCalATC,PSsdUnMatchedCompANNCalATC,
#VRs
VRANNCal,VRANNCalATC
)
Final.Sim.Data.A.AfterGBM<-cbind(
#All,variables,AFTER,GBM
#Averages
AvgX1TreatAGBM,AvgX2TreatAGBM,AvgX3TreatAGBM,AvgX4TreatAGBM,AvgX5TreatA
GBM,AvgX1CompAGBM,AvgX2CompAGBM,
AvgX3CompAGBM,AvgX4CompAGBM,AvgX5CompAGBM,AvgX1TreatAGBMATC,AvgX2TreatA
GBMATC,AvgX3TreatAGBMATC,
AvgX4TreatAGBMATC,AvgX5TreatAGBMATC,AvgX1CompAGBMATC,AvgX2CompAGBMATC,A
vgX3CompAGBMATC,AvgX4CompAGBMATC,AvgX5CompAGBMATC,
#Standard Deviations
SDX1TreatAGBM,SDX2TreatAGBM,SDX3TreatAGBM,SDX4TreatAGBM,SDX5TreatAGBM,S
DX1CompAGBM,SDX2CompAGBM,

190

SDX3CompAGBM,SDX4CompAGBM,SDX5CompAGBM,SDX1TreatAGBMATC,SDX2TreatAGBMAT
C,SDX3TreatAGBMATC,SDX4TreatAGBMATC,
SDX5TreatAGBMATC,SDX1CompAGBMATC,SDX2CompAGBMATC,SDX3CompAGBMATC,SDX4Co
mpAGBMATC,SDX5CompAGBMATC,
#Standardized Mean Differences
SMD_X1_AGBM,SMD_X2_AGBM,SMD_X3_AGBM,SMD_X4_AGBM,SMD_X5_AGBM,SMD_X1_AGBM
ATC,SMD_X2_AGBMATC,SMD_X3_AGBMATC,SMD_X4_AGBMATC,SMD_X5_AGBMATC,
#PBRs
PBR_X1_AGBM,PBR_X2_AGBM,PBR_X3_AGBM,PBR_X4_AGBM,PBR_X5_AGBM,PBR_X1_AGBM
ATC,PBR_X2_AGBMATC,PBR_X3_AGBMATC,PBR_X4_AGBMATC,PBR_X5_AGBMATC,
#Outcome Variables
#Regression Coefficients
Y1AGBM,Y2AGBM,Y3AGBM,Y4AGBM,Y1AGBMATC,Y2AGBMATC,Y3AGBMATC,Y4AGBMATC,
#t values
tGBMY1A,tGBMY2A,tGBMY3A,tGBMY4A,tGBMATCY1A,tGBMATCY2A,tGBMATCY3A,tGBMAT
CY4A,
#Cohen's d
GBMCohenY1A,GBMCohenY2A,GBMCohenY3A,GBMCohenY4A,GBMATCCohenY1A,GBMATCCo
henY2A,GBMATCCohenY3A,GBMATCCohenY4A,
#Ns
GBMtreatNA,GBMcompNA,GBMATCtreatNA,GBMATCcompNA,
#Additional
ESS_CompGBM,mean.esGBM,iterGBM,ESS_CompGBMATC,mean.esGBMATC,iterGBMATC
)
BeforeMatchingWeighting<-as.data.frame(Final.Sim.Data.A.BeforeMatching)
AfterNNMatching<-as.data.frame(Final.Sim.Data.A.AfterNNMatching)
AfterNNMatchingCaliper<as.data.frame(Final.Sim.Data.A.AfterNNCaliperMatching)
AfterGBM<-as.data.frame(Final.Sim.Data.A.AfterGBM)
library(writexl)
write_xlsx(list(BeforeMatchingWeighting = BeforeMatchingWeighting,
AfterNNMatching = AfterNNMatching, AfterNNMatchingCaliper =
AfterNNMatchingCaliper, AfterGBM = AfterGBM), path="ScenarioA.xlsx")
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